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Abstract IV 
Abstract 
The three endothelin isoforms (Endothelin 1, 2, 3), signal through two G-protein coupled 
receptors: Endothelin receptor type a (Eta) and Endothelin receptor type a (Etb). In the 
eye, the role of Endothelin signalling is discussed controversially.  
 
Thus, the main aim of the current thesis was to investigate the role of endothelin 
signalling in the eye and in particular whether Etb mediates neuroprotective effects for 
photoreceptor survival following experimentally induced photoreceptor degeneration. 
Moreover, the underlying molecular mechanisms mediating the potential neuroprotection 
were examined in detail.  
First, the localization of Etb in the eye was analysed and its cell-type specific localization 
was identified using immunohistochemical co-staining. Furthermore, its quantitative 
expression in the retina was determined.  
Next, we examined an activation of the entire Endothelin signalling in the retinae of 
wildtype mice in response to different ocular traumata (puncture of the eye, PBS-
injections, light-induced damage). 
Then, conditional knockout mice with a deletion of Etb in the entire eye (EtbΔeye) and a 
second mouse line with a cell type specific deletion of Etb in retinal neurons and Müller 
cells (EtbΔOC) were generated using the Cre-loxP-System. Additionally, photoreceptor 
cell lines (661WΔEtb) with a stable deletion of Etb were created via CRISPR/Cas9.  
The in vivo ablation of Etb in Müller cells and retinal neurons showed no obvious 
alterations of retinal morphology and vasculature. However, EtbΔOC mice showed a 
higher vulnerability of photoreceptors after light-induced photoreceptor degeneration 
concomitant with a significantly thinner outer nuclear layer (ONL). In accordance, our in 
vitro data obtained a significantly higher apoptosis rate in Etb-deficient photoreceptor 
cells after serum-deprivation compared to controls. Quite intriguingly, the expression 
levels of neuroprotective molecules leukaemia inhibitory factor (Lif), and fibroblast 
growth factor 2 (Fgf2) were significantly elevated in light-exposed EtbΔOC mice compared 
to light-exposed control littermates. Still we detected a significantly upregulated mRNA 
expression of Caspase 8 indicating that the increased apoptosis of photoreceptors was 
mediated via extrinsic death-receptor mediated apoptosis in EtbΔOC mice. Furthermore, 
we identified an impaired activation (phosphorylation) of the neuroprotective Protein 
Kinase B (Akt) signalling pathway.  
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Taken together, our data identified Etb mediated signalling as the essential and even 
more potent neuroprotective event for photoreceptor survival compared to the 
neuroprotective factors fibroblast growth factor 2 (Fgf2) and leukaemia inhibitory factor 
(Lif). Downstream of Etb its neuroprotective signalling is mediated through activation of 
Akt signalling. 
 
In summary, our data identified Etb mediated signalling for the first time as the essential 
pathway for photoreceptor survival. Thus, targeting Endothelin signalling might be a 
promising approach for the development of new therapeutic strategies in the context of 
retinal degenerations. 
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Zusammenfassung 
Das vasoaktive Peptid Endothelin wird als drei Isoformen (Endothelin 1, 2, 3) exprimiert, 
die an zwei G-Protein gekoppelte Rezeptoren Endothelin Rezeptor Typ a (Eta) und 
Endothelin Rezeptor Typ b (Etb) binden können. Die Rolle von des Endothelin-
Signalwegs im Auge ist noch weitgehendst unbekannt und wird kontrovers diskutiert.  
Deshalb war es das Hauptziel dieser Arbeit die Rolle des Endothelin-Signalwegs im 
Auge zu untersuchen und besonders einem potenziellen neuroprotektiven Effekt von Etb 
für das Überleben von Photorezeptoren nach Licht-induzierter Schädigung 
nachzugehen. Außerdem sollten die zugrundeliegenden molekularen Mechanismen 
aufgeschlüsselt werden. 
Zunächst wurde die Lokalisation des Etb im Auge untersucht und durch 
immunhistochemische Doppelfärbungen dessen zelltypspezifische Lokalisation 
bestimmt. Außerdem wurde die retinale Expressionstärke von Etb im Vergleich zu Eta 
ermittelt. Des Weiteren sollte die Expression des gesamten Endothelin-Signalwegs in 
wildtypischen Retinae im Falle von okulärem Trauma, hervorgerufen durch alleinige 
Perforation des Auges, PBS-Injektion oder Lichtschaden, untersucht werden. In allen 
drei Schadensmodellen kam es zu einer Aktivierung des gesamten Endothelin-
Signalwegs.  
Anschließend generierten wir mittels Cre-loxP-System eine Mauslinie mit einer Deletion 
von Etb im gesamten Auge (EtbΔeye) und eine weitere Mauslinie mit einer Etb Deletion in 
Müllerzellen und retinalen Neuronen (EtbΔOC). Darüber hinaus etablierten wir 
Photorezeptorzelllinien mit einer stabilen Deletion von Etb mittels des CRISPR/Cas9-
System.  
Die Deletion von Etb in retinalen Neuronen und Müllerzellen führte zu keinen 
offensichtlichen Veränderungen der retinalen Morphologie und Gefäßstruktur. Allerdings 
war die Vulnerabilität der Photorezeptoren bei EtbΔOC Mäusen nach Licht-induzierten 
Photorezeptor Degeneration signifikant höher, einhergehend mit einer signifikant dünner 
äußeren Körnerschicht 14 Tage nach Lichtschaden. Auch die Etb-defizienten 
Photorezeptor-Zelllinien wiesen eine signifikant höhere Apoptoserate nach Zellstress, 
verursacht durch Serum-Entzug, auf. Weiterführende molekulare Analysen zeigten, eine 
signifikante Erhöhung der neuroprotektiven Faktoren leucaemia inhibitory factor (lif) und 
fibroblast growth factor (fgf2) bei lichtgeschädigten EtbΔOC Mäusen im Vergleich zu 
lichtgeschädigten Kontrolltieren. Überraschenderweise detektierten wir dennoch eine 
signifikante Erhöhung von Caspase 8 bei lichtgeschädigten EtbΔOC Mäusen im Vergleich 
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zu lichtgeschädigten Kontrolltieren, was den Rückschluss nahelegt, dass die 
beobachtete verstärkte Degeneration der Photorezeptoren durch den extrinsischen, d.h. 
durch Todesrezeptoren vermittelten Signalweg ablief. Weiterführende Analysen 
identifizierten eine verminderte Aktivierung (Phosphorylierung) des neuroprotektiven 
Protein Kinase B (Akt) Signalwegs als den Signalweg worüber Etb sein neuroprotektives 
Signal vermittelt. 
Zusammenfassend zeigen die erhobenen Daten erstmals, dass das durch den Etb 
vermittelte Signal essenziell und weitaus potenter für das Überleben von 
Photorezeptoren ist als die Wirkung der neuroprotektiven Faktoren fibroblast growth 
factor 2 (Fgf2) und leukaemia inhibitory factor. Downstream von Etb wird die 
Neuroprotektion über den Akt-Signalweg vermittelt. 
Zukünftig kann dieser durch Etb vermittelte Signalweg einen vielversprechenden Ansatz 
für die Entwicklung von neuen Therapieansätzen zur Behandlung retinaler 
Degenerationen wie Retinopathia pigmentosa oder altersbedingte Makuladegeneration 
darstellen. 
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1 Introduction 
1.1 The retina 
The retina, a light-sensitive layer, which lines the inner surface of the posterior part of 
the eye and can be described as visible part of the central nervous system (CNS) 
(Kaufman et al., 2003). The retina is organized in several different layers that can be 
clearly defined histologically (Figure 1).  
 
 
Figure 1 Schematic structure of the 
mammalian retina. Detailed schema 
is shown with the layers beginning 
from the outermost side (PE= 
pigment epithelium) to the innermost 
side (NFL= nerve fiber layer). 
Different cell types are situated in the 
retina. Ch=Choroid, PE=pigment 
epithelium, OS=outer segments of 
photoreceptors, ONL=outer nuclear 
layer, OPL=outer plexiform layer, 
INL=inner plexiform layer, IPL=inner 
plexiform layer, GCL=ganglion cell 
layer,  ON=optic nerve, NFL=nerve 
fibre layer, R=rod, C=cone, 
H=horizontal cell, G=ganglion cell 
M=Müller cell, B=bipolar cell, 
A=amacrine cell, As=astrocyte, 
Mi=microglia, BV=blood vessel 
(Vecino et al., 2016) 
 
The single layered retinal pigment epithelium (RPE or PE) is part of the blood retina 
barrier and provides nutrition and waste removal to photoreceptors, the light sensitive 
cells of the retina (Strauss, 2005). The outer limiting membrane is rather a narrow zone 
comprising a series of heterotypic adherens junctions between Müller cells themselves 
and between Müller cells and photoreceptors (Williams et al., 1990). The photoreceptors’ 
cell bodies and processes constitute the outer nuclear layer (ONL), whereas their 
synapses form together with the synapses of bipolar and horizontal cells the outer 
plexiform layer (OPL). The cell bodies of horizontal, bipolar and amacrine cells and the 
nuclei of the Müller cells are located in the inner nuclear layer (INL), followed by the 
synapses between bipolar, amacrine and ganglion cells resulting in the inner plexiform 
layer (IPL) (Purves and Williams, 2001). The perikarya of the ganglion cells are located 
together with “displaced” amacrine cells in the ganglion cell layer (GCL), their axons build 
the nerve fiber layer (NFL) converging to form the optic nerve. At last, the Müller cell 
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endfeet form the inner limiting membrane, that separates the retina from the vitreous 
body (Purves and Williams, 2001; Kaufman et al., 2003)  
 
1.1.1 Retinal neurons 
The neural retina comprises an interacting network of five different specialized sensory 
neurons (Sachsenweger and Klauss, 2014): Ganglion cells, amacrine cells, bipolar cells, 
horizontal cells and photoreceptors. Photoreceptors are light-sensitive cells and capable 
of visual phototransduction (Kefalov, 2012), the initial step of vertebral vision. The visual 
phototransduction is the conversion of incident light energy into neural signals that can 
be transmitted to the brain by the optic nerve (Mannu, 2014).  
 
 
 
There are two different types of classic photoreceptors: the highly light-sensitive rods 
(100-125 million) for scotopic (night) vision, located mainly in the peripheral retina and 
the less sensitive cones (6-7 million) for achromatic (colour) vision located mainly at the 
fovea centralis in humans (Figure 2). Cones are divided in three types, each with different 
visual pigments, namely: S-cones, M-cones and L-cones. Each cone is therefore 
sensitive to visible wavelengths of light that correspond to short-wavelength (S-cones), 
medium-wavelength (M-cones) and long-wavelength (L-cones) (Mustafi et al., 2009). 
Figure 2 Left. Semithin section of a human retina illustrating rod and cones, differentiated in short 
wavelength cones (S-cone, blue) and long wavelength cones (red arrows) (Kolb et al., 1995). Right. 
Electronic microscopy of rod and cones of a monkey retina showing the inner and outer segments of rod 
and cones and a high magnification of the membrane discs (Anderson and Fisher, 1976). I.S.=inner 
segment, O.S.=outer segment 
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Both photoreceptors show the same basic structure: An outer segment (O.S.) for light-
absorption by containing photopigment-filled disks (rods) or membrane enfoldings 
(cones), an inner segment (I.S.) full of ATP-providing mitochondria and endoplasmatic 
reticulum, the cell body (located in the outer nuclear layer) with the nucleus and other 
cell’s organelles and the synaptic terminal which is located in the outer plexiform layer 
(OPL). It releases neurotransmitter (e.g glutamate) to amacrine cells, interneurons which 
are responsible for lateral interaction in the retina, or to horizontal cells and bipolar cells 
which transmit the signal onwards to the ganglion cells, the neurons that transfer all 
visual information processed in the retina to the brain (Masland, 2012).  
 
1.1.2 Retinal glia cells: Müller cells, astrocytes and microglia cells 
The retinal glia cells consist of Müller cells, astrocytes and microglia cells (Vecino et al., 
2016).  
Müller cells radially span the retina with their processes from the outer to the inner limiting 
membrane and with their cells bodies residing in the inner nuclear layer (INL). They also 
infold all retinal neurons which enables a multifunctional interaction between Müller cells 
and neurons such as a homeostatic and metabolic support of retinal neurons (Bringmann 
et al., 2006; Reichenbach and Bringmann, 2013). A further important function of Müller 
cells is the release of neuroprotective (e.g. Fibroblast Growth Factor 2 (Fgf2), angiogenic 
factors (e.g. vascular endothelial growth factor (Vegf) and the recycling of 
neurotransmitters (Pierce et al., 1995; Bringmann et al., 2006). In case of retinal injury 
or disease, Müller cells become reactive and undergo a cytoskeleton remodelling called 
reactive gliosis which is characterized by a rounded shape and enlarged endfeet (García 
and Vecino, 2003) as well as an upregulation of the intermediate filament protein glial 
fibrillary acidic protein (Gfap) (Lupien et al., 2004).  
In the healthy retina, Gfap is regularly expressed by astrocytes, a second type of glial 
cells in the central nervous system (Hol and Pekny, 2015). In the retina, their processes 
are almost confined to the nerve fiber layer (NFL) and ganglion cell layer (RGC) (Büssow, 
1980; Hol and Pekny, 2015). As a main producer of the angiogenic factor Vegf (West et 
al., 2005), astrocytes are of significance in retinal vascularization (O'Sullivan et al., 
2017).They migrate ahead of the vessels to promote the formation of superficial or deep 
vasculature  (Stone et al., 1995; van der Wijk et al., 2018). Together with endothelial 
cells lining retinal microvessels and pericytes, they also support the integrity of the inner 
blood retinal barrier (BRB), which is constituted through the tight junctions of the 
endothelial cells (Klaassen et al., 2013). 
The third glial subpopulation, the microglia cells, are the phagocytic immune cells of the 
CNS including the retina. Under physiological conditions, microglia cells remain in the 
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plexiform layers in a resting state and surveil their neuronal microenvironment to cleanse 
metabolic products and tissue debris  (Langmann, 2007). In case of retinal injury, 
microglia react rapidly by transitioning to an activated status and undergoing gliosis. 
Therefore, they switch their appearance through dynamic remodeling of their 
cytoskeleton and they withdraw their filopodic processes to acquire an oval, amoeboid 
shape. (Wang and Wong, 2014).  
 
1.1.3 Retinal vasculature 
The eye obtains nutrients and oxygen from two different vascular systems: the retinal 
vessels within the inner parts of the retina and the uveal vessels within the iris, ciliary 
body and choroid (Luo et al., 2015). The choroid mostly persists of a fenestrated capillary 
network (choriocapillaris) and supplies the outer retinal layers and photoreceptors 
(Nickla and Wallman, 2009).   
The inner ocular blood supply is predominantly provided by the ophthalmic artery, which 
is the first branch of the internal carotid artery. The branches of the ophthalmic artery 
extend form three intra-retinal vascular beds (plexus). In the murine retina, the plexus 
formation starts with the superficial plexus arising from the optic nerve head by a radial 
outgrowth to the periphery and lies on the RGC (Stahl et al., 2010). The superficial 
capillaries continue sprout vertically to first form the deep plexus in the outer plexiform 
layer and then the intermediate plexus located in the inner plexiform layer (Anand-Apte 
and Hollyfield, 2010; Stahl et al., 2010). Also in the human eye, the plexus formation also 
starts with the generation of the superficial plexus, but is then – in contrast to the murine 
retina- followed by the intermediate plexus and at least deep plexus (Figure 3). 
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Figure 3 Schematic illustration of the ocular vasculature. A. Drawing showing a sagittal section of an entire 
eye B. Detailed illustration of a sagittal section of the retina including retinal and choroidal vasculature. 
Three capillary plexus of the retina are embedded among retinal neurons: the superficial plexus along the 
ganglion cell (GCL) and nerve fibre layer (NFL), the intermediate and deep plexus along each side of the 
inner nuclear layer (INL). The choroidal vessels are located beneath the RPE and Bruch's membrane and 
supply oxygen and nutrients to the outer portion of the retina. GCL=ganglion cell layer; INL=inner nuclear 
layer; IS/OS=inner segment/outer segment of photoreceptor; NFL=nerve fibre layer; ONL=outer nuclear 
layer; RPE=retinal pigment epithelium (Liu et al., 2017). 
 
In human embryos, the development of vessels is dependent on oxygen-supply and 
bases on two different mechanisms: vasculogenesis and angiogenesis (Patan, 2004). 
Whereas vasculogenesis describes the de novo formation of primary vessels out of 
common progenitor cells (Anand-Apte and Hollyfield, 2010; Lutty and McLeod, 2018), 
angiogenesis characterises the maturation or rather sprouting of vessels from already 
existing vessels (Risau, 1997; Hughes et al., 2000). The retinal vessels differentiation 
out of the avascular, immature retina starts at 14-16 weeks of gestation and is nearly 
complete vascularized by term birth (Penn, 2008). In mice, the developmental process 
of the retinal vasculature is angiogenesis only and vessel growth begins at the optic 
nerve and sprouts peripherally. In contrast to humans, mice still possess immature 
vasculature with hyaloid vessels postnatal and (Gyllensten Lars J. and Hellstöm, 1954) 
the three vascular plexus will develop during the first three weeks postnatal (Stahl et al., 
2010)). 
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1.2 Retinal degeneration in the context of photoreceptor cell death 
The vision loss in hereditary retina degenerations is generated by a progressive 
dysfunction and apoptosis of photoreceptors (Wright et al., 2010). As in the healthy retina 
only a small number of photoreceptors undergo apoptosis, our workgroup uses the light-
induced damage model to mimic photoreceptor degeneration that occur in retinal 
degenerations like Retinopathia Pigmentosa.  
1.2.1 Retinopathia pigmentosa 
Retinopathia pigmentosa (RP) is a clinically and genetically heterogeneous group of 
hereditary disorders, which are characterized by a progressive loss of photoreceptors 
and pigment epithelial function (Pagon, 1988). Its genetic heterogeneity is reflected in 
the different inheritance patterns (autosomal-dominant, autosomal-recessive or X-
linked) and mapping of mutations in over 45 causative gene loci in the typical RP, with 
the majority of them expressed in either the photoreceptors or the retinal pigment 
epithelium  (Dryja and Li, 1995; Hamel, 2006). With a prevalence of 1:4000 worldwide 
(Hamel, 2006), RP represents one of the most common causes of blindness or severe 
low-vision at the age from 20 to 60 years (Parmeggiani, 2011).  
 
 
 
The typical RP is described as rod-cone dystrophy, which implies a primary degeneration 
of rod photoreceptors and a following degeneration of cones in later stages (Ferrari et 
al., 2011; Hamel, 2006). This order of photoreceptor degeneration correlates with the 
typically slow progress (over three to five decades) after its usual first manifestation from 
age 20 to 30 years (Dryja and Li, 1995), with initial symptoms of night blindness the loss 
of the mid-peripheral visual field, due to the fact that rod photoreceptors are almost 
entirely responsible for night vision and mainly located in the retinal periphery (Shintani 
et al., 2009). Further visual loss progresses to the central visual field resulting in tunnel 
vision and eventual blindness, which can also be accompanied by further clinical 
Figure 4 Fundus of patient with normal fundus (left) and patients with retinitis pigmentosa at mid stage (left) 
and end stage (right) show bone spicule-shaped pigment deposits and vascular atrophy (Hamel, 2006). 
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hallmarks like photopsia and diminished or absent electroretinogram (Ferrari et al., 2011) 
and an abnormal fundus with bone-spicule deposits (Figure 4), formed by migration of 
pigment-containing cells to perivascular sites in the inner retina (Li et al., 1995).  
At current status, there is no cure of RP available. The only treatment options aim to slow 
down the progression of disease. Besides a vitamin and nutritional supplementation 
therapy such as vitamin A and omega-3 fatty acid, several emerging technologies like 
retinal cell transplantation, retinal prosthesis devices and gene therapy may provide 
additional promising therapeutic options (Hamel, 2006). 
 
1.1.1 Light-induced damage paradigm as mouse model for photoreceptor 
degeneration  
In rodents, the exposure of eyes to bright, white light leads to the death of 
photoreceptors, which is typically confined to rod photoreceptors (Organisciak and 
Vaughan, 2010). This susceptibility to light was used for establishing an experimental 
animal model for the induction of photoreceptor degeneration, the light-induced damage 
paradigm (Grimm and Remé, 2013; Wenzel et al., 2005). Hereby, the exposure to 
excessive light leads to photoreceptor cell death via apoptosis, which is followed by 
morphological and functional retinal alterations, quite similar to photoreceptor cell death 
in retinal hereditary dystrophies and age-related macular degenerations (Marc et al., 
2003). With the help of the light-induced damage model, a large number of 
photoreceptors undergo apoptosis at the same time, which simplifies the analysis of 
molecular mechanisms in photoreceptor apoptosis and neuroprotective signalling 
pathways in the retina. According to the length of light exposure, the light damage can 
be induced in an acute or chronic way. There are also different types of light qualities 
used such as energy-rich blue light or cool, white light with a similar emission spectrum 
like daylight (Grimm and Remé, 2013; Wenzel et al., 2005). In the current thesis, we 
used the acute protocol with cool white light to induce photoreceptor degeneration and 
to examine whether Endothelin receptor b has neuroprotective effects on photoreceptor 
cells and which underlying mechanisms might mediate this effect. 
 
1.1.2 Neuroprotection in the retina following light-induced damage paradigm 
Light-induced photoreceptor degeneration leads to the activation of Müller cells, which 
suggests the existence of a signalling system that informs Müller cells about the health 
status of photoreceptors and monitors the release of neuron-derived signalling 
molecules (Rattner and Nathans, 2005). Microarray analysis showed that transcripts 
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coding for Endothelin 2 (Et-2) were highly upregulated following light induced damage 
(Rattner and Nathans, 2005). Its localization in the ONL was determined by using in situ 
hybridization, which indicates that photoreceptors react to excessive light exposure by 
the release of Et-2 (Rattner and Nathans, 2005). A simultaneous upregulation of 
Endothelin receptor b (Etb) in Müller cells indicated that the release of Et-2 leads to an 
activation of Müller cells via binding to Etb as response to light-induced damage (Rattner 
and Nathans, 2005).   
Moreover, Müller cells react directly to photoreceptor cell stress by an upregulation of 
the neuroprotective factor leukemia inhibitory factor (Lif) (Joly et al., 2008; Gao and 
Hollyfield, 1996; Joly et al., 2007), which is essential for Müller cell activation and 
photoreceptors’ survival (Joly et al., 2008; Gao and Hollyfield, 1996; Joly et al., 2007) 
Furthermore, Lif was also shown to interact with Et-2, as the expression of Et-2 reduced 
to 2% of wild-type levels in Lif deficient mouse retinae, as well with fibroblast growth factor 
2 (Fgf2), as intravitreal injections of recombinant Lif lead to an induction of Et-2 and Fgf2 
in wildtype and remarkably also in Lif-deficient mice, (Joly et al., 2008; Gao and 
Hollyfield, 1996; Joly et al., 2007). Fgf2 is considered to promote survival on 
photoreceptor cells in a paracrine manner in different models of photoreceptor 
degeneration (Faktorovich et al., 1990; Joly et al., 2007; Gao and Hollyfield, 1996). It is 
likely, that photoreceptor damage leads to the activation of Et-2 in photoreceptors, which 
mediates expression of Lif and Fgf-2 expression in Müller cells. As photoreceptor-derived 
Et-2 itself leads to an activation of Müller cells and in turn the expression of Lif, a positive 
feedback loop is very likely. Thus, the activation of Et-2 and its mediation of Lif and Fgf-
2 expression is essential for retinal neuroprotection in response to photoreceptor 
degeneration. 
 
1.2 The Endothelin system 
In 1985, Hickey et al. first discovered a vasoconstricting factor obtained from the culture 
media of bovine aortic endothelial cells (Hickey et al., 1985). Three years later, 
Yanagisawa et al. identified the structure of this endothelin-derived vasoconstrictor and 
termed it endothelin (Yanagisawa et al., 1988). It is a 21-amino acid peptide linked with 
a free amino terminus and C-terminal carboxylic acid. This C-terminal helical tail seems 
to be crucial for receptor interaction, as well as two intramolecular disulfide bonds 
between Cys residues. Endothelin is expressed in three isoforms Endothelin 1, 2 and 3 
(Et-1, Et-2, Et-3), which differ by the amount of amino acids (Davenport et al., 2016). 
All three isoforms are first encoded as large precursor peptides (Prepro-Et-1/-2/-3) which 
are then abbreviated by 17 amino acids into proPeptides (proEt-1/2/3) by a signal 
peptidase. A second cleavage by furin enzymes removes 35 and 122 amino acids and 
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results in the immediate precursor of Endothelin (BigEt-1/2/3) (Xu et al., 1994). Its 
activation to mature Endothelin (Et-1/2/3) occurs via cleavage by membrane-bound 
metalloproteinases, the endothelin converting enzymes (ECE-1, ECE-2). Amongst the 
endothelin isoforms, Et-1 is the most extensively studied isoform and one of the most 
known potent vasoconstrictors (Yanagisawa et al., 1988). 
Endothelins activate two main class I G-protein coupled receptor subtypes: endothelin 
receptor a (Eta) and b (Etb). ET-1 and ET-2 bind with equal affinity to the receptors, 
whereas Et-3 has a lower binding affinity for Eta (Sakurai et al., 1990; Arai et al., 1990; 
Barton and Yanagisawa, 2008; Kedzierski and Yanagisawa, 2001). Eta is predominantly 
expressed by vascular smooth muscle cells, whereas Etb is expressed by both vascular 
smooth muscle and endothelial cells (Guan et al., 2015). Given physiological conditions, 
the two receptors are considered to possess synergistic but also opposite actions with 
Eta and Etb promoting vasoconstriction by the release of calcium by the sarcoplasmic 
reticulum resulting in increased smooth muscle contraction and vasoconstriction 
(Schneider et al., 2007), whereas Etb on endothelial cells contributes additionally to 
vasodilation (Filep et al., 1991; Schneider et al., 2007; Hirata et al., 1993). In addition, 
Etb acts as clearing receptor of circulating Et-1 (Fukuroda et al., 1994a). Endothelin 
signaling is involved in a variety of physiological functions, above all the regulation of 
vasomotricity, blood pressure and vascular homeostasis (Rautureau et al., 2015). 
 
1.2.1 Distribution of Endothelin signalling in the eye 
In the eye, the expression of Et-1 is well described in tissues like lens epithelium, optic 
nerve , ciliary body, trabecular meshwork as well as vascular endothelial cells in the 
choroid and retina (Chakravarthy et al., 1994; Wollensak et al., 2002), whereas Et-2 is 
expressed by photoreceptors (Bramall et al., 2013; Alrashdi et al., 2018). The expression 
of Et-3 is barely known. It has been shown that Et-1 modulates pericyte contractility to 
regulate retinal blood flow (Kawamura et al., 2002, 2002) and is involved in the regulation 
of intraocular pressure and aqueous humor dynamics (Taniguchi et al., 1994) Eta and 
Etb are expressed on perivascular cells of retinal and choroidal blood vessels to promote 
vasoconstriction (Choritz et al., 2005; Torbidoni et al., 2005; MacCumber and D'Anna, 
1994). Etb is additionally expressed on vascular endothelial cells to promote vasodilation 
(Clozel et al., 1992; Schneider et al., 2007). Furthermore, Etb is expressed on 
photoreceptors and Müller cells (Braunger et al., 2013a; Rattner and Nathans, 2005).  
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1.2.2 Diverse roles of Endothelin signalling in the ocular system 
The role of the endothelin signalling in the eye is discussed controversially. Recently, our 
group and others could demonstrate its contribution to the protection of retinal neurons 
(Braunger et al., 2013a; Rattner and Nathans, 2005; Joly et al., 2007), with Et-2 being 
discussed to act as a general stress factor following photoreceptor damage and to 
mediate neuroprotection on photoreceptors in the light-induced damage model, 
presumably via Etb (Rattner and Nathans, 2005; Braunger et al., 2013a). However, there 
are conflicting reports concerning the protective properties of endothelin signalling, as it 
is dysregulated in several ocular diseases (Vingolo et al., 2010; Sorrentino et al., 2018; 
Good and Kahook, 2010). In particular, Et-1 has been suspected as contributing factor 
for the development of glaucoma as Et-1 levels were elevated in the aqueous humor 
(Noske et al., 1997; Tezel et al., 1997) and in the blood plasma of glaucoma patients (Li 
et al., 2016). The precise underlying mechanisms are still not fully understood, but it is 
discussed that Et-1 could promote ganglion cell death and contribute to optic nerve 
neuropathy through mechanisms of vascular dysregulation and (Krishnamoorthy et al., 
2008; Lau et al., 2006). Furthermore, Et-2 is discussed to contribute to a breakdown of 
the blood retinal barrier with increased vascular leakage, vascular endothelial growth 
factor expression and infiltrating macrophages (Alrashdi et al., 2018). Thus, we aimed to 
examine the role of endothelin signaling in the retina in the current thesis. 
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2 Aim of study 
This thesis focuses on Endothelin receptor b (Etb) mediated signalling and its potential 
neuroprotective function for the survival of photoreceptors. To this end, animals with an 
inducible, tamoxifen-dependent deletion of Etb in the entire retina (EtbΔeye) and animals 
with a conditional deletion of Etb in retinal neurons and Müller cells (EtbΔOC) will be 
generated using the Cre/loxP system. Additionally, an Etb-deficient murine 
photoreceptor cell line (661WΔEtb) will be created via CRISPR/Cas9-System. A 
successful Etb-deletion in EtbΔeye and EtbΔOC mice and 661WΔEtb cells will be validated 
via molecular analysis (quantitative realtime RT-PCR and western blot analyses) and in 
situ hybridization (BaseScope®). To address this we will: 
 
• We will characterize the localization of Etb in the eye 
For a general characterization of the localization of Etb in the eye, we will first use 
wildtype albino (CD1) mice to examine the distribution of Etb in the murine eye by 
performing in situ hybridization (BaseScope®) and co-immunohistochemical staining for 
different retinal cell types (astrocytes: glial fibrillary acidic protein, Müller cells: glutamine 
synthetase, vasculature: Collagen IV).  
 
• We will investigate the expression levels of the endothelin signalling family 
following ocular trauma 
To this end, we will investigate the mRNA expression levels of the Endothelin signalling 
family following different damages of the retina or the eye, respectively (puncture of the 
eye, PBS-injection, light-induced photoreceptor degeneration). 
 
• We will characterize the impact of an Etb deletion on the morphology of the eye 
and the molecular expression levels of the endothelin signalling family, the Tgf-β 
signalling family, pro-and anti-apoptotic factors and neuroprotective factors in the 
retina. 
We will furthermore characterize the effect of the Etb-deficiency on the retinal 
architecture in EtbΔeye and EtbΔOC mice using semi-thin sections. To obtain statistically 
meaningful data, we will perform morphometric analyses and measure the thickness of 
the INL and ONL to generate Spider diagrams. We will analyse the morphology and a 
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potential leakiness of the retinal vessels in EtbΔeye and EtbΔOC mice by high molecular 
FITC-dextran perfusion, and immunohistochemical staining for their basal lamina 
(collagen IV) and for pericytes (neuron glia antigen 2 (Ng-2)). We will complete these 
analyses by studying the mRNA expression levels of the endothelial cell maker cluster 
of differentiation 31 (Cd31) and the perivascular cell markers alpha smooth muscle actin 
(α-Sma), neuron glia antigen 2 (Ng-2) and platelet-derived growth factor receptor beta 
(Pdgfrb). Moreover, we will analyse whether the Etb deletion might result in retinal 
hypoxia using hypoxia-inducible factor 1 alpha (Hif1α) western blot analyses. We will 
furthermore use specific antibodies (glial fibrillary acidic protein (Gfap) and ionized 
calcium-binding adapter molecule 1 (Iba1)) for immunohistochemical staining to analyse 
whether the deletion of Etb in EtbΔeye and EtbΔOC mice might influence the reactivity of 
Müller cells or microglia cells. To study whether the deletion of Etb will affect the mRNA 
expression levels of the other members of the Endothelin signalling pathway we will 
analyse their expression levels (Endothelin receptor type a (Eta), Endothelin 1/2/3 (Et-
1/-2-3). In addition, we will analyse the mRNA expression levels of the transforming 
growth factor beta signalling pathway (Tgf-β receptor 1 (Tgfbr1), Tgf-β receptor 2 
(Tgfbr2), Tgf-β 1, Tgf-β 2, Tgf-β 3), pro-apoptotic factors (Caspase 8, Caspase 9, BH3-
only BCL-2-interacting mediator of cell death (Bim), Bcl2 associated X (Bax), Bcl2 
associated death promotor (Bad)) and the anti-apoptotic factor B-Cell Lymphoma 2 
(Bcl2) as well neuroprotective factors (leukaemia inhibitory factor (Lif), fibroblast growth 
factor 2 (Fgf2)) . 
Proteomic analyses of 661WΔEtb cells and controls will give unbiased and hypothesis-
free information about the impact of an Etb deletion in photoreceptor cells. 
 
• We will investigate a potential neuroprotective role of Etb mediated signalling for 
the survival of photoreceptors. 
Therefore, we will use the light damage paradigm to induce photoreceptor apoptosis in 
EtbΔOC mice and controls. We will additionally cause cell stress by serum-deprivation in 
661WΔEtb cells and controls to induce their apoptosis. TUNEL labelling will be used to 
detect apoptotic cells and we will quantify the TUNEL labelled apoptotic cells to clarify, 
whether the apoptotic rate might be altered in Etb-deficient mice and 661WΔEtb cells 
compared to their respective controls. Furthermore, we will use semi-thin sections to 
investigate the retinal morphology and perform morphometric analyses to compare the 
thickness of the ONL between light-exposed EtbΔOC mice and light-exposed controls. To 
learn more about the underlying molecular mechanisms, the transcript levels of the 
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members of the Endothelin signalling family (Eta, Et-1/-2/-3), transforming growth factor 
beta signalling pathway (Tgf-βr1, Tgf-βr2, Tgf-β 1, Tgf-β 2, Tgf-β 3), pro-apoptotic factors 
(Caspase 8, Caspase 9, Bim, Bad, Bax) and the anti-apoptotic factor Bcl2 as well 
neuroprotective factors (Lif, Fgf2) will be examined by quantitative realtime RT-PCR. 
Western blot analyses for the cell survival factor Protein Kinase B (Akt) and its 
phosphorylated (p) form pAkt, a main component of the PI3K-Akt pathway, will be 
performed in light-exposed EtbΔOC mice and controls to clarify whether Etb might use this 
signalling pathway to mediate its neuroprotective effect. 
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3 Results 
3.1 Expression of Endothelin receptor b in the eye 
Initially, we used 6-week old albino (CD1) wildtype mice to study the expression and 
localization of Etb in the eye. 
We first performed quantitative real-time RT-PCR of retinal lysates to detect the relative 
mRNA expression levels of Endothelin receptor a (Eta) and Endothelin receptor b (Etb) 
in the retina. Both receptors were detectable in the retina of wildtype mice (Figure 5). 
Quite intriguingly, Etb was identified as predominant receptor in the retina as the relative 
mRNA expression level of Etb (24.34 ± 3.34) was significantly (p=0.02) higher than Eta 
mRNA expression (9.72 ± 3.01). 
 
 
Next, we performed in situ hybridization BaseScope® (Chapter 6.5.7); which was friendly 
provided by Prof. Dr. Charlotte Wagner (University Regensburg, Germany) on sagittal 
sections of the entire eye to detect the mRNA signal of Etb and further localize Etb in the 
entire eye via conventional fluorescent microscopy (Figure 6 A-F). In the retina (A), the 
Etb signal was confined to the retinal ganglion cell layer (GCL), inner nuclear layer (INL), 
outer nuclear layer (ONL) and retinal pigment epithelium (RPE).There was also a distinct 
Etb mRNA signal detectable in the lens (B), strictly defined to the lens epithelium and 
lens fibres, whereas Etb signal was not visible in the lens capsule. In the iris (C), the Etb 
mRNA signal was only traceable in the stroma, whereas the iris epithelium had no signal 
for Etb. Furthermore, there were Etb mRNA signals in the entire cornea (D) detectable. 
The corneal epithelium as well endothelium showed intense Etb signals, whereas the 
stroma had less positive Etb mRNA signals. The entire ciliary body (E) showed an 
intense signal for Etb, in its pigmented as well as its non-pigmented epithelium. 
Furthermore, intense Etb mRNA signals were detected in the entire area of the optic 
nerve head and the optic nerve (F).  
Figure 5 Relative mRNA expression of 
Eta and Etb in the retina. 
Both receptors were detectable, but 
Etb was identified as predominant 
receptor with a significantly higher 
expression than Eta. The mean value 
of the housekeeping genes Gapdh and 
Gnb2l was used for normalization. Data 
are means ± SEM. Eta n = 6; Etb n = 4; 
p* = 0.02, student’s t-test. 
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Figure 6 In situ hybridization BaseScope® of a 6-week old wildtype mouse.Etb mRNA signal (red); Nuclei 
were Dapi stained (blue). (A) Retina. There was an Etb mRNA signal in several layers of the retina 
detectable. GCL=ganglion cell layer, INL=inner nuclear layer, ONL=outer nuclear layer, RPE=retinal 
pigment epithelium (B) Lens. Etb was located in the lens epithelium as well as lens fibres, but not in the 
capsule. epi= epithelium, fib= lens fibres, cap=capsule (C) Iris. Only the iridal stroma depicted a positive Etb 
mRNA signal. epi= epithelium, S= stroma (D) Cornea. Etb was detectable in the entire cornea. epi= 
epithelium, S= stroma, end= endothelium (E) Ciliary body. Etb was detectable in the entire ciliary body. PE= 
pigmented epithelium, NE= non-pigmented epithelium (F) Optic nerve head. Etb was detectable in the entire 
area of the optic nerve head. R=retina, ONH=optic nerve head, ON=optic nerve 
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For a cell-specific Etb localization in the retina, the in situ hybridization BaseScope®-
labelled sagittal sections were co-stained against Glial fibrillary acidic protein (Gfap) 
(Figure 7 A), a marker for astrocytes and reactive Müller cells and glutamine synthetase 
(Gs) (Figure 7 B), a Müller cell specific marker. Again, a positive Etb mRNA signal was 
detected in the GCL, INL and ONL, indicating a localization on neurons and 
photoreceptor cells. Immunohistochemical staining against Gfap (Figure 7 A) revealed a 
characteristic staining on top of the GCL, the typical localization of astrocytes. Here, no 
Etb mRNA signal was detectable, showing that astrocytes did not express Etb in the 
retina. The immunohistochemical staining against Gs (Figure 7 B) displayed the regular 
pattern of Gs Müller glia staining in the inner plexiform layer as well a distinct staining 
along the elongated glia processes stretching through the entire retina from the inner 
limiting membrane to the outer limiting membrane. Here, the Etb mRNA signal partly 
overlapped with GS within the inner plexiform layer and additionally in the region of the 
GCL, where the Müller cell endfeet are located, indicating an Etb expression in Müller 
cells, especially in their end feet. 
 
 
A 
B 
Figure 7 (A) In situ hybridization BaseScope® (red) and immunohistochemical staining against Gfap (green) 
of a 6 week-old wildtype mouse.Immunohistochemical staining against Gfap revealed a characteristic 
staining on top of the ganglion cell layer (GCL), the typical localization of astrocytes. Here, no Etb signal 
was detectable (detailed magnification, arrows) indicating that astrocytes do not express Etb. (B) In situ 
hybridization BaseScope® (red) and immunohistochemical staining against Gs (green) of a 6 week-old 
wildtype mouse. Gs staining displayed the regular pattern of Gs Müller glia staining with a distinct staining 
along the elongated glia processes stretching through the entire retina from the inner limiting membrane to 
the outer limiting membrane. Etb mRNA signal partly overlapped within the inner plexiform layer (detailed 
magnification, arrows) and additionally the GCL, indicating an Etb expression in Müller cells. GCL =ganglion 
cell layer, INL = inner nuclear layer, ONL = outer nuclear layer, RPE = retinal pigment epithelium. Nuclei 
were Dapi stained (blue). In situ hybridization BaseScope® was performed in cooperation with Dr. Thomas 
Neder (University Regensburg) 
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Next, we performed immunohistochemical staining against Collagen IV, an abundant 
protein of the basal lamina of blood vessels, that encloses endothelial cells located on 
the inner (luminal) side of the basal lamina, and perivascular cells still enclosed by the 
Collagen IV positive basal lamina but located at the outside of the vascular lumen. Thus, 
Collagen IV is a reliable marker to label the retinal vasculature and to distinguish between 
endothelial and perivascular cells, based on their inner (endothelial cells) or outer 
(perivascular cells) luminal position. E.g. positive Collagen IV staining was detected in 
retinal vessels located in the GCL showing a distinct Etb mRNA expression on the 
luminal side of the retinal vessels, indicating that Etb is expressed in retinal endothelial 
cells. Furthermore, we detected Etb positive signals at the outer luminal side of the 
vessels indicating the expression of Etb in perivascular cells.  
 
 
 
  
Figure 8 In situ hybridization BaseScope® (red) and immunohistochemical staining against Collagen IV 
(green) of a 6 week-old wildtype mouse.Collagen IV positive staining (green) was detected in retinal vessels 
located in the GCL showing a distinct Etb mRNA expression on the luminal side of the retinal vessels, 
indicating that Etb is expressed in retinal endothelial cells (arrowheads). Furthermore, we detected Etb 
positive signals at the outer luminal side of the vessels indicating the expression of Etb in perivascular cells 
(arrows). GCL =ganglion cell layer, INL = inner nuclear layer, ONL = outer nuclear layer, RPE = retinal 
pigment epithelium. Nuclei were Dapi stained (blue).  
 
 
  
Results page | 19 
3.2 Role of Endothelin signalling in the damaged retina 
Our workgroup and other already showed that Et-2 is upregulated in experimentally 
induced photoreceptor degeneration (Braunger et al., 2013a; Rattner and Nathans, 
2005; Joly et al., 2007). We aimed to characterize the role of the entire Endothelin 
signalling pathway in the damaged retina and therefore performed three different 
experimental setups leading to induce a retinal damage: Puncture of the eye (wildtype 
puncture, Figure 9 A) intravitreal injections of PBS (wildtype PBS,Figure 9 B) and light-
induced damage (wildtype light, Figure 10) 
 
 
 
 
 
 
Quite intriguingly, the sole puncture of the bulbus (wildtype puncture) led to significantly 
elevated mRNA expression levels of Eta (6.40 ± 1.53, p**=0.005) and Etb (8.34 ± 1.01, 
p***=0.00005) as well as Et-1 (6.89 ± 1.05, p***=0.0001) and Et-2 (5.66 ± 0.93, p *=0.04) 
compared to untreated controls (Eta: 1.00 ± 0.21; Etb: 1.00 ± 0.28; Et-1: 1.00 ± 0.33; Et-
2: 1.00 ± 3.57). The relative mRNA expression of Et3 remained unaffected (control: 1.00 
± 0.02; wildtype PBS: 1.33 ± 0.32, p=0.7). Mice that received additionally an intravitreal 
injection of 3 μl PBS (wildtype PBS) showed a comparably increased relative mRNA 
Figure 9 Quantitative real-time RT-PCR of retinal lysates of 6 to 8-week old wildtype mice (A) relative mRNA 
expression levels of Eta, Etb, Et-1 and Et2 were significantly elevated after the solely puncture of the eye 
into the vitreous (wildtype puncture) compared to controls. (B) The intravitreal injection with PBS (wildtype 
PBS) resulted in significantly elevated mRNA expression levels of Eta, Etb, Et1 and Et2 compared to 
controls. Expression was normalized to Gnb2l. Data are means ± SEM. Wildtype puncture: Eta (n≥ 3; 
p**=0.005), Etb (n≥ 3; p***=0.00005), Et1 (n≥ 4; p***=0.0001), Et2 (n≥ 2; p*=0.04), Et3 (n≥ 3; p=0.7 (not 
significant); wildtype PBS: Eta (n≥ 3; p=0.09 (not significant)), Etb (n≥ 3; p*=0.02), Et1 (n≥ 4; p**=0.003), 
Et2 (n≥ 2; p*=0.05), Et3 (n≥ 3); p=0.6 (not significant). Student’s t test. [AU]= arbitrary unit; Figures taken 
from Schmitt et al. New insights into endothelin signalling and its diverse roles in the retina, in press. 
Experiment performed by Sabrina Schmitt 
A B 
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expression of Eta (7.34 ± 4.25, p=0.09) and a significant increase of Etb (8.99 ± 3.12, 
p*=0.02), Et-1 (3.85 ± 0.73, p**=0.003) and Et-2 (4.52 ± 0.95, p*=0.05) compared to 
untreated controls (Eta: 1.00 ± 0.21; Etb: 1.00 ± 0.28; Et1: 1.00 ± 0.33; Et2: 1.00 ± 3.57). 
Again, the relative mRNA expression level of Et-3 (control: 1.00 ± 0.02, wildtype PBS: 
1.33 ± 0.32, p=0.6) remained unaffected.  
Quite similarly, the light exposed mice (Figure 10) showed significantly elevated mRNA 
expression levels of Eta (10.15 ± 2.69, p**=0.004), Etb (7.10 ± 3.31, p*=0.05), Et-1 (4.77 
± 0.56, p***=0.0004) and predominantly, an up to 36-fold increase of Et-2 (36.37 ± 2.32, 
p**=0.002) compared to controls (Eta: 1.00 ± 0.22; Etb: 1.00 ± 0.30; Et-1: 1.00 ± 0.37; 
Et-2: 1.00 ± 3.60). However, Et-3 (control: 1.00 ± 0.01, wildtype light: 1.2 ± 0.40, p=0.7) 
expression levels were not significantly altered following experimentally induced 
photoreceptor degeneration. Taken together, our results show, that endothelin signaling 
is upregulated following various retinal damages, indicating that the endothelin signaling 
pathway may act neuroprotective in the retina. 
 
 
 
 
  
Figure 10 Quantitative real-time RT-PCR of 
6 to 8-week old albino mice after light-
induced damage.Relative mRNA 
expression levels of Eta, Etb, Et1 and Et2 
are significantly upregulated after light-
induced damage (wildtype light) compared 
to controls that were not exposed to light. 
Expression was normalized to Gnb2l. Data 
are means ± SEM. Eta (n≥ 3; p**=0.004), 
Etb (n≥ 4; p*=0.05), Et1 (n≥ 4; 
p***=0.0004), Et2 (n≥ 3; p**=0.002), Et3 
(n≥ 4; p=0.7. Student’s t test. [AU]= 
arbitrary unit. Figures taken from Schmitt et 
al. New insights into endothelin signalling 
and its diverse roles in the retina, in press. 
Experiment performed by Sabrina Schmitt 
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3.3 Etb-deficiency in vitro and in vivo 
To analyse the potential neuroprotective effect of Etb on photoreceptor cells in detail, we 
generated two mouse strains, one with a conditional deletion of Etb in the entire retina 
(EtbΔeye mice) and a second mouse strain with a cell type specific deletion in Müller cells 
and retinal neurons (EtbΔOC mice) via the CreloxP-System. Furthermore, we generated a 
stable Etb deletion in a photoreceptor cell line (661WΔEtb) via the CRISPR/Cas9-System 
to further study its physiological and molecular function. 
 
3.3.1 Characterization of EtbΔeye mice 
For simplicity, Etbflox/flox mice lacking the Cre recombinase are referred to as controls and 
Etbflox/flox mice expressing Cre recombinase are referred to as EtbΔeye or conditional 
knockout mice.  
 
3.3.1.1 Successful deletion of Endothelin receptor b in the entire retina  
To activate the CAG-CreERTM-Recombinase and thereby induce the conditional deletion 
of Etb in the entire retina via the CreloxP-System (Chapter 6.1.2), all mice were injected 
intraperitoneally with tamoxifen [20mg/ml] at the age of 4 weeks twice a day for five days. 
The mice were sacrificed at the age of 6 weeks for further analyses. 
The relative mRNA expression levels of Etb in retinal tissue of EtbΔeye mice and controls 
were compared via quantitative real-time RT-PCR analysis. The mean value of the 
housekeeping genes Gapdh and Gnb2l was used for normalization. A significant (p = 
0.001) decrease of 87% of the relative Etb mRNA expression level in the EtbΔeye mice 
(0.13 ± 0.30) compared to controls (1.00 ± 0.16) confirmed a successful deletion of Etb 
in the entire retina (Figure 11 A).   
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Figure 11 (A) Relative mRNA expression of Etb in EtbΔeye and controls showed a successful deletion of 
Etb in the entire retina following tamoxifen treatment. Mice with a conditional deletion of Etb expressed 
significantly lower amounts of Etb mRNA in the retina compared to controls. The mean value of the 
housekeeping genes Gapdh and Gnb2l were used for normalization. Data are means ± SEM. control n = 
4; EtbΔeye n = 4; p*** = 0.001, student’s t-test. (B) Western blot analysis of retinal lysates and densitometry 
of Etb in EtbΔeye and controls following tamoxifen treatment. Significant decrease of Etb expression in the 
entire retina after tamoxifen treatment in EtbΔeye mice compared to controls. Gapdh was used as 
housekeeping protein. Data are means ± SEM. control n = 6, EtbΔeye n = 4; p* = 0.03, student’s t-test; 
Experiments were performed by Anna Huber and Sabrina Schmitt  
 
The densitometric analysis of the relative protein expression level of Etb (54 kDa) 
showed a significantly (p* = 0.03) decreased expression of Etb in EtbΔeye mice (0.55 ± 
0.12) compared to controls (1.00 ± 0.12) again confirming the successful deletion of Etb 
in the entire retina (Figure 11). Gapdh (37 kDa) was used as housekeeping gene.  
To further verify a successful deletion of Etb we performed in situ hybridization 
BaseScope® on sagittal sections, to detect mRNA signal of Etb and to precisely localize 
potentially remaining Etb in retina (Figure 12). In control mice, Etb was distributed 
throughout the entire retina (Figure 12 A). The detailed magnification (Figure 12 B) 
showed Etb mRNA signals as described before (Figure 6). In contrast, there was no Etb 
mRNA signal detectable in EtbΔeye mice validating a successful deletion of Etb in the 
retina of conditional knockout mice. 
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A                                                                     B 
Figure 12 In situ hybridization BaseScope® of EtbΔeye mice and controls of an entire retinal hemisphere 
(A) and detailed magnification (B). Control mice showed an Etb mRNA signal (red spots, arrows) in the 
ganglion cell layer (GCL), inner nuclear layer (INL) and outer nuclear layer (ONL). Nuclei were stained 
with haematoxylin.  
 
3.3.1.2 No obvious alterations on retinal morphology following Etb-deficiency  
To examine whether the deletion of Etb in the entire retina influenced the retinal 
structure, we used conventional light microscopy to analyse the retinal morphology on 
Richardson stained horizontal semithin sections (1µm) of 6 week-old (Figure 13 A) 
EtbΔeye mice and controls.  
The control mice as well as EtbΔeye mice both showed a normal architecture of the retina 
with all retinal layers present along the entire hemisphere (Figure 13 A).  
  
  
Results page | 24 
A                                                               B 
Figure 13 (A) Semithin-sections of a 6 week-old EtbΔeye mouse and controls. Horizontal (1µm) semithin- 
sections (Richardson stained) of retinal hemispheres showed no obvious alterations of retinal morphology. 
Lower panel shows a higher magnification of the central retina. RGC =retinal ganglion cell layer, INL = inner 
nuclear layer, ONL = outer nuclear layer, RPE = retinal pigment epithelium. (B) Spider diagram of the 
thickness of the INL and ONL in EtbΔeye mice and controls. The thickness of the ONL and INL was measured 
on semithin-sections at defined measure points from ora serrata to the optic nerve head. There were no 
differences in the thickness of ONL as well as INL detectable between EtbΔeye mice (n=6, p > 0.05 (not 
significant)) and controls (n=4, p > 0.05 (not significant)). OS = ora serrata; ONH = optic nerve head. Data 
are means ± SEM, student’s t-test; Experiments were performed by Anna Huber and Sabrina Schmitt 
 
For further quantification, the thickness of the ONL and INL was measured at defined, 
different measure points throughout the retinal hemispheres and their means were 
represented in a spider diagram (Figure 13 B). Following statistical analyses, the 
thickness of ONL and INL did not differ between conditional knockout mice and the 
controls. 
 
3.3.1.3 Lens phenotype: Pathological morphology of the lens 
Quite intriguingly, some of the EtbΔeye mice showed abnormalities of the lens, whereas 
all controls exhibited normal formed lenses. Semithin sections (Figure 13) of the entire 
eye showed a collapsed, vacuolated structure of the lens of EtbΔeye mice compared to 
controls. Presumably, a rupture of the lens capsule led to a release of lenticular material 
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in the vitreous. We furthermore observed scarring material in the raptured areas. This 
identifies a severe phenotype in the lens. Quantitative evaluation of the occurrence of 
this phenomenon demonstrated that lens abnormalities occurred in 30% of EtbΔeye mice, 
whereas the remaining 70% EtbΔeye mice manifested lenses with normal appearance. 
 
 
 
To further examine the constitution of the lens capsule, we labelled lenses of control 
mice, EtbΔeye mice without phenotype and EtbΔeye mice with phenotype against Collagen 
IV, a main constituent of the lens capsule. All sections were recorded at the identic 
exposure time via conventional fluorescence microscopy (Figure 15). Control mice 
showed a distinct Collagen IV expression on top of the lens capsule, whereas 
fluorescence intensity was attenuated in EtbΔeye mice without any phenotype. 
Remarkably, EtbΔeye mice with phenotype showed only a punctually Collagen IV 
expression with slight intensity on top of the lens capsule. For further investigations, only 
EtbΔeye mice without phenotype were used.  
  
Figure 14 Semithin-sections of the entire eye of 6 week-old control mouse.(A) EtbΔeye mouse without a lens-
specific phenotype (EtbΔeye) and a EtbΔeye mouse with a lens-specific phenotype (EtbΔeye phenotype). The 
EtbΔeye phenotype eye demonstrates a collapsed, vacuolated structure of the lens with a rupture of the lens 
capsule (arrows). Horizontal (1µm) semithin- sections were Richardson stained. 
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3.3.1.4 No obvious alterations on retinal vasculature following Etb-deficiency  
Endothelin signalling is involved in the regulation of vasomotricity, blood pressure and 
vascular homeostasis. As Endothelin usually acts in a vasoactive manner, the two 
receptors (Eta and Etb) are considered to possess opposite actions with Eta and Etb 
mainly promoting vasoconstriction, whereas Etb contributes additionally to vasodilation 
Figure 15 Immunohistochemical staining against Collagen IV (red) of the lens in a EtbΔeye mouse (with 
phenotype and without phenotype) and controls. Detailed magnification of the lens showed Collagen IV 
expression in the lens capsule (cap). Fluorescence intensity weakens in EtbΔeye mice without phenotype 
compared to controls (arrow). EtbΔeye mice with occurring phenotype only showed punctually Collagen IV 
expression (arrow). Nuclei were Dapi stained. fib = lens fibres; epi = lens epithelium, cap = capsule 
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under physiological conditions (Schneider et al., 2007). Consequently, we aimed to 
analyze the influence of the Etb-deficiency on the retinal vasculature. 
We first stained sagittal sections of EtbΔeye mice and controls against Collagen IV (Figure 
16), which is the most abundant protein of the basal lamina of blood vessels and thus a 
reliable target to label retinal vasculature. 
 
 
Figure 16 Immunohistochemichal staining against Collagen IV in an EtbΔeye mouse and control showed 
no alterations of the retinal vasculature with a regular deep, intermediate and superficial plexus (white 
arrows). GCL =ganglion cell layer, INL = inner nuclear layer, ONL = outer nuclear layer, RPE = retinal 
pigment epithelium. Nuclei were Dapi stained; Experiment performed by Anna Huber and Sabrina 
Schmitt. 
 
There were no obvious alterations detectable in the three capillary plexus of the retinal 
vessels in EtbΔeye mice compared to controls. A regular deep and intermediate capillary 
plexus at the INL as well as a normal developed superficial plexus on top of the GCL 
were observed. Furthermore, an intact, continuous choriocapillaris was labelled next to 
the basal side of the RPE.  
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The choriocapillaris was additionally examined by labelling retinal sagittal sections 
against Plasmalemma Vesicle-Associated Protein (Pv-1). Pv-1 is involved in the 
formation of stomatal and fenestral diaphragms and may function in microvascular 
permeability. Diaphragmed fenestrae are characteristic structural elements of all 
fenestrated endothelia like the choriocapillaris in the eye. Pv-1 staining (white arrows, 
Figure 17) showed no obvious alterations in EtbΔeye mice and controls. 
 
Figure 17 Immunohistochemical staining against Pv-1 of sagittal sections of an EtbΔeye mouse and control 
showed no obvious alterations of the choriocapillaris. GCL =ganglion cell layer, INL = inner nuclear layer, 
ONL = outer nuclear layer, RPE = retinal pigment epithelium. Nuclei were DAPI stained; supported by 
Anna Huber 
 
To further confirm a regular formation of the capillary plexus, we perfused EtbΔeye mice 
and controls with high molecular weight FITC-dextran for vascular labelling. The detailed 
magnifications of retinal whole mounts of the FITC-dextran-labelled retinae showed a 
regular appearance of the superficial, intermediate and deep vascular plexus (Figure 18). 
Again, there were no obvious differences detectable, regarding the capillary networks in 
the retina of controls and conditional knockout mice.  
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Furthermore, we analysed whether the deletion of Etb in the entire retina might influence 
the pericytes. We therefore labelled FITC-dextran perfused retinal whole mounts against 
the pericyte-marker Neuron-glial antigen 2 (Ng-2) and detected an increased number of 
pericytes wrapping around retinal vessels in EtbΔeye mice compared to controls (Figure 
19 A). In accordance, the relative mRNA expression levels of Ng-2 (Figure 19 B) were 
significantly (p = 0.03) increased in EtbΔeye mice (Ng-2: 2.97 ± 0.63) compared to controls 
(Ng-2: 1.00 ± 0.07). We further analysed the relative mRNA expression level of the 
further pericyte-marker platelet-derived growth factor receptor (Pdgfrb) (Figure 19 C), 
which showed a significant elevation (p = 0.03) in EtbΔeye mice; (Pdgfrb: 4.61 ± 1.46) 
compared to controls (Pdgfrb: 1.00 ± 0.27). 
Figure 18 FITC-dextran perfused retinal wholemounts of EtbΔeye mouse and control at the age of 6 weeks. 
Control and EtbΔeye mice showed no alterations of the morphology of the superficial, intermediate and deep 
vascular plexus. 
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In addition, we performed quantitative real-time RT-PCR to examine the relative mRNA 
expression levels of alpha-smooth muscle actin (α-Sma) and cluster of differentiation 31 
(Cd31) (Figure 20). Whereas α-Sma is expressed by smooth muscle cells of large 
vessels and pericytes of smaller capillaries, Cd31 is reliable marker for endothelial cells. 
The relative α-Sma mRNA expression level was not significantly altered in EtbΔeye mice 
(1.66 ± 0.36, p = 0.2) compared to controls (1.00 ± 0.18). Moreover, there were no 
significant alterations detectable concerning the relative Cd31 mRNA expression levels 
in the retinae of EtbΔeye mice (1.34 ± 0.41, p = 0.5) and controls (1.00 ± 0.29). 
Figure 19 (A) Immunohistochemical staining against Ng-2 (red, arrows) of FITC-dextran perfused (green) 
retinal wholemounts of a EtbΔeye mouse and control showed an increased number of pericytes in the EtbΔeye 
mouse compared to the control. (B) Relative Ng-2 mRNA expression level was also significantly increased 
in EtbΔeye mice and controls. The mean values of the housekeeping genes Gapdh and Gnb2l were used for 
normalization. Data are means ± SEM; Ng-2: control n = 4; EtbΔeye n = 5; p* = 0.03 (C) Relative Pdgfrb 
mRNA expression level was significantly increased in EtbΔeye mice compared to controls. The mean value 
of the housekeeping genes Gapdh and Gnb2l were used for normalization. Data are means ± SEM; 
student’s t-test. control n = 6; EtbΔeye n = 5; p* = 0.03; student’s t-test. 
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Figure 20 Relative mRNA expression levels of α-Sma and 
Cd31 of retinal lysates of 6 week old mice showed no 
significant differences between EtbΔeye and controls. The 
mean value of the housekeeping genes Gapdh and Gnb2l 
were used for normalization. Data are means ± SEM; 
student’s t-test. α-Sma control n = 4; EtbΔeye n = 4; p = 0.2; 
Cd31 control n = 6; EtbΔeye n = 6; p = 0.5. 
To analyse whether the deletion of Etb might result in hypoxia of the retina, the relative 
protein expression level of hypoxia-inducible factor 1-alpha (Hif1α), which is a very 
sensitive hypoxic marker, was compared in retinal lysates of EtbΔeye mice and controls. 
Western blot analysis and quantitative densitometry (Figure 21) showed comparable 
Hif1α expression levels in control (1.00 ± 0.17) and EtbΔeye mice (1.39 ± 0.16, p = 0.2). 
Gapdh was used as housekeeping protein. 
 
Figure 21 Western blot analysis of retinal 
proteins and relative densitometry of Hif1α in 
control and EtbΔeye mice. Western blot 
analysis of 6 week-old control and EtbΔeye 
mice for Hif1α (120 kDa). Gapdh (37 kDa) 
was used as housekeeping protein. The 
relative densitometry shows no differences 
of Hif1α expression levels between control 
and EtbΔeye mice. Data are means ± SEM. 
Control n = 3, EtbΔeye n = 3. p = 0.2  
 
 
 
3.3.1.5 Influence of Etb-deficiency on macroglia and microglia cells  
In the retina reside three main types of glial cells: astrocytes, microglia and Müller glia 
cells. All of them are involved in neurodegeneration (Seitz et al. 2013) and response 
prominently to retinal injury or disease by modifications of their function and 
morphological appearance, a process named as reactive gliosis (Nakazawa et al. 2007). 
We therefore labelled retinal sagittal sections of EtbΔeye mice and controls with markers 
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specific for macro- or microglia cells to examine whether the deletion of Etb affected the 
mentioned cell-populations. 
First, we performed staining against Glial fibrillary acidic protein (Gfap) to detect 
astrocytes and reactive Müller cells, the prevalent macroglia cells in the retina. Gfap is 
an intermediate filament protein which is primarily detected in astrocytes. However, in 
case of retinal injury, Müller cells get reactive and express Gfap, too. As expected, 
sections of control and conditional knockout mice showed a staining against Gfap on top 
of the GCL, the characteristic location for astrocytes in the retina (Figure 22). 
Additionally, EtbΔeye mice showed an extended staining against Gfap in the inner parts of 
the retina showing the characteristic shape of reactive Müller cells. Their elongated glial 
processes spread through the entire retina from the inner limiting membrane to the outer 
limiting membrane, strongly indicating that the deletion of Etb resulted in the reactivity of 
Müller cells. 
 
Figure 22 Immunohistochemical staining against Gfap of sagittal sections of a EtbΔeye mouse and control 
showed Gfap staining (green, arrowheads) in astrocytes on top of the GCL. EtbΔeye mice additionally 
showed a distinct staining along the elongated glia processes stretching through the entire retina from the 
inner limiting membrane to the outer limiting membrane (arrows). GCL =ganglion cell layer, INL = inner 
nuclear layer, ONL = outer nuclear layer, RPE = retinal pigment epithelium. Nuclei were Dapi stained. 
 
Besides Müller cells, microglia cells are affected by degenerative processes in the retina, 
too. Microglia cells show a ramified shape in their mature resting stage. In response to 
injury they get reactive and switch their appearance through dynamic remodeling of their 
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cytoskeleton. Hence, they withdraw their filopodic processes to acquire an oval, 
amoeboid shape. Microglia cells express ionized calcium-binding adapter molecule 1 
(Iba-1) which therefore served as marker for microglial cells in the retina. The staining 
against Iba-1 of sagittal sections of the control mice showed microglia cells in their resting 
stage with a branching appearance and their characteristic localization in the inner and 
outer plexiform layer (Figure 23, A). In contrast, the morphology of the Iba-1 positive 
microglia cells changed to an oval to roundish appearance indicating the reactivation of 
microglia cells in EtbΔeye mice. This finding was confirmed by Iba-1 staining of retinal 
whole mounts (Figure 23, B). The detailed magnification of single microglia cells 
confirmed the transformation of microglia cells from a resting (controls) to a reactive state 
(EtbΔeye). The analysis of the relative Iba-1 mRNA expression level showed no 
differences between EtbΔeye mice (1.01 ± 0.27, p = 0.9) and controls (1. ± 0.37) (Figure 
23, C). 
  
 
 
Figure 23 Immunohistochemical staining against Iba-1 in a EtbΔeye mouse and 
control. (A) Sagittal sections of control mice showed Iba-1 positive microglia cells 
(red) with a characteristic ramified morphology and their characteristic localization 
in the inner and outer plexiform layer. Iba-1 staining of EtbΔeye mice revealed cell 
morphological characteristics of reactive microglia cells with roundish cell 
morphology (arrows). (B) Iba-1 staining of retinal whole mounts and the detail 
magnification of single microglia cells (right panel) elucidates changing shape of 
microglia cells from a resting (control) to a reactive (EtbΔeye) stage (arrows). (C) No 
differences of Iba-1 mRNA expression level of between control and EtbΔeye mice. 
The mean value of the housekeeping genes Gapdh and Gnb2l were used for 
normalization. Data are means ± SEM. control n = 6; EtbΔeye n = 6; p = 0.9. student’s 
t-test. GCL =ganglion cell layer, INL = inner nuclear layer, ONL = outer nuclear 
layer, RPE = retinal pigment epithelium. Nuclei were Dapi stained. 
A B 
C 
  
Results page | 34 
3.3.2 Characterization of EtbΔOC mice 
For simplicity, Etbflox/flox mice lacking the Cre recombinase are referred to as controls and 
Etbflox/flox mice expressing Cre recombinase are referred to as EtbΔOC or conditional 
knockout mice. 
 
3.3.2.1 Successful deletion of Endothelin receptor b in Müller cells and retinal neurons 
For the induction of the conditional deletion of Etb in Müller cells and retinal neurons via 
the CreloxP system, the self-inducible alpha Cre-Recombinase was used. This Cre 
recombinase starts its activity at embryonic day (E) 10.5 (Marquardt et al., 2001) and is 
not tamoxifen dependent. The experimental mice were sacrificed at the age of 6 weeks 
for further analysis, unless stated otherwise. 
The relative mRNA expression levels of Etb in retinal tissue of EtbΔOC mice and controls 
were analysed via quantitative real-time RT-PCR. The mean value of the housekeeping 
genes Gapdh and Gnb2l were used for normalization. The relative Etb mRNA expression 
level was significantly (p = 0.02) decreased (-70%) EtbΔOC mice (0.29 ± 0.21) compared 
to controls (1.00 ± 0.29) confirming a successful deletion of Etb in Müller cells and retinal 
neurons (Figure 24 A).  
 
Figure 24 (A) Relative Etb mRNA expression in EtbΔOC mice and controls showed a successful deletion of 
Etb in Müller cells and retinal neurons. Mice with a conditional deletion of Etb express significantly lower 
amounts of Etb mRNA in the retina compared to controls. The mean value of the housekeeping genes 
Gapdh and Gnb2l were used for normalization. Data are means ± SEM. control n = 9; EtbΔOC n = 6; p* = 
0.02, student’s t-test. (B) Western blot analysis of retinal lysates and densitometry of Etb showed a 
significant decrease of Etb expression in the retinae in EtbΔOC mice compared to controls. Gapdh was used 
as housekeeping protein. Data are means ± SEM. control n = 6, EtbΔOC n = 7; p* = 0.05, student’s t-test 
  
Results page | 35 
Western blot analysis also confirmed a successful deletion of Etb in the retina as the 
relative protein expression levels of Etb (54 kDa) showed a significantly (p = 0.05) 
decreased expression (-60%) in EtbΔOC mice (0.38 ± 0.02) compared to controls (1.00 ± 
0.19) (Figure 24 B). Gapdh (37 kDa) was used as housekeeping protein.  
 
To further verify a successful deletion of Etb, In situ hybridization BaseScope® on retinal 
sagittal sections were performed to detect mRNA signals of Etb in the retina. In control 
mice, Etb was contributed throughout the entire retina (Figure 25 A). The detailed 
magnification (Figure 25 B) showed Etb mRNA signals (red spots, arrows) as described 
before (Figure 12). In contrast, there were only rare Etb mRNA signals detectable in 
EtbΔOC mice. A finding, that again validated a successful deletion of Etb in retinae of 
EtbΔOC mice compared to controls. 
A                                                                      B 
Figure 25 In situ hybridization BaseScope® of a EtbΔOC mouse and control of an entire retinal hemisphere 
(A) and detailed magnification (B). In comparison to EtbΔOC mice, control mice showed Etb mRNA signals 
(red, arrows) in the ganglion cell layer (GCL), inner nuclear layer (INL) and outer nuclear layer (ONL). 
Nuclei were stained with haematoxylin. 
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3.3.2.2 No obvious alterations on retinal morphology following ETB-deficiency  
By using conventional light microscopy, retinal morphology was analysed on Richardson 
stained horizontal semithin sections (1µm) of 6 week-old (Figure 26 A) EtbΔOC mice and 
controls. We additionally analysed semithin sections of 6 month-old EtbΔOC mice (Figure 
27 A) and controls to investigate whether an Etb-deletion leads to long-term effects on 
the retinal structures.  
No alterations of the retinal morphology were detectable in the 6 week-old and in the 6 
month-old control mice compared to EtbΔOC mice. Both, the control mice as well as EtbΔOC 
mice, showed a normal architecture of the retina with all retinal layers present along the 
entire hemisphere.  
A                                                                B 
 
Figure 26 (A) Semithin-section of a EtbΔOC mouse and control (6 week-old). Horizontal (1µm) semithin- 
sections (Richardson stained) of retinal hemispheres showed no alterations of retinal morphology. Lower 
panel showed a higher magnification of the central retina. RGC =retinal ganglion cell layer, INL = inner 
nuclear layer, ONL = outer nuclear layer, RPE = retinal pigment epithelium. (B) Spider diagram of the 
thickness of the ONL and INL of EtbΔOC mice and controls (6 week-old). The thickness of the ONL and INL 
was measured on semithin-sections at defined measure points from ora serrata to the optic nerve head. 
There were no differences in the thickness of ONL as well as INL detectable between EtbΔOC mice and 
controls. OS = ora serrata; ONH = optic nerve head. Data are means ± SEM, student’s t-test. Control: n=7, 
p > 0.05; EtbΔOC: n=6, p > 0.05. 
 
For further quantification, the thickness of the ONL and INL was measured along the 
entire retina and the mean values of 9 individual measure points were represented in 
spider diagrams. The thickness was measured on semithin-sections along the distance 
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from ora serrata to the optic nerve head. The thickness of ONL and INL does not differ 
between EtbΔOC mice and the controls at the age of 6 weeks (Figure 26 B) as well as at 
the age of 6 months (Figure 27 B). 
A                                                              B 
 
 
 
Figure 27 (A) Semithin-section of a EtbΔOC mice and control (6 month-old). Horizontal (1µm) semithin- 
sections (Richardson stained) of retinal hemispheres showed no alterations of the retinal morphology. 
Lower panel shows a higher magnification of the central retina. RGC =retinal ganglion cell layer, INL = inner 
nuclear layer, ONL = outer nuclear layer, RPE = retinal pigment epithelium. (B) Spider diagram of the 
thickness of the ONL and INL of EtbΔOC mice and controls (6 month-old). The thickness of the ONL and INL 
was measured on semithin-sections at defined measure points from ora serrata to the optic nerve head. 
There were no differences in the thickness of ONL as well as INL detectable between EtbΔOC mice (n=6, p 
> 0.05 (not significant)) and controls (n=7, p > 0.05 (not significant)). OS = ora serrata; ONH = optic nerve 
head. Data are means ± SEM, student’s t-test. Controls: n=7, p > 0.05; EtbΔOC mice (n=6, p > 0.05. 
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3.3.2.3 No obvious alterations on retinal vasculature following Etb-deficiency  
Next, we examined, whether Etb-deficiency in Müller cells and retinal neurons affected 
the retinal vasculature. 
The immunohistochemical staining against Collagen IV of the basal lamina of retinal 
vessels on sagittal sections of EtbΔOC mice and controls (Figure 28) showed no obvious 
alterations of the morphological appearance of all three capillary plexus in the retina. A 
regular deep and intermediate capillary plexus of the inner and outer part of the INL as 
well as a normally developed superficial plexus on top of the GCL were clearly 
distinguishable. Moreover, the vessels of the choriocapillaris located characteristically 
next to the basal side of the retinal pigment epithelium (RPE) showed a regular 
morphology. 
 
Figure 28 Immunohistochemichal staining against Collagen IV (red, arrows) in a EtbΔOC mouse and 
control showed no alterations of the retinal vasculature in the EtbΔOC mouse compared to control. 
GCL =ganglion cell layer, INL = inner nuclear layer, ONL = outer nuclear layer, RPE = retinal pigment 
epithelium. Nuclei were Dapi stained. 
 
The choriocapillaris was investigated in more detail by staining sagittal sections against 
Plasmalemma Vesicle-Associated Protein (Pv-1), a marker for fenestrated epithelium 
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(Figure 29). There were no alterations of the fenestrations of the choriocapillaris between 
the EtbΔOC mice and their control littermates.  
 
Figure 29 Immunohistochemical staining against Pv-1 (red, arrows) of sagittal sections of a EtbΔOC mouse 
and its control littermate showed no obvious alterations of the choriocapillaris. GCL =ganglion cell layer, 
INL = inner nuclear layer, ONL = outer nuclear layer, RPE = retinal pigment epithelium. Nuclei were Dapi 
stained. 
 
To further confirm a regular formation of the capillary plexus, we perfused EtbΔOC mice 
and controls with high molecular weight FITC-dextran. Retinal whole mounts of the FITC-
dextran-perfused retinae showed a regular appearance of the superficial, intermediate 
and deep vascular plexus. Again, there were no obvious differences regarding the 
architecture of the capillary networks in the retina of controls and EtbΔOC mice.  
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Figure 30 FITC-dextran (green) perfused wholemounts of a EtbΔOC mouse and its control littermate at the 
age of 6 weeks. Control and EtbΔOC mouse showed a comparable morphology of the superficial, 
intermediate and deep vascular plexus. 
 
Furthermore, we analysed whether the deletion of Etb in retinal neurons and Müller cells 
might influence the pericytes. We therefore stained FITC-dextran perfused retinal whole 
mounts against the pericyte-marker Neuron-glial antigen 2 (Ng-2) and detected no 
influence on the location and appearance of pericytes (Figure 30 A). The retinal vessels 
were surrounded by pericytes in EtbΔOC mice and controls. We additionally analysed the 
relative mRNA expression levels of Ng-2 (Figure 30 B) and platelet-derived growth factor 
receptor (Pdgfrb) (Figure 31 C), also a pericyte marker, in the retina, which did not 
significantly differ between EtbΔOC mice (Ng-2: 0.63 ± 0.14, p = 0.2; Pdgfrb: 1.09 ± 0.34, 
p = 0.8) and controls (Ng-2: 1.00 ± 0.19, Pdgfrb: 1.0 ± 0.43). 
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Figure 31 (A) Immunohistochemical staining against Ng-2 (red, arrow) of FITC-dextran perfused (green) 
retinal wholemounts of a EtbΔOC mouse and control showed no obvious alterations of pericytes. (B): 
Relative Ng-2 mRNA expression levels also showed no differences between EtbΔOC mice and controls. 
The mean value of the housekeeping genes Gapdh and Gnb2l were used for normalization. Data are 
means ± SEM; control n = 5; EtbΔOC n = 6; p = 0.2; student’s t-test. (C) Relative Pdgfrb mRNA expression 
levels showed no differences between EtbΔOC mice and controls. The mean value of the housekeeping 
genes Gapdh and Gnb2l were used for normalization. Data are means ± SEM; control n = 5; EtbΔOC n = 6; 
p = 0.8; student’s t-test. 
 
Furthermore, we performed quantitative real-time RT-PCR to measure the relative 
mRNA expression levels of alpha-smooth muscle actin (α-Sma) a specific marker for 
smooth muscle cells) and cluster of differentiation 31 (Cd31), a specific marker for 
endothelial cells) (Figure 32). Relative α-Sma mRNA expression level was not 
significantly affected in conditional knockout mice (1.36 ± 0.31, p = 0.5) compared to 
controls (1.00 ± 0.29) and there were no significant differences of the relative Cd31 
mRNA expression levels between EtbΔOC mice (1.16 ± 0.33, p = 0.5) and controls (1.00 
± 0.21) detectable. 
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Additionally, the protein expression level of the very sensitive hypoxic marker hypoxia-
inducible factor 1-alpha (Hif1α) was compared in retinal lysates of conditional knockout 
mice and controls. Western blot analysis and relative densitometry (Figure 33) showed 
comparable expression levels of Hif1α between control (1.00 ± 0.41) and EtbΔOC mice 
(1.12 ± 0.19, p = 0.8). Gapdh was used as housekeeping protein. Taken together our 
findings strongly indicate that the deletion of Etb in retinal neurons and Müller cells did 
not affect the retinal vasculature. 
 
Figure 33 Western blot analysis and relative 
densitometry of retinal lysates of EtbΔOC 
mice controls . (6 week-old) for Hif1α (120 
kDa). Gapdh (37 kDa) was used as 
housekeeping protein. The relative 
densitometry showed no significant 
differences of Hif1α expression levels 
between control and EtbΔOC mice. Data are 
means ± SEM. Control n = 8, EtbΔOC n = 6. 
p = 0.8; student’s t-test. 
 
 
3.3.2.4 Influence of Etb-deficiency on retinal macro- and microglia cells 
To examine whether Etb-deficiency leads to a reactivity (gliosis) of Müller cells 
(macroglia cells) and microglia cells, retinal sagittal sections of EtbΔOC mice and controls 
were stained against markers specific markers for macro- or microglia cells.  
Figure 32 Relative mRNA expression 
levels of α-Sma and Cd31 of retinal 
lysates EtbΔOC mice and controls. The 
mean value of the housekeeping genes 
Gapdh and Gnb2l were used for 
normalization. Data are means ± SEM; α-
Sma: control n = 5; EtbΔOC n = 5; p = 0.5; 
Cd31: control n = 6; EtbΔOC n = 6; p = 0.5; 
student’s t-test. 
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Glial fibrillary acidic protein (Gfap) is an intermediate filament protein which is primarily 
detected in astrocytes and also expressed by reactive Müller cells. A Gfap-positive 
staining was detected on top of the GCL, the characteristic location for astrocytes in the 
retina in control as well as in EtbΔOC mice (Figure 34). We did not observe the 
characteristic stripe-like appearance of Gfap positive signals that would indicate a 
reactivity of Müller cells, indicating that the deletion of Etb in retinal neurons and Müller 
cells did not induce a gliotic reaction in Müller cells.  
 
Figure 34 Immunohistochemical staining against Gfap of sagittal sections of a EtbΔOC mice and control 
showed Gfap staining (green, arrowheads) in astrocytes on top of the GCL. GCL =ganglion cell layer, INL 
= inner nuclear layer, ONL = outer nuclear layer, RPE = retinal pigment epithelium. Nuclei were Dapi 
stained 
 
To analyse whether the deletion of Etb in retinal neurons and Müller cells might influence 
the activation state of microglia cells, sagittal sections were stained against express 
ionized calcium-binding adapter molecule 1 (Iba-1), a marker for microglial cells and 
macrophages. Both, controls and EtbΔOC mice showed microglia cells in their resting 
stage with a branching appearance and their characteristic localization in the inner and 
outer plexiform layers in sagittal sections (Figure 35 A). The detailed magnification of 
single microglia cells in retinal whole mounts also illustrated resting microglia cells in 
controls and EtbΔOC (Figure 35 B). In addition, we analysed the Iba-1 mRNA expression 
  
Results page | 44 
levels and detected no differences between EtbΔOC mice (0.85 ± 0.23, p = 0.4) and 
controls (1.00 ± 0.29) (Figure 35 C).  
A                                                                                  B 
 
C 
 
 
 
  
Figure 35 (A)Immunohistochemical staining against Iba-1 on sagittal 
sections of a EtbΔOC mouse and its control littermateshowed Iba-1 positive 
microglia cells (red, arrows) with a characteristic ramified morphology and 
their characteristic localization in the ganglion cell layer, outer plexiform 
layer and retinal pigment epithelium. GCL =ganglion cell layer, INL = inner 
nuclear layer, ONL = outer nuclear layer, RPE = retinal pigment epithelium. 
Nuclei were DAPI stained. (B) Iba-1 staining of retinal whole mounts and the 
detail magnification of single microglia cells (right panel) confirmed the 
resting microglia cells in control and EtbΔOC mice. (C) No differences of 
mRNA expression analysis of Iba-1 in control and EtbΔOC mice. The mean 
value of the housekeeping genes Gapdh and Gnb2l were used for 
normalization. Data are means ± SEM. control n = 6; EtbΔOC n = 6; p = 0.4. 
student’s t-test.  
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3.3.3 Characterisation of 661WΔEtb 
To generate an in vitro model system that would allow more mechanistic analyses about 
the function of Etb in photoreceptors, we additionally created a murine, immortalized 
photoreceptor cell line (661W) with a stable deletion of Etb via the CRISPR/Cas9-
System. In the following, these cells are referred to as 661WΔEtb. As controls, we used 
661W cells which were only transfected with the Cas9 enzyme and consequently still 
express Etb. These cells are referred to as 661W control cells. In summary, we 
generated four individual colonies of 661W controls as well as four individual colonies of 
661WΔEtb with a stable deletion of Etb. Those individual colonies were created out of the 
expansion of single cells isolated after transfection. The cells were harvested during the 
period of passage (P) 10 to P 15. 
To verify a successful deletion of Etb in the individual colonies of photoreceptor cells, we 
performed western blot analysis and used Gapdh (37 kDa) as housekeeping gene for 
normalization. The densitometric analysis of cell lysate illustrated a significant (p= 0.02) 
decrease of the relative Etb protein expression (-94%) in 661WΔEtb (0.06 ± 0.2) compared 
to controls (1.00 ± 0.8) confirming the successful deletion of Etb (Figure 36 A). 
We furthermore performed in situ hybridization BaseScope® of each individual colony of 
4%PFA-fixed 661WΔEtb cells and 661W control cells, to detect and identify mRNA signals 
of Etb in photoreceptors cells. In control cells, we observed a robust Etb mRNA signal in 
661W control cells (Figure 36 B). In contrast, there was no Etb mRNA signal detectable 
in 661WΔEtb cells, again validating a successful deletion of Etb in the 661WΔEtb. 
 
 
Figure 36 (A) Western blot analysis of cell lysates and densitometry of Etb in 661WΔEtb and 661W control cells. 
Gapdh was used as housekeeping protein. The statistical analysis confirmed the significant decrease of Etb 
expression in 661WΔEtb cells compared to 661W control cells. Data are means ± SEM. 661W control cells n = 4, 
661WΔEtb n = 4; p*= 0.02, student’s t-test (B) In situ hybridization BaseScope® of 661WΔEtb cells and 661W control 
cells. An intense Etb mRNA signal could be detected in the 661W control cells, that was no longer detectable in 
661WΔEtb cells. Nuclei were stained with Dapi (blue).  
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3.4 Impact of an Etb-deficiency in vivo and in vitro under 
physiological conditions 
Next, we aimed to study the impact of a deletion of Etb under physiological conditions 
on the expression levels of 1.) members of the endothelin signalling family, 2.) the TGF-
ß signalling pathway, 3.) neuroprotective factors and 4.) pro- and antiapoptotic factors. 
We therefore analysed the expression levels of the mentioned pathways in the two 
different experimental mice strains with a conditional deletion of Etb in the entire retina 
(EtbΔeye) or in Müller cells and retinal neurons (EtbΔOC) at the age of 6 weeks. For the in 
vitro studies, four individual photoreceptor cell lines with a stable deletion of Etb 
(661WΔEtb) were used and four individual 661W control cell lines expressing Etb were 
used and are referred to as controls. The experimental cells (661WΔEtb and 661W control 
cells) were analysed in three independent experiments and harvested at P13, P14 and 
P15. 
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3.4.1 Relative mRNA expression levels of Endothelin signalling 
First we analysed whether the deletion of Etb in the entire retina (EtbΔeye), retinal neurons 
and Müller cells (EtbΔOC) or photoreceptor cells (661WΔEtb) would have an impact on the 
expression levels of members of the endothelin signalling pathway in vivo and in vitro 
(Figure 37). 
 
 
 
 
In vitro 
In vivo 
Figure 37 mRNA expression levels of members of 
the Endothelin signalling in retinal lysates (A,B) 
and cell lysates (C). There was a significant 
increase of Et-3 in EtbΔeye mice as well of Eta in 
EtbΔOC mice compared to controls. The mean 
value of the housekeeping genes Gapdh and 
Gnb2l were used for normalization. Data are 
means ± SEM; (A) EtbΔeye: Eta (n = 6/6; p = 0.07), 
Et-1 (n = 5/4; p = 0.6), Et-2 (n = 6/6; p = 0.6), Et-3 
(n = 5/4; p*= 0.03); (B) EtbΔOC: Eta (n = 4/6; p* = 
0.05), Et-1 (n = 7/6; p = 0.8), Et-2 (n = 6/7; p = 0.2), 
Et-3 (n = 4/5; p = 0.1); (C) 661WΔEtb: Eta (n = 4/3; 
p = 0.8), Et-1 (n = 8/8; p = 0.9), Et-2 (n = 5/3; p = 
0.3), Et-3 (n = 9/8; p = 0.4). 
student’s t-test. 
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The relative mRNA expression levels of the members of the endothelin signalling 
pathway in vitro the showed comparable levels of all evaluated factors in 661WΔEtb (Eta: 
0.89 ± 0.32, p = 0.8; Et-1: 1.01 ± 0.22, p = 0.9; Et-2: 1.16 ± 0.15; p = 0.3; Et-3: 1.21 ± 
0.19, p = 0.4) compared to 661W control cells (Eta: 1.00 ± 0.3; Et-1: 1.00 ± 0.2; Et-2: 
1.00 ± 0.1; Et-3: 1.00 ± 0.2).  
Et-1 and Et-2 were expressed at comparable mRNA levels in EtbΔeye (Et-1: 0.79 ± 0.19, 
p = 0.6; Et-2: 0.76 ± 0.37, p = 0.7) and control mice (Et-1: 1.00 ± 0.26; Et-2: 1.00 ± 0.51). 
The relative mRNA expression of Eta was not significantly altered in EtbΔeye mice (1.96 
± 0.15, p = 0.07) compared to controls (1.00 ± 0.31).Strikingly, EtbΔeye mice depicted a 
significant (p *= 0.03) 3.6-fold increase of relative Et-3 mRNA expression levels (3.57 ± 
0.29) compared to controls (1.00 ± 0.17)  
In EtbΔOC mice, the relative mRNA expression levels of Et-1, Et-2 and Et-3 showed no 
significant alterations (Et-1:1.07 ± 0.34, p = 0.8; Et-2: 1.59 ± 0.19, p = 0.2; Et-3: 0.31 ± 
0.20, p = 0.1) compared to controls (Et-1: 1.00 ± 0.36; Et-2: 1.00 ± 0.31; Et-3: 1.00 ± 
0.44). The relative mRNA expression level of Eta was significantly increased (2.22 ± 
0.18, p* = 0.05) in EtbΔOC mice compared to controls (1.00 ± 0.21).  
Taken together, our results showed that the ablation of Etb in vivo resulted in an 
upregulation of members of the Endothelin signalling. 
 
3.4.2 Relative mRNA expression levels of transforming growth factor β (Tgf-β) 
signalling 
Tgf-β signalling is discussed to be associated with Endothelin signalling. Unpublished 
data from our group showed, that mice with a deletion of Tgf-β signalling in retinal 
neurons and Müller cells had significantly reduced Et-2 mRNA expression levels in the 
retina. Moreover, Castañares and coworkers (2007) depicted an induction of Et-1 by Tgf-
β as there was a time-dependent increase in the steady-state Et-1 mRNA levels of 
cultured vascular endothelial cells after incubation with Tgf-β compared with cells 
incubated under basal conditions (Castañares et al., 2006). Thus, we aimed to analyse 
whether the deletion of Etb in the entire retina (EtbΔeye), retinal neurons and Müller cells 
(EtbΔOC) or photoreceptor cells (661WΔEtb) would have an impact on the expression levels 
of members of the Tgf-β signalling pathway. Consequently, we analysed the mRNA 
expression levels of Tgf-β receptor 1 (Tgfbr1) and Tgf-β receptor 2 (Tgfbr2) as well their 
ligands Tgf-β1, Tgf-β2 and Tgf-β3  in retinal lysates of 6 week-old EtbΔeye (Figure 38 A 
left), EtbΔOC (Figure 38 A right) mice and cell lysates of 661WΔEtb photoreceptor cells  
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(Figure 38 B) and 661W control cells.  
 
In EtbΔOC mice (Figure 38 B), the relative mRNA expression levels of all members of the 
Tgf-β signalling pathway remained unaffected in retinae of EtbΔOC mice (Tgfbr1: 0.85 ± 
0.23, p = 0.7; Tgfbr2: 0.83 ± 0.06, p = 0.3; Tgf-β1: 0.63 ± 0.10, p = 0.3; Tgf-β2: 0.81 ± 
0.16; p = 0.5; Tgf-β3: 0.95 ± 0.27, p = 0.9) compared to controls (Tgfbr1: 1.00 ± 0.23, p 
= 0.7; Tgfbr2: 1.00 ± 0.06, p = 0.3; Tgf-β1: 1.00 ± 0.27, p = 0.3; Tgf-β2: 1.00 ± 0.21; p = 
0.5; Tgf-β3: 1.00 ± 0.19, p = 0.9 ).  
In EtbΔeye mice (Figure 38 A), the relative mRNA expression levels of both receptors 
(Tgfbr1: 1.83 ± 0.38, p = 0.3; Tgfβr2: 2.81 ± 0.31, p = 0.09) and controls (Tgfbr1: 1.00 ± 
0.43; Tgfbr2: 1.00 ± 0.27) as well as of the ligands Tgf-β1 (1.42 ± 0.44, p = 0.6) and 
Tgfβ2 (1.42 ± 0.45, p = 0.5) compared to controls (Tgf-β1: 1.00 ± 0.31; Tgf-β2: 1 ± 0.28) 
remained unaffected. EtbΔeye mice with a deletion of Etb in the entire retina showed a 
Figure 38 Relative mRNA expression levels of Tgf-
β signalling of retinal lysates (A,B) and cell lysates 
B. There was a significant increase of Tgf-β3 in 
EtbΔeye mice compared to controls as well of Tgfbr1 
and Tgf-β1 in 661WΔEtb compared to 661W control 
cells detectable. The mean value of the 
housekeeping genes Gapdh and Gnb2l were used 
for normalization. Data are means ± SEM; (A) 
EtbΔeye: Tgfbr1 (n = 6/6; p = 0.3), Tgfbr2 (n = 5/6; p 
= 0.09), Tgf-β1 (n = 6/6; p = 0.6), Tgf-β2 (n = 6/6; p 
= 0.5), Tgf-β3 (n = 5/5; p* = 0.03); (B) EtbΔOC: Tgfbr1 
(n = 6/6; p = 0.7), Tgfbr2 (n = 5/4; p = 0.3), Tgf-β1 (n 
= 6/6; p = 0.3), Tgf-β2 (n = 6/6; p = 0.5), Tgf-β3 (n = 
6/5; p = 0.9); (C) 661WΔEtb: Tgfbr1 (n = 8/9; p*** = 
0.0004), Tgfbr2 (n = 9/8; p = 0.3), Tgf-β1 (n = 9/9; p 
*** = 0.0002), Tgf-β2 (n = 8/9; p = 0.9), Tgf-β3 (n = 
9/9; p = 0.8); student’s t-test 
 
In vitro 
In vivo In vivo 
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significant increase (p = 0.03) of the relative mRNA expression level of Tgf-β3 (3.25 ± 
0.24) compared to controls (1.00 ± 0.29).  
In Etb-deficient 661WΔEtb photoreceptor cells (Figure 38 C), the relative mRNA 
expression levels of Tgfbr2 (1.27 ± 0.23, p = 0.3), Tgf-β2 (0.99 ± 0.15, p = 0.9) and Tgf-
β3 (1.13 ± 0.14, p = 0.8) were not altered significantly compared to 661W control cells 
(Tgfbr2: 1.00 ± 0.17, Tgfβ2: 1.00 ± 0.19; Tgfβ3: 1.00 ± 0.18). In contrast, there were 
significant elevations of Tgfbr1(1.27 ± 0.15, p= 0.0004) as well as Tgfβ1 (1.64 ± 0.11, p 
= 0.0002) in cell lysates of 661WΔEtb cells compared to 661W control cells (Tgfbr1: 1.00 
± 0.15; Tgfβ1: 1.00 ± 0.08) ascertainable.  
Taken together, our results showed that, depending on the affected cellular 
population(s), the deficiency of Etb results in an upregulation of the Tgf-β signalling 
pathway. 
 
3.4.3 Relative mRNA expression levels of pro-apoptotic and anti-apoptotic factors 
As the overall aim of this thesis was to investigate whether the deletion of Etb might 
result in retinal neurodegeneration, we consequently analysed whether the Etb deletion 
itself might influence the expression levels of pro- and anti-apoptotic factors in vivo 
(EtbΔeye; EtbΔOC) and in vitro (661WΔEtb) and their corresponding controls. We analysed 
the expression levels of pro-apoptotic factors Caspase 8, Caspase 9, BH3-only BCL-2-
interacting mediator of cell death (Bim), Bcl2 associated X (Bax), Bcl2 associated death 
promotor (Bad) and the anti-apoptotic factor B-Cell Lymphoma 2 (Bcl2) (Figure 39). 
Whereas Caspase 8 is a key player in the extrinsic apoptotic signalling pathway via death 
receptors (Kominami et al., 2012), Caspase 9 plays a decisive role in the intrinsic or 
mitochondrial pathway of apoptosis. This intrinsic pathway is regulated by proteins, 
which are pro- or anti-apoptotic, depending on their ability to promote (Bim, Bax, Bad) or 
suppress (Blc2) apoptotic mechanisms (Elmore, 2007). 
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EtbΔOC mice (Figure 39 B) showed no alterations of the relative mRNA expression levels 
of pro- as well as anti-apoptotic factors (Caspase 8: 1.01 ± 0.16, p = 0.9; Caspase 9: 
1.07 ± 0.19, p = 0.8; Bim: 1.51 ± 0.81, p = 0.7; Bax: 0.83 ± 0.13, p = 0.4; Bad: 0.93 ± 
0.10, p = 0.7; Bcl2: 1.09 ± 0.19 p = 0.8) compared to controls (Caspase 8: 1.00 ± 0.24; 
Caspase 9: 1.00 ± 0.20; Bim: 1.00 ± 0.60; Bax: 1.00 ± 0.16; Bad: 1.00 ± 0.16; Bcl2: 1.00 
± 0.26).  
In EtbΔeye mice (Figure 39 A) the mRNA expression levels of the anti-apoptotic factor 
Bcl2 (1.68 ± 0.35, p = 0.3) and Caspase 8 (1.09 ± 0.32, p = 0.9) as part of an extrinsic 
pathway of apoptosis were not significantly altered compared to controls (Bcl2: 1.00 ± 
0.35; Caspase 8: 1.00 ± 0.31). There were significant elevations of pro-apoptotic factors 
of the intrinsic pathway of apoptosis EtbΔeye mice detectable, as the relative mRNA 
expression levels of Caspase 9 (3.12 ± 0.29, p= 0.04), Bim (5.51 ± 0.14, p= 0.02), Bax 
(1.86 ± 0.15; p = 0.04) and Bad (1.65 ± 0.15, p = 0.05) compared to controls (Caspase 
9: 1.00 ± 0.21; Bim: 1.00 ± 0.37; Bax: 1.00 ± 0.22; Bad: 1.00 ± 0.14).  
In vitro 
Figure 39 Relative mRNA expression levels of pro- 
and anti-apoptotic factors in retinal lysates (A,B) and 
cell lysates (C). There was a significant increase of 
Caspase9, Bim, Bax and Bad in EtbΔeye mice 
compared to controls as well of Caspase9, Bim and 
Bcl2 in 661WΔEtb cells compared to controls 
detectable. The mean values of Gapdh and Gnb2l 
were used for normalization. Data are means ± SEM; 
(A) EtbΔeye: Caspase 8 (n = 5/5; p = 0.9), Caspase 9 
(n = 6/6; p* = 0.04), Bim (n = 3/3; p* = 0.02), Bax (n 
= 6/6; p* = 0.04), Bad (n = 6/6; p* = 0.05), Bcl2 (n = 
6/6; p= 0.3); (B) EtbΔOC: Caspase 8 (n = 6/6; p= 0.9), 
Caspase 9 (n = 6/6; p= 0.8), Bim (n = 3/4; p= 0.7), 
Bax (n = 6/6; p= 0.4), Bad (n = 6/6; p= 0.7), Bcl2 (n = 
6/6; p= 0.8); (C) 661WΔEtb: Caspase 8 (n = 8/9; p= 
0.7), Caspase 9 (n = 9/8; p* = 0.04), Bim (n = 4/4; p* 
= 0.03), Bax (n = 9/6; p = 0.2), Bad (n = 9/9; p= 0.8), 
Bcl2 (n = 9/9; p* = 0.02); student’s t-test. 
In vivo In vivo 
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The in vitro studies (Figure 39 C) constituted no significant alterations of Caspase 8 (1.03 
± 0.06, p = 0.7), Bax (1.07 ± 0.15, p = 0.2) and Bad (0.95 ± 0.05, p = 0.8) in cell lysates 
of photoreceptor cells lacking Etb (661WΔEtb) compared to 661W control cells (Caspase 
8: 1.00 ± 0.10; Bax: 1.00 ± 0.12; Bad: 0.95 ± 0.15) detectable. Noticeably, there was a 
2.5-fold significant increase (p = 0.03) of the relative Bim mRNA expression level 
traceable in 661WΔEtb cells (2.45 ± 0.38) compared to controls (1.00 ± 0.38). The relative 
mRNA expression level of Caspase 9 (1.49 ± 0.15, p = 0.04) and Bcl2 (1.45 ± 0.08, p = 
0.02) were also significantly increased in 661WΔEtb cells compared to controls (Caspase 
9: 1.00 ± 0.10, Bcl2: 1.00 ± 0.13).  
 
Taken together, our results showed that the deficiency in vivo in the entire retina (EtbΔeye) 
and in vitro in photoreceptor cells (661WΔEtb) resulted in an activation of an intrinsic 
pathway of apoptosis. 
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3.4.4 Relative mRNA expression levels of neuroprotective factors 
Next, we aimed to investigate whether the mRNA expression levels of, leukaemia 
inhibitory factor (Lif), fibroblast growth factor 2 (Fgf2) and again of Endothelin 2 (Et-2) 
(Chapter 3.4.1), all crucial factors of the neuroprotective loop in the retina, as well as 
brain-derived neurotrophic factor (Bdnf), debated as survival factor for photoreceptors, 
were affected by an Etb-deficiency in vivo (Figure 40 A, B) and in vitro (Figure 40 C). 
 
 
In vitro 
In vivo 
Figure 40 Relative mRNA expression levels of neuroprotective 
factors of retinal lysates (A,B) and cell lysates (C). There was 
a significant increase of Fgf2 in EtbΔeye mice compared to 
controls. In 661WΔEtb cells Lif and Fgf2 were significantly 
increased compared to controls. Bdnf was not detectable in 
661WΔEtb and 661W control cells. The mean value of Gapdh 
and Gnb2l were used for normalization. Data are means ± 
SEM; (A) EtbΔeye: Lif (n = 4/3; p = 0.2), Fgf2 (n = 5/4; p* = 
0.05), Bdnf (n = 5/5; p = 0.9); (B) EtbΔOC: Lif (n = 4/4; p = 0.9), 
Fgf2 (n = 7/9; p = 0.9), Bdnf (n = 4/5; p = 0.8); (C) 661WΔEtb: 
Lif (n = 8/9; p*** = 0.0002), Fgf2 (n = 6/6; p* = 0.04); student’s 
t-test. 
 
In vivo 
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In EtbΔeye mice (Figure 40 A) the relative mRNA expression levels of Lif (2.08 ± 0.32, p = 
0.2) and Bdnf (0.91 ± 0.37, p = 0.9) were not altered significantly compared to controls 
(Lif: 1.00 ± 0.42; Bdnf: 1.00 ± 0.39) Predominantly, the relative mRNA expression level 
of Fgf2 (6.76 ± 0.39) were significantly p = 0.05 increased compared to controls (1.00 ± 
0.49).  
In EtbΔOC mice, the relative mRNA expression levels of Lif, Fgf2 and Bdnf did not differ 
between EtbΔOC mice (Lif: 1.06 ± 0.37; Fgf2: 1.04 ± 0.35; Bdnf: 1.12 ± 0.34) and controls 
(Lif: 1.00 ± 0.15; Fgf2: 1.00 ± 0.36, Bdnf: 1.00 ± 0.31).  
As photoreceptors do not express receptors for Bdnf, the were no relative Bdnf mRNA 
expression levels detectable of 661WΔEtb cells and 661W control cells. Tough, the relative 
mRNA expression of both Lif and Fgf2 were significantly increased at comparable levels 
in 661WΔEtb cells (Lif: 2.43 ± 0.18; Fgf2: 2.43 ± 0.39) compared to controls (Lif: 1.00 ± 
0.18; Fgf2: 1.00 ± 0.23).  
Taken together, our results showed that the deficiency of Etb led to elevated levels of 
neuroprotective factors of the retina in vivo (EtbΔeye) and in vitro (661WΔEtb). 
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3.5 Neuroprotective role of Etb in vivo and in vitro under 
pathological conditions 
Next, we wanted to investigate potential neuroprotective aspects of Endothelin signalling 
for the survival of photoreceptor cells under pathological conditions in vitro (serum-
deprivation) as well as in vivo (light-induced damage). 
 
3.5.1 In vivo: Neuroprotective role of Etb on photoreceptors in the light-damaged 
retina 
To examine whether Etb mediates a neuroprotective effect on photoreceptor survival, 
light-induced damages were performed to experimentally induce photoreceptor 
degeneration. As the rupture of the lens and the subsequent scar formation that we have 
observed in EtbΔeye mice, would tremendously affect the efficiency of the experimentally 
induced light damages, we decided to perform the following light-induced damages 
exclusively in EtbΔOC mice and controls. For light-induced damage, the experimental mice 
were dark adapted for a period of five days and then kept in transparent plastic cages 
and illuminated with cool white light (5000 lux) from the top for 1 h. The light-exposed 
EtbΔOC mice and the dark-adapted controls are referred to as EtbΔOC light or control light, 
respectively. In addition, light-unexposed EtbΔOC and control mice that were kept in the 
dark period of five days without any light exposure served as light-damage reference 
groups and referred to as EtbΔOC and controls.  
 
3.5.1.1 TdT-mediated dUTP-biotin nick end labeling (TUNEL): Validation of light-
induced damage and analysis of Etb-mediated neuroprotection 
The examine whether Etb mediates a neuroprotective effect on photoreceptor survival, 
the rate of apoptotic photoreceptor cells was assessed in 6 week-old EtbΔOC light and 
control light animals after light exposure (light-induced damage). The eyes were 
enucleated 30 h after light-induced damage. To validate a successful induction of light 
induced apoptosis in photoreceptors and to investigate whether the deletion of Etb in 
retinal neurons and Müller cells might influence the rate of apoptosis, TdT-mediated 
dUTP-biotin nick end labeling (TUNEL) was performed on horizontal retinal sections to 
label apoptotic cells. To allow for statistical meaningful data, the number of apoptotic 
cells in light-exposed EtbΔOC mice and controls was determined and normalized to the 
area of the ONL (Figure 41). 
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On horizontal retinal sections, we  observed the characteristic distribution of apoptotic 
cells following light exposure with only a small number of TUNEL-positive cells in the 
periphery, and numerous apoptotic cells in the central part of the illuminated retinae of 
EtbΔOC mice and controls (Figure 41 A). Remarkably, the number of TUNEL-positive cells 
(Figure 41 B) was significantly (p = 0.04) higher in light-exposed EtbΔOCmice (4004.23 ± 
1143.41) compared to controls (8769.04 ± 15776.61).  
C 
B 
A 
Figure 41 TUNEL staining of horizontal sections of the entire eye (A) and detailed magnification of the 
central retina (B) of a 6 week-old light exposed EtbΔOC and control mouse. TUNEL staining (green) showed 
a higher amount of apoptotic cells in the central part of the retina and in the outer nuclear layer (ONL) 30 h 
after light exposure in EtbΔOC mice compared to controls. The nuclei were stained with Dapi (blue). GCL= 
ganglion cell layer, INL= inner nuclear layer, RGC= retinal ganglion cell layer. (C) The number of apoptotic 
cells was counted and calculated as TUNEL-positive cells (= apoptotic cells)/mm2 ONL in controls and 
EtbΔOC mice. Statistical analysis showed a significantly higher apoptosis rate in EtbΔOC mice than in controls. 
Data are means ± SEM. Control light n = 6; EtbΔOC light n = 8. p* = 0.04; student’s t-test. 
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3.5.1.2 Morphometric analysis after light-induced damage 
To verify, whether the observed higher rate of apoptotic cells in the ONL would affect the 
number of surviving photoreceptor cells, we used morphometric analysis of horizontal 
semithin-sections from nasal to temporal orientation of EtbΔOC mice and controls 14 days 
after light-induced damage (Figure 42). As expected, the light-induced damage was 
restricted to the central part of the retina resulting in a thinning of the ONL (Figure 42 A). 
A detailed magnification of the central retina (Figure 42 B) exemplified a remarkable 
thinning of the ONL following light exposure, which was considerably more pronounced 
in the EtbΔOCmice compared to controls. 
  
 
 
A 
Figure 42 Semithin-sections of the eyes of a EtbΔOC mouse and its control littermate (8 week-old) 14 days 
after light-induced damage. Horizontal (1µm) semithin- sections (Richardson stained) of retinal 
hemispheres (A) and the central part of the retinae (B) showed an obvious thinning of the ONL in the central 
part which is more pronounced in EtbΔOC mice compared to controls, RGC =retinal ganglion cell layer, INL 
= inner nuclear layer, ONL = outer nuclear layer, RPE = retinal pigment epithelium. (C) Spider diagram of 
the thickness of the ONL in EtbΔOC mice and controls after light exposure. The thickness was measured on 
semithin-sections at 21 measure points from temporal to nasal side and the mean values of the ONL 
measurements were blotted in spider diagrams. There was a significant thinning of the INL and especially 
ONL detectable in the EtbΔOC mice (INL n=5, p > 0.05 (not significant); ONL n=5, p* ≤ 0.05, p** ≤ 0.01) and 
controls (n=4, p** ≤ 0.01). OS = ora serrata; ONH = optic nerve head. Data are means ± SEM, student’s t-
test. 
B C 
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For further quantification, the remaining thickness of the ONL was measured at 21 
measure points from temporal to nasal side and the mean values of the ONL 
measurements were blotted in spider diagrams (Figure 42 C). The ONL EtbΔOC mice 
showed a significant thinning at 10 measure points compared to controls strongly 
indicating that the evaluated higher rate of apoptotic cells following light exposure indeed 
resulted in a pronounced degeneration of photoreceptors. In summary, these findings 
identify Etb mediated signalling as neuroprotective for the survival of photoreceptors.  
 
3.5.1.3 Relative mRNA expression of Endothelin signalling after light-induced damage 
An increased expression of Endothelin2 is well described in the context of photoreceptor 
degeneration and we furthermore recently showed that other members of the endothelin 
signaling pathway are upregulated following different ocular trauma (Chapter 0) (Rattner 
and Nathans, 2005; Joly et al., 2008; Braunger et al., 2013a). Hence, we analysed the 
mRNA expression levels of endothelin receptor a (Eta), endothelin 1 (Et-1), endothelin 2 
(Et-2) and endothelin 3 (Et-3) (Figure 43). 6 h after light damage, the eyes of EtbΔOC light 
and control light were enucleated and analysed via quantitative real-time RT-PCR. Two 
further experimental groups, light un-exposed EtbΔOC and control mice, served as 
reference groups for the light damage experiments. For that purpose, these mice were 
kept in the dark period for five days without any light exposure. These dark-adapted mice 
are referred to as EtbΔOC and control. 
  
  
Results page | 59 
 
 
 
After light exposure, the relative Et-1 mRNA expression levels were not significantly 
altered in EtbΔOC mice (2.11 ± 0.39) compared to controls (control no light: 1.00 ± 0.33, 
p=0.47; EtbΔOC light: 2.11 ± 0.34, p=0.21, control light: 0.96 ± 0.03, p=0.96). In light-
exposed EtbΔOC mice, there was a significant increase of the relative mRNA expression 
levels of Eta (4.84 ± 0.47) compared to un-exposed controls (1.00 ± 0.79, p=0.007), un-
exposed EtbΔOC mice (1.91 ± 0.47, p=0.04). and light-exposed controls (1.55 ± 0.74, 
p=0.03), Et-2 (3.33 ± 0.72) compared to un-exposed controls (1.00 ± 0.09, p=0.05) and 
un-exposed EtbΔOC mice (2.21 ± 0.47, p=0.34) and Et-3 (3.33 ± 0.72) compared to un-
exposed controls (1.00 ± 0.21, p=0.01) and light-exposed controls (1.07 ± 0.26, p=0.01). 
Taken together, our results show that there was an activation of endothelin signalling 
(Eta, Et-2, Et-3) in EtbΔOC mice after light exposure. 
3.5.1.4 Relative mRNA expression of Tgf-β Signalling after light-induced damage 
Furthermore, we examined the effect of the deletion of Etb in retinal neurons and Müller 
cells following light damage on the relative mRNA expression levels of members of the 
Tgf-β signalling pathway (Figure 44). 
Figure 43 Relative mRNA expression levels of Endothelin signalling in 6 week-old 
controls and EtbΔOC retinae 6 h after light exposure and without light exposure. 
Relative Et-1 mRNA levels were not significantly altered in control and EtbΔOC mice 
without and with light exposure. However, the relative Eta mRNA expression 
levels were significantly increased in EtbΔOC light retinae compared to un-exposed 
and light-exposed controls and EtbΔOC retinae without light exposure. The Et-2 
mRNA expression levels of EtbΔOC were significantly increased after light 
exposure compared to un-exposed EtbΔOC and controls. The Et-3 mRNA 
expression was significantly elevated in light exposed EtbΔOC retinae compared to 
un-exposed and light-exposed controls. The mean value of Gapdh and Ubiquitin 
c were used for normalization. Data are means ± SEM. Eta: control no light n =3, 
control light n = 2, EtbΔOC no light n = 3, EtbΔOC light n = 2; Et-1: control no light n 
=4, control light n = 5, EtbΔOC no light n = 3, EtbΔOC light n = 6; Et-2: control no light 
n =3, control light n = 6, EtbΔOC no light n = 6, EtbΔOC light n = 6; Et-3: control no 
light n =4, control light n = 5, EtbΔOC no light n = 5, EtbΔOC light n = 5. p* ≤ 0.05, 
p** ≤ 0.01, one-way ANOVA. 
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In light exposed EtbΔOC mice, the relative mRNA expression levels of Tgfbr1 (1.49 ± 
0.23), Tgfbr2 (1.87 ± 0.31) and Tgfβ1 (2.71 ± 0.28) were not significantly altered 
(compared to Tgfbr1: control no light: 1.00 ± 0.42, p= 1.05; EtbΔOC no light: 0.91 ± 0.25, 
p= 0.95; control light: 0.58 ± 0.04, p= 0.12 ; Tgfbr2: control no light: 1.00 ± 0.20, p= 0.43; 
EtbΔOC no light: 1.58 ± 0.36, p= 0.83; control light: 1.22± 0.23, p= 0.77;Tgf-β1: control no 
light: 1.00 ± 0.17, p= 0.45; EtbΔOC no light: 2.00 ± 0.59, p= 0.063; control light: 1.56 ± 
0.28, p= 0.39). Following light exposure the relative mRNA expression level of Tgfβ-2 
was significantly increased in EtbΔOC light mice (1.89 ± 0.18) compared to un-exposed 
EtbΔOC mice (0.75 ± 0.12, p= 0.004). Also the relative mRNA expression level of Tgfβ-3 
was significantly increased in EtbΔOC light mice (1.95 ± 0.22) compared to light-exposed 
control mice (1.19 ± 0.06, p= 0.02) and un-exposed control mice (1.00 ± 0.19, p= 0.008). 
Taken together, our results show that there was an activation of Tgf-β signalling (Tgfβ-
2, Tgfβ) in EtbΔOC mice after light exposure. 
3.5.1.5 Relative mRNA expression of pro- and anti-apoptotic factors after light-
induced damage 
Furthermore, the impact of excessive light exposure on the relative mRNA expression 
levels of extrinsic (Caspase 8) and intrinsic (Caspase 9, Bim, Bax, Bad) apoptotic 
Figure 44 Relative mRNA expression levels of Tgf-β signalling in 6 week-old controls and 
EtbΔOC retinae without and 6 h after light exposure. Relative Tgfbr1, Tgfbr2 and Tgf-β1 mRNA 
expression levels were not significantly altered in all experimental mice. However, there was a 
significantly increased Tgf-β2 mRNA expression level in light-exposed EtbΔOC mice compared 
to un-exposed EtbΔOC mice. Relative Tgf-β3 mRNA levels were significantly increased EtbΔOC 
mice after light damage compared to un-exposed and light-exposed controls. The mean value 
of Gapdh and Ubiquitin c were used for normalization. Data are means ± SEM. Tgfβr1: control 
no light n =4, control light n = 6, EtbΔOC no light n = 5, EtbΔOC light n = 5; Tgfβr2: control no light 
n =4, control light n = 6, EtbΔOC no light n = 6, EtbΔOC light n = 5; Tgfβ1: control no light n =4, 
control light n = 6, EtbΔOC no light n = 6, EtbΔOC light n = 6; Tgfβ2: control no light n =4, control 
light n = 6, EtbΔOC no light n = 6, EtbΔOC light n = 5; Tgfβ3: control no light n =4, control light n 
= 6, EtbΔOC no light n = 6, EtbΔOC light n = 6. p* ≤ 0.05, p** ≤ 0.01, one-way ANOVA 
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signalling as well as the anti-apoptotic factor Bcl2 was determined in EtbΔOC animals and 
controls (Figure 45).   
 
 
Following light-induced damage, the relative mRNA expression levels of Caspase 9 (1.19 
± 0.62), Bim (2.23 ± 0.89), Bax (0.88 ± 0.09), Bad (0.80 ± 0.09) and Bcl2 (0.47 ± 0.09) 
were not significantly altered in EtbΔOC mice (compared to Caspase 9: control no light: 
1.00 ± 0.14, p=0.25; EtbΔOC no light: 1.11 ± 0.15, p=0.29; control light: 0.93 ± 0.08, 
p=0.11; Bim: control no light: 1.00 ± 0.25, p=0.31; EtbΔOC no light: 1.75 ± 0.39, p=0.56; 
control light: 1.63 ± 0.31, p=0.42; Bax: control no light: 1.00 ± 0.22, p=0.61; EtbΔOC no 
light: 0.79 ± 0.08, p=0.49; control light: 1.24 ± 0.38, p=0.11; Bad: control no light: 1.00 ± 
0.07, p=0.17; EtbΔOC no light: 0.85 ± 0.07, p=0.69; control light: 0.73 ± 0.07, p=0.57; Bcl2: 
control no light: 1.00 ± 0.50, p=0.22; EtbΔOC no light: 0.46 ± 0.11, p=0.41; control light: 
0.25 ± 0.05, p=0.11). Intriguingly, there was a significant elevation of the relative 
Caspase 8 mRNA expression in light-exposed EtbΔOC mice (1.59 ± 0.22) compared to 
un-exposed EtbΔOC mice (0.73 ± 0.11, p=0.02) and light-exposed control mice (0.43 ± 
0.004)  
Taken together, our results show that light exposure promotes the extrinsic pathway of 
apoptosis (Caspase 8) in EtbΔOC mice. 
Figure 45 Relative mRNA expression levels of pro- and anti-apoptotic factors in 6 week-old controls and 
EtbΔOC retinae without and 6 h after light exposure. Relative Caspase 8 mRNA expression levels were 
significantly increased in light-exposed EtbΔOC mice compared to un-exposed EtbΔOC mice and light-
exposed controls. There were no significant alterations of the relative mRNA expression levels of the other 
investigated pro- and anti-apoptotic factors. The mean values of Gapdh and Ubiquitin c were used for 
normalization. Data are means ± SEM. Caspase 8: control no light n =4, control light n = 6, EtbΔOC no light 
n = 5, EtbΔOC light n = 5; Caspase 9: control n =4, control light n = 5, EtbΔOC n = 6, EtbΔOC light n = 5; Bim: 
control n =2, control light n = 6, EtbΔOC no light n = 4, EtbΔOC light n = 2; Bax: control no light n =2, control 
light n = 4, EtbΔOC no light n = 5, EtbΔOC light n = 3; Bad: control no light n =4, control light n = 6, EtbΔOC no 
light n = 6, EtbΔOC light n = 6; Bcl2: control no light n =3, control light n = 5, EtbΔOC no light n = 6, EtbΔOC 
light n = 5. p* ≤ 0.05, p** ≤ 0.01; one-way ANOVA 
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3.5.1.6 Relative mRNA expression of neuroprotective factors after light-induced 
damage 
Next, we examined the influence of the light-induced photoreceptor degeneration in 
EtbΔOC animals and controls on the expression levels of neuroprotective factors Lif, Fgf2 
and Bdnf, all involved in a molecular neuroprotective loop in the retina (Figure 46). As 
Et-2 (already mentioned in Chapter 3.5.1.3) also distributes to retinal neuroprotection, it 
is again shown in this chapter. 
 
 
 
The relative Bdnf mRNA expression levels were not significantly altered in light-exposed 
EtbΔOC mice (1.33 ± 0.22) (compared to control no light: 1.00 ± 0.39, p=; EtbΔOC  no light: 
0.39 ± 0.12, p=0.18; control light: 0.89 ± 0.18, p=0.47 ). There was a significant increase 
of the relative mRNA expression levels of Lif in light-exposed EtbΔOC mice (89.12 ± 7.54) 
compared to un-exposed controls (1.00 ± 0.19, p=0.0003), un-exposed EtbΔOC mice 
(0.95 ± 0.16, p=0.0001) and light-exposed controls (39.63 ± 7.02, p=0.0002) The 
excessive light exposure led also to a significant elevation of the relative Fgf2 mRNA 
expression in EtbΔOC mice (4 ± 0.5) compared to un-exposed mice (control: 1.00 ± 0.16, 
Figure 46 Relative mRNA expression levels of neuroprotective factors 
in 6 week-old controls and EtbΔOC retinae without and 6 h after light 
exposure. There were no significant alterations of the relative mRNA 
expression of Bdnf detectable Relative Lif and Fgf2 mRNA expression 
levels were significantly increased in light-exposed EtbΔOC mice 
compared to un-exposed controls, un-exposed EtbΔOC mice and light-
exposed controls. The mean value of Gapdh and Ubiquitin c were used 
for normalization. Data are means ± SEM. Lif: control no light n =4, 
control light n = 6, EtbΔOC no light n = 5, EtbΔOC light n = 5; Fgf2: control 
no light n =4, control light n = 5, EtbΔOC no light n = 6, EtbΔOC light n = 
5; Bdnf: control no light n =2, control light n = 6, EtbΔOC no light n = 4, 
EtbΔOC light n = 2, p* ≤ 0.05, p** ≤ 0.01, p*** ≤ 0.001 one-way ANOVA 
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p=0.0002), un-exposed EtbΔOC mice (1.18 ± 0.23, p= p=0.0001) as well as light-exposed 
controls (1.54 ± 0.28, p= p=0.0002). 
Taken together, our results show that light exposure induces the neuroprotective 
signalling, which is mediated by Et-2, Lif, Fgf2. 
 
3.5.1.7 Relative protein expression level of pAKT/AKT signalling 
Finally, we examined whether the observed increase in Lif and Fgf2 after light-induced 
damage might have an impact on the activation of the Akt signaling pathway, a signal 
transduction pathway that promotes directly survival on the cell by its phosphorylated 
and activated form p(phospho)Akt. Western blot analysis and relative densitometry of 
retinal protein lysates of controls and EtbΔOC mice following light exposure (Figure 47 A) 
showed comparable relative protein levels of Akt in control (1.00 ± 0.29) and EtbΔOC mice 
(1.12 ± 0.23, p = 0.8).  
 
 
Quite intriguingly, the relative protein level of the activated form pAkt was remarkably 
decreased in the EtbΔOC mice (0.19 ± 0.05, p = 0.2) compared to controls (1.00 ± 0.51), 
a finding that might well explain the observed higher rate of apoptotic photoreceptors in 
EtbΔOC mice following light exposure. 
 
3.5.2 In vitro: Neuroprotective role of Etb on cultured photoreceptor cells following 
serum-deprivation  
To allow for a more detailed analysis of the impact of a deletion of etb on photoreceptor 
cells (in vitro) under pathological conditions, we caused a starvation stress in 661WΔEtb 
and controls (P13) by serum-deprivation for 24 h. These cells are referred to as 661WΔEtb 
serum-free and controls serum-free. 661WΔEtb and 661W control cells were maintained 
Figure 47 Relative densitometry of Akt and phospho-Akt in 6 week-old control and EtbΔOC retinae 6 h after 
light exposure. (A) Relative densitometry of Akt showed comparable protein expression levels in EtbΔOC mice 
compared to controls. (B) Relative densitometry of pAkt showed decreased expression in EtbΔOC mice 
compared to controls. Gapdh was used as for normalization. Data are means ± SEM, Akt: Control light n = 
6; EtbΔOC light n = 6; p = 0.8; pAkt: Control light n = 5; EtbΔOC light n = 5; p = 0.2. student’s t-test. 
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in normal amounts of serum and served as reference groups for the serum-free 
conditions.  
 
3.5.2.1 TdT-mediated dUTP-biotin nick end labeling (TUNEL): Validation of serum-
deprivation 
To examine whether Etb mediates a direct neuroprotective effect on photoreceptor 
survival in an autocrine manner, we analysed the number of apoptotic cells in 661WΔEtb 
cells and 661W control cells after serum-deprivation for 24 h as well as in serum-treated 
661WΔEtb cells and 661W control cells. To validate a successful cell stress via serum-
deprivation, TdT-mediated dUTP-biotin nick end labeling (TUNEL, Chapter 6.5.6) was 
performed on 4%-PFA-fixed cells and the number of apoptotic cells in 661WΔEtb  cells 
and 661W controls cells with and without serum was analysed (Figure 48) . The number 
of apoptotic cells was counted and calculated as the relative apoptosis rate of the totality 
of cells was determined (Figure 49). Serum-treated 661WΔEtb cells (2.5 ± 0.1) as well as 
serum-deprived controls (2 ± 0.06) and serum-deprived 661WΔEtb cells showed a higher 
number of TUNEL-positive cells compared to the serum-treated 661W control cells (1 ± 
0.3). Strikingly, serum-deprived 661WΔEtb cells (4.1 ± 0.1) showed a significantly 
increased rate of apoptotic photoreceptor cells compared to all other experimental 
conditions (serum-treated 661W control cells, serum-deprived 661W cells and serum-
treated 661W 661WΔEtb cells). 
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 Figure 48 TUNEL staining of 4%PFA fixed 661WΔEtb cells and 661W control cells after 
serum-deprivation for 24 h and after serum-treatment. Numerous TUNEL positive 
cells were detectable (green) in cells after serum-deprivation for 24 h. The nuclei were 
stained with Dapi (blue). 
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Figure 49 Relative apoptosis rate in 661WΔEtb 
cells and 661W control cells after serum-
deprivation for 24 h as wells as in serum-treated 
661WΔEtb cells and serum-treated 661W control 
cells. After serum-deprivation, 661WΔEtb cells 
showed a significant increased relative 
apoptosis rate. Data are means ± SEM, 661W 
control cells serum-treated n = 6; EtbΔOC serum-
treated n = 6; 661W control cells serum-free n = 
6; EtbΔOC serum-free n = 6. p* = 0.02; p* = 0.005, 
p** = 0.04, p***= 0.0001. one-way ANOVA 
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3.5.2.2 Relative mRNA expression of Endothelin signalling after serum-deprivation  
Next, we analysed the mRNA expression levels of the Endothelin signalling family and 
therefore compared the relative mRNA expression levels of Eta, Et-1, Et-2 and Et-3 in 
cell lysates of serum-treated and serum-deprived cells (Figure 50).  
 
 
In serum-free 661WΔEtb cells, there were no significant alterations of the relative mRNA 
expression of Eta (3.81 ± 1.97), Et-1 (0.20 ± 0.07) Et-2 ( 3.14 ± 1.52) and Et-3 (2.48 ± 
1.13) detectable compared to serum-free 661W control cells (Eta: 5.37 ± 2.04; p= 0.64 
Et-1: 0.70 ± 0.48, p=0.28; Et-2: 2.28 ± 0.44, p=0.61; Et-3: 3.25 ± 2.11, p=0.78) and to 
serum-treated cells (661W control cells: Eta: 1.00 ± 0.41, p=0.30; Et-1: 1.00 ± 0.00, 
p=0.81 ; Et-2: 1.00 ± 0.27, p=0.24; Et-3: 1.00 ± 0.33, p=0.34; 661WΔEtb: Eta: 2.49 ± 1.22, 
p=0.58; Et-1: 1.49 ± 0.47, p=0.07, Et-2: 0.92 ± 0.28, p=0.61; Et-3: 1.38 ± 0.16, p=0.78).  
Taken together, our results show that the lack of Etb in photoreceptor cells does not 
affect the expression of the remaining endothelin signalling, under physiological as well 
as pathological conditions. 
3.5.2.3 Relative mRNA expression levels of Tgf-β signalling after serum-deprivation 
Subsequently, we aimed to analyse whether the deletion of Etb in photoreceptor cells 
would affect the expression of Tgf-beta signalling. We therefore examined the relative 
mRNA expression levels of Tgfbr1, Tgfbr2, Tgf-β1, Tgf-β2 and Tgf-β3 (Figure 51). 
Figure 50 mRNA expression levels of Endothelin signalling in cell lysates of serum-treated 661WΔEtb and 
661W control cells as well as serum-deprived (24 h) 661WΔEtb and 661W control cells. There were no 
significant alterations detectable. The mean values of Gapdh and Gnb2l were for normalization. Data are 
means ± SEM; Eta: control serum-treated n =2, 661WΔEtb serum-treated n = 2, control serum-free n = 3, 
661WΔEtb serum-free n = 2; Et-1: control serum-treated n =2, 661WΔEtb serum-treated n = 3, control serum-
free n = 2; 661WΔEtb serum-free n = 3; Et-2: control serum-treated n =2, 661WΔEtb serum-treated n = 3, 
control serum-free n = 3, 661WΔEtb serum-free n = 3; Et-3: control serum-treated n =2, 661WΔEtb serum-
treated n = 2, control serum-free n = 2, 661WΔEtb serum-free n = 2; p ˃0.05; one-way ANOVA.  
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The relative mRNA expression levels of Tgfbr1, Tgf-β1, Tgf-β2 and Tgf-β3 were not 
significantly altered in serum-free 661WΔEtb cells (Tgfbr1: 4.16 ± 1.98; Tgf-β1: 4.72 ± 
1.42; Tgf-β2: 0.35 ± 0.08; Tgf-β3: 2.16 ± 0.52) compared to serum-treated 661W control 
cells (Tgfbr1: 1.00 ± 0.33, p=0.69; Tgf-β1: 1.00 ± 0.19, p=0.07; Tgf-β2: 1.00 ± 0.30, 
p=0.10; Tgf-β3: 1.00 ± 0.16, p=0.11); serum-treated 661WΔEtb cells (Tgfbr1: 1.99 ± 0.34, 
p=0.34; Tgf-β1: 1.88 ± 0.16, p=0.12; Tgf-β2: 0.62 ± 0.18, p=0.24; Tgf-β3: 0.96 ± 0.11, 
p=0.10) and serum-free 661W control cells (Tgfbr1: 5.06 ± 1.79, p=0.75; Tgf-β1: 5.74 ± 
2.40, p=0.74; Tgf-β2: 0.84 ± 0.36, p=;0.25 Tgf-β3: 2.73 ± 1.14, p=0.53). After serum-
deprivation, the relative mRNA expression levels of Tgfbr2 was significantly (p=0.003) 
elevated (4.63 ± 1.85) in serum-deprived 661WΔEtb cells compared to serum treated 
controls (1.00 ± 0.23).  
Taken together, our results show that serum-deprived photoreceptor cell stress activates 
Tgf-β signalling (Tgfbr2). 
 
Figure 51 mRNA expression levels of Tgf-β signalling in cell lysates of serum-treated 661WΔEtb 
and 661W control cells as well as serum-deprived (24 h) 661WΔEtb and 661W control cells. The 
relative mRNA expression levels of Tgfbr2 was significantly in serum-deprived 661WΔEtb cells 
compared to serum-treated controls, whereas the remaining members of Tgf-β signalling were 
not significantly altered. The mean of values of Gapdh and Gnb2l were used for normalization. 
Data are means ± SEM; Tgfbr1: control serum-treated n =3, 661WΔEtb serum-treated n = 3, 
control serum-free n = 3, 661WΔEtb serum-free n = 3; Tgfbr2: control serum-treated n =3, 
661WΔEtb n = 3, control serum-free n = 3, 661WΔEtb serum-free n = 3; Tgf-β1: control serum-
treated n =3, 661WΔEtb serum-treated n = 3, control serum-free n = 3, 661WΔEtb serum-free n = 
3; Tgf-β2: control serum-treated n =3, 661WΔEtb serum-treated n = 3, control serum-free n = 3, 
661WΔEtb serum-free n = 3; Tgf-β3: control serum-treated n =3, 661WΔEtb serum-treated n = 3, 
control serum-free n = 3, 661WΔEtb serum-free n = 2; p* ≤ 0.05; p ˃0.05, one-way ANOVA. 
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3.5.2.4 Relative mRNA expression levels of pro- and anti-apoptotic factors after 
serum-deprivation 
Next, the effect of serum-deprivation on apoptotic pathways was determined by 
analysing the members of the extrinsic (Caspase 8) and intrinsic (Caspase 9, Bim, Bax, 
Bad) pathway of apoptosis as well as the anti-apoptotic factor Bcl2 (Figure 52). 
 
 
After serum-deprivation, the relative mRNA expression levels of the pro-apoptotic factors 
Caspase 9, Bim, Bax, Bad and the anti-apoptotic factor Bcl2 were not significantly altered 
in 661WΔEtb cells (Caspase 9: 8.29 ± 3.99; Bim: 1.08 ± 1.00; Bax: 2.30 ± 1.45; Bad: 2.49 
± 0.67; Bcl2: 0.94 ± 0.22) compared to serum-treated 661W control cells (Caspase 9: 
1.00 ± 0.15, p=0.14; Bim: 1.00 ± 0.13, p=0.49; Bax: 1.00 ± 0.06, p=0.31; Bad: 1.00 ± 
0.27, p=0.1; Bcl2: 1.00 ± 0.26, p=0.89), serum-treated 661WΔEtb (Caspase 9: 1.06 ± 0.26, 
p=0.15; Bim: 1.22 ± 0.78, p=0.80; Bax: 1.23 ± 0.02, p=0.54; Bad: 1.03 ± 0.06, p=0.10; 
Bcl2: 1.41 ± 0.17, p=0.17) and serum-free 661W control cells (Caspase 9: 6.03 ± 2.59, 
p=0.66; Bim: 0.31 ± 0.04, p=0.52; Bax: 2.02 ± 0.03, p=0.87; Bad: 2.43 ± 0.52, p=0.96; 
Bcl2: 1.71 ± 0.46, p=0.20). In contrast, the relative Caspase 8 mRNA expression was 
significantly elevated in serum-deprived controls (2.73 ± 0.10) compared to serum-
Figure 52 mRNA expression levels of pro- and anti-apoptotic factors in cell lysates of serum-treated 
661WΔEtb and 661W control cells as well as serum-deprived (24 h) 661WΔEtb and 661W control cells. The 
relative Caspase 8 mRNA expression was significantly elevated in serum-deprived 661W control cells and 
661WΔEtb cells. There were no further significant alterations detectable. The mean value of Gapdh and 
Gnb2l were used for normalization. Data are means ± SEM; Caspase8: control serum-treated n =3, 
661WΔEtb serum-treated n = 3, control serum-free n = 3, 661WΔEtb serum-free n = 3; Caspase9: control 
serum-treated n =3, 661WΔEtb serum-treated n = 3, control serum-free n = 3, 661WΔEtb serum-free n = 3; 
Bim: control serum-treated n =3, 661WΔEtb serum-treated n = 3, control serum-free n = 3, 661WΔEtb serum-
free n = 3; Bax: control serum-treated n =3, 661WΔEtb serum-treated n = 3, control serum-free n = 3,  
661WΔEtb serum-free n = 3; Bad: control serum-treated n =3, 661WΔEtb serum-treated n = 3, control serum-
free n = 3, 661WΔEtb serum-free n = 2; Bcl2: control serum-treated n =3, 661WΔEtb serum-treated n = 3, 
control serum-free n = 3, 661WΔEtb serum-free n = 2; p* ≤ 0.05, p** ≤ 0.01, p ˃0.05 one-way ANOVA.  
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treated 661W control cells (1.00 ± 0.38, p=0.005) and serum-treated 661WΔetb cells (1.37 
± 0.07, p=0.02). Furthermore, the relative Caspase 8 mRNA expression levels was 
significantly increased after serum-deprivation in 661WEtb cells (2.58 ± 0.11) compared 
to serum-treated 661W control cells (1.00 ± 0.38, p=0.02). 
In summary, the serum-deprivation of 661W control cells as well as 661WEtb cells leads 
to an activation of the extrinsic pathway of apoptosis (Caspase 8). 
 
3.5.2.5 Relative mRNA expression levels of neuroprotective factors after serum-
deprivation 
At last, we examined the effect of serum-deprivation on the relative mRNA expression of 
the neuroprotective factors Lif and Fgf2. As Et-2 (already mentioned in Chapter 3.5.2.2) 
is also member of the retinal neuroprotective loop, it is again listed in this chapter. 
 
 
 
After serum-deprivation, the were no significant alterations of the relative Et-2, Lif and 
Fgf2 mRNA expression levels in 661WΔEtb cells (Lif: 0.93 ± 0.15; Fgf2: 1.25 ± 0.17) 
compared to serum-treated controls (Lif: 1.00 ± 0.54, p=0.90; Fgf2: 1.00 ± 0.41, p=0.68), 
serum-treated 661WΔEtb cells (Lif: 1.70 ± 0.85, p=0.38; Fgf2: 2.78 ± 0.57, p=0.14) and 
serum-untreated controls (Lif: 0.76 ± 0.29, p=0.65; Fgf2: 2.18 ± 1.00, p=0.53). 
In summary, serum-deprivation does not induce neuroprotection in photoreceptor cells. 
Figure 53 mRNA expression levels of neuroprotective factors 
in cell lysates of serum-treated 661WΔEtb and 661W control 
cells as well as serum-deprived (24 h) 661WΔEtb and controls. 
There were no significant alterations detectable. The mean 
value of Gapdh and Gnb2l were used for normalization. Data 
are means ± SEM; Lif: control serum-treated n =3, 661WΔEtb 
serum-treated n = 3, control serum-free n = 3, 661WΔEtb 
serum-free n = 3; Fgf2: control n =3, 661WΔEtb serum-treated 
n = 3; p ˃0.05; one-way ANOVA.  
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3.6 Proteomics analysis: proteasomal dysregulation in 
photoreceptor cells following Etb-deficiency (in vivo) 
In cooperation with Dr. Stefanie Hauck (Helmholtz-Zentrum München), we performed 
proteomics, a large-scale study of the proteome, the totality of proteins, of the Etb-
deficient 661WΔEtb cells and controls (James et al., 1997). The objective of the following 
proteomics analysis was to identify proteins in photoreceptor cells that were affected by 
the Etb -deficiency and allow to classify the underlying molecular mechanisms that might 
be affect through the deletion of Etb. With the help of mass spectrometry, the proteome 
analysis allowed us to identify 5801 proteins among them 144 proteins with a down-
regulation and 130 proteins with an up-regulation after correcting the significance for 
multiple comparison (Figure 54 A). For describing correlation patterns among the 
analysed proteins, weighted correlation network analysis (WGCNA) was performed in 
cooperation with Dr. Andreas Neueder (Neurology, University Ulm). The WGCNA 
network displayed regulated modules (Figure 54 B). Each vertical line represented a 
specific protein, whereas branches illustrated proteins with highly correlated expression 
pattern and were summarized to modules. One negatively and one positively module 
was identified with a significant association to Etb-deficiency (Figure 54 C). A positive 
correlation corresponded to a higher expression or rather a negative correlation to a 
lower expression in 661WΔEtb cells compared to controls. The highest regulated 
proteins were defined as hub genes via an intra-module connectivity in the positive 
module (Pos 1 hub proteins) and negative module (Neg1 hub proteins). Figure 54 (D, E) 
illustrates the Top 50 hub proteins with the Top 500 strongest connectivities. Mainly, 
661WΔEtb cells showed significant alterations of protein expression in several sections 
like catabolic and metabolic processes as well as protein transport. Remarkably, 
661WΔEtb cells depicted significant alterations in a group of proteins which are associated 
with proteasomal degradation processes (e.g.PSMA1/3, PSMD13, USP14 Protein) 
indicating a proteasomal dysregulation following Etb-deficiency. 
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Figure 54 Proteomics and WGCNA analyses of 661WΔEtb cells and controls. (A) Volcano Plot showing 
analysis of dysregulation in 661WΔEtb cells and 661W control cells. Padj are Benjamini-Hochberg corrected 
p-values (two-tailed, homoscedastic student’s t-test). (B) WGCNA network displaying regulated modules. 
Each vertical line represented a specific protein, whereas branches illustrated proteins with highly correlated 
expression pattern and were summarized to modules. (C) One negatively and one positively correlated 
module was identified with a significant association to Etb-deficiency. A positive correlation corresponded 
to a higher expression or rather a negative correlation to a lower expression in 661WΔEtb cells compared to 
controls. (D/E) The highest regulated proteins were defined as hub genes via an intra-module connectivity 
in the positive module (Pos 1 hub proteins) and negative module (Neg1 hub proteins). The Top 50 hub 
proteins with the Top 500 strongest connectivities (connecting line) were shown. The strength of each 
connecting line correlates to the intensity of co-regulation. Hub proteins were coloured according to their 
ontologies (generic GOslim Ontology for mice). Only significant ontologies are shown (hypergeometric test, 
Benjamini-Hochberg corrected FDR < 0.05). Remarkably, 661WΔEtb cells depicted significant alterations in 
a group of proteins which are associated with proteasomal degradation processes indicating a proteasomal 
dysregulation following Etb-deficiency. In cooperation with Dr. Andreas Neueder (Neurology, University 
Ulm). 
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4 Discussion 
Based on the data of this thesis, we conclude that Etb mediated signalling in the entire 
eye is (1) essential for the cellular and morphological organization of the lens. (2) Does 
not obviously affect the retinal morphology but results in an (3) increased expression Eta 
and of specific pericyte markers indicating that Eta and the pericyte population most likely 
compensate for the loss of Etb mediated signalling in the retina and the vascular 
microenvironment, respectively.  
We furthermore conclude that the cell type specific deletion of Etb mediated signalling in 
retinal neurons and Müller cells (4) does not obviously affect the retinal morphology but 
results in an (5) increased expression of retinal Eta. The data of this thesis furthermore 
show that after light induced degeneration or serum deprivation, Etb mediated signalling 
is (6) an essential key regulator of photoreceptor survival that (7) mediates its 
downstream signalling through activation of Akt signalling, concomitant with (8) the 
regulation of caspase-mediated apoptosis. Thus, we conclude that Etb-mediated 
signalling is crucial for photoreceptor survival following traumatic damages. 
 
4.1 Lens phenotype: Endothelin receptor b is essential for cellular 
homeostasis and Collagen IV synthesis in the lens 
Quite intriguingly, we observed morphological alterations of the lens in 30% of the EtbΔeye 
mice, whereas the remaining 70% EtbΔeye mice and controls manifested lenses with 
normal appearance. One possible explanation for the non-fully penetrant effects could 
be due to a varying degree of cells that are affected by the deletion of Etb following 
tamoxifen induced recombination. 
The affected lenses showed a collapsed, vacuolated structure. Presumably, a rupture of 
the lens capsule led to a release of lenticular material in the vitreous and we furthermore 
observed scar-like formation in the raptured areas.  
Similar to our findings, comparable pathologies of the lens were already observed at our 
department in mice with a Tgf-β1 overexpression in the lens, driven by the very strong 
chicken βB1‐crystallin promotor (Flügel-Koch et al., 2002). This promotor has been 
shown to drive lens‐specific expression and to be active in both primary and secondary 
lens fibres from embryonic (E) day 12.5 until adulthood (Flügel-Koch et al., 2002; Duncan 
et al., 1996). In these transgenic lenses, besides the degeneration and deformation of 
anterior fibres, also epithelial cells underwent apoptotic cell death leading to a missing 
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lens epithelium following Tgf-β1 overexpression. Probably, this phenotype was due the 
high activity of the βB1‐crystallin promotor and the consequently resulting very high 
expression of Tgf-β1, as other Tgf-β1 overexpressing mice using the less active, but also 
lens-specific αA‐crystallin promoter (αA–TGF‐β1) showed no comparable lens 
pathologies (Srinivasan et al., 1998; Overbeek et al., 1985; Flügel-Koch et al., 2002). 
The lens phenotype in Tgf-β1 overexpression mice was already manifested at embryonic 
stages suggesting developmental lenticular disorganization, which probably based on 
the βB1‐crystallin promotor activation and Tgf-β1 expression starting its activity at E12.5. 
The tamoxifen inducible chicken β actin promoter in EtbΔeye mice was induced at adult 
age and led to a downregulation of endothelin receptor b (Etb). Thus, based on our data, 
we hypothesized that a deletion of Etb in the lens might lead to a rupture of the lens 
epithelium and in turn of the lens capsule resulting to the release of lenticular material in 
the vitreous and the formation of scarring structures. The lens epithelium is a simple 
cuboidal epithelium (Forrester, 1996) and regulates osmotic concentration and volume 
of the lens via Na+/K+-ATPase pumps in the lens epithelial cells (Candia, 2004). In this 
regard, there are publication showing that Et-1 has an inhibitory effect on Na+/K+-
transport as measurements of ouabain-sensitive potassium (86Rb) ex vivo indicated that 
a dose-dependent treatment with Et-1 reduced the rate Na+/K+-ATPase–mediated 
potassium transport in porcine lens resulting in a detectable increase of the sodium 
content of the lens (Okafor and Delamere, 2001). This Et-1 mediated effect was 
suppressed by a pharmacological inhibition of Eta and Etb suggesting that Et1 slows 
active Na+/K+-transport by a mechanism involving an activation of both endothelin 
receptors (Okafor and Delamere, 2001). Similar Et-1 mediated inhibitory effects on 
Na+/K+-ATPase were also shown in cultured rat vascular smooth muscle cells (Meyer-
Lehnert et al., 1989) and in the rat renal proximal tubule (Garvin and Sanders, 1991). It 
is therefore reasonable to assume that the lack of Etb in the lens epithelium of EtbΔeye 
mice resulted in a disturbed Na+/K+-transport and thus the collapse of the cellular 
homeostasis of the lens. 
Furthermore, the lens capsule, a specialized thickened basement membrane, is mainly 
composed of the extra cellular matrix protein collagen IV, which comprises a family of 
six polypeptides, subunits alpha1(IV)-alpha6(IV), each of which is encoded by a distinct 
gene (COL4A1-A6) (Kelley et al., 2002). Mutations in COL4A3,COL4A4, and COL4A5 
like in the Alport Syndrome prevent the proper assembly of a specialised collagen 
network, in basement membranes. Amongst other pathologies, these mutations are 
associated with an increased risk of lens capsular rupture (Firtina et al., 2009), quite 
similar to the observed phenotype in EtbΔeye mice. Our immunohistochemical staining 
against collagen IV showed a distinct and continuous collagen IV expression on top of 
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the lens capsule in the control mice, whereas fluorescence intensity was attenuated in 
EtbΔeye mice without any lens phenotype. However, EtbΔeye mice demonstrating the lens 
phenotype, showed only a weak and punctual collagen IV signal in the lens capsule. 
Therefore, we hypothesized that Etb-deficiency in the lens is associated with a gradually 
reduced collagen IV expression in the lens capsule resulting in a collagen improper 
capsular network formation and finally resulting in the rupture of the lens. Supporting our 
hypothesis Rao et al. found a dose-dependent Et-1 mediated regulation of collagen 
synthesis in primary cultured human lamina cribrosa cells (Rao et al., 2008). However, 
this effect was mediated via both receptors as only a dual pharmacological blockage of 
Eta and Etb inhibited collagen protein expression (Rao et al., 2008), while the blocking 
of Eta and Etb alone had no effects on collagen expression (Rao et al., 2008). Similar 
effects were reported from studies using human peritoneal mesothelial cells and 
fibroblasts where a combined Eta/Etb-blockage also interrupted Et-1 mediated collagen 
synthesis (Morgera et al., 2003, 2003, 2003; Shi-Wen et al., 2001, 2001). However, as 
our Eta staining showed only very faint Eta signals in the lens, Etb is obviously the most 
dominant endothelin receptor in the lens. Thus, the lack of Etb in the lens of in EtbΔeye 
mice might very well result in an impaired collagen IV synthesis. 
 
4.2  The regulation of the endothelin receptors 
Remarkably, we could show a compensatory regulation of Eta and Etb receptors in 
retinal samples. Retinal lysates of Etb-deficient EtbΔeye mice showed a two-fold increase 
in Eta expression compared to controls. Moreover, retinal lysates of EtbΔOC mice showed 
a two-fold and significant increase in Eta expression compared to controls. These 
findings suggest that an upregulation of Eta expression might compensate for the lacking 
expression of Etb. Regarding vascular motricity, it has already been shown that Eta and 
Etb receptors underly a complex synergistic interaction (Just et al., 2004) to regulate the 
balance between primarly Eta-mediated vasoconstriction in smooth muscle cells and Etb 
promoted vasodilatation in vascular endothelial cells (Kedzierski and Yanagisawa, 2001; 
Hirata et al., 1993; Davenport et al., 2016). In this context Just and coworkers showed 
that Etb mediated vasodilation, caused by a selective pharmacological agonistic via 
direct infusion into the renal artery of rats, only after a pharmacological stimulation of 
Eta, which indicates a close interaction of both receptors (Just et al., 2004). Furthermore, 
such Eta/Etb receptors’ synergy has been shown in the vasculature as an Et-1 induced 
contraction of vascular smooth muscle cells measured by isometrically recordings of an 
ex vivo isolated rabbit pulmonary artery was only completely inhibited by a combined 
pharmacological blockage of both receptors, but not by  Eta or Etb only (Fukuroda et al., 
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1994b). This indicates that the activation of either only Eta or only Etb may be sufficient 
to compensate the expression of the lacking receptor and to cause vasoconstriction 
(Fukuroda et al., 1994b). Remarkably, EtbΔeye mice showed no vascular phenotype, 
probably due to the compensatory effect of Eta. It is reasonable to assume that the 
pericytes might be one of the cell-types reacting with an increased Eta expression. Eta 
is expressed by these cells (McDonald et al., 1995) and we furthermore detected an 
increased number of pericytes enclosing the vasculature of EtbΔeye  mice by 
immunohistochemical staining concomitant with an upregulation of the mRNA 
expression of the pericyte marker Ng-2 and Pdgfrb in retinae of EtbΔeye mice. In contrast, 
in our in vitro experiments Eta levels were not altered between Etb-deficient 
photoreceptor cells (661WΔOC) and 661W control cells. 
 
4.3 Etb deficiency and its effects on the retinal and choroidal 
vasculature  
Endothelin signaling is involved in a variety of physiological functions, above all the 
regulation of vasomotricity, blood pressure and vascular homeostasis (Rautureau et al., 
2015). Regarding the vasculature, Eta is predominantly expressed by vascular smooth 
muscle cells, whereas Etb is expressed by both vascular smooth muscle and endothelial 
cells (Guan et al., 2015). Given physiological conditions, the two receptors are 
considered to possess synergistic but also opposite actions with Eta and Etb promoting 
vasoconstriction and vasoconstriction, whereas Etb on endothelial cells contributes 
additionally to vasodilation (Schneider et al., 2007). Just as a short reminder, of the two 
analysed mouse strains in this thesis (EtbΔeye and EtbΔOC), only in EtbΔeye animals the 
deletion of Etb affected all ocular cells (including (peri)vascular cells), while in EtbΔOC 
mice the deletion was restricted to retinal neurons and Müller cells only. Thus 
remarkably, the EtbΔeye mice manifested no obvious morphological alterations of the 
retinal and choroidal vasculature. In this context it is important to note that the CAGGCre-
ER recombinase in EtbΔeye mice was activated at the age of four weeks to induce Etb-
deficiency, a time point when retinal vessel development was already completed. 
Presumably, an induction of the CAGGCre-ER recombinase before or during vascular 
development might result in quite remarkable vascular pathologies.  
Hypoxia-inducible factor 1-alpha (Hif1α), which is a very sensitive marker for hypoxia 
(Majmundar et al., 2010), was expressed in comparable amounts in retinal lysates of 
EtbΔeye mice and controls, indicating, that the retinal perfusion and blood supply was not 
affected through the deletion of Etb. There are reports of a conditional knockout mouse 
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strain with an endothelial cell-specific Etb-deficiency (Etb flox/flox Tie2-Cre) showing 
impaired endothelium-dependent vasodilatation in ex vivo aortic ring assays, presumably 
due to an endothelial dysfunction (Bagnall et al., 2006). Though, an in vivo long-term 
telemetric recording of the carotid arterial pressure in Etb flox/flox Tie2-Cre mice showed 
that the ablation of Etb in endothelial cells had no influence on blood pressure, regardless 
of dietary salt intake (Bagnall et al., 2006). This outcome was quite surprising as the in 
vivo measurement of the plasma Et-1 concentration in Etb flox/flox Tie2-Cre mice via 
radioimmunoassay by a direct cardiac puncture showed elevated plasma Et-1 levels, 
concomitant with increased vasodilatation (Bagnall et al., 2006). Increased Et-1 levels 
might be a result of an interference of a very sensitive Et1/Etb-balance in the vasculature 
or a disturbed clearance of Et1 by the lack of endothelial Etb. The prolonged exposure 
to increased Et-1 levels might have caused a downregulation or desensitization of Eta 
activity leading to an inconspicuous blood pressure (Bagnall et al., 2006). In our 
analyses, the endothelial cell marker cluster of differentiation 31 (Cd31) was comparably 
expressed between EtbΔeye mice and controls.indicating that the number of endothelial 
cells was not affected by the ablation of Etb. When comparing the Et-1 and Et-2 mRNA 
expression levels between EtbΔeye mice and controls, we could not detect significant 
differences following Etb-deficiency. Consequently, both ligands, Et-1 and Et-2 can still 
mediate signal through the remaining Eta. This might maintain the functionality of 
endothelial cells in EtbΔeye mice and maybe an explanation for the normal vascular 
appearance. In contrast, the relative Et-3 mRNA expression levels were significantly 
increased in EtbΔeye mice. Et-3 has a higher binding affinity for Etb and signals mainly 
through this receptor (Kedzierski and Yanagisawa, 2001; Barton and Yanagisawa, 
2008). It is therefore tempting to speculate that Et-3 tries to compensate for the lack of 
Etb by increasing its expression.  
Besides the endothelial cells of the inner vessel wall, blood vessels further consist of 
perivascular cells like smooth muscle cells, expressing a-Sma, and pericytes, expressing 
e.g. a-Sma, Ng-2 or Pdgfrb (Bergers and Song, 2005)). These cells wrap around 
endothelial cells and envelop the surface of the vascular tube (Gaengel et al., 2009; 
Ahmed and El-Badri, 2018) to regulate (micro)vascular blood flow by altering capillary 
diameter e.g. in response to endogenous signals, presumably mediated by neurons 
(Ahmed and El-Badri, 2018; Ribatti et al., 2011; Winkler et al., 2017; Thomas et al., 
2017). In our analyses, EtbΔeye mice had a comparable α-Sma expression compared to 
controls potentially indicating that smooth muscle cell population was not affected 
through the Etb deletion. Remarkably, we were able to detect a significant elevation of 
mRNA expression levels of the proteoglycan glial antigen-2 (Ng-2) and platelet-derived 
growth factor receptor-β (Pdgfrb), which are both well-known surface marker for 
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pericytes, in the retinae of EtbΔeye mice (Ozerdem et al., 2001). This could be confirmed 
by an immunohistochemical staining against Ng-2, which showed a higher number of 
pericytes enclosing the vessels of EtbΔeye mice. These finding could indicate that an 
increased number of pericytes following Etb deletion, might be a compensatory reaction 
to promote vessel stability and functionality.  
In summary, our findings show that the ablation of Etb in the entire eye had no effect on 
endothelial cells, whereas the expression of pericyte markers was increased, indicating 
an increased number of pericytes and a possible early onset of vascular remodelling. 
Nevertheless, we decided to not further utilize the EtbΔeye mice for analysis regarding 
Etb-mediated neuroprotection as the lens phenotype would obviously have a 
tremendous impact on the light damage experiments and the subsequently planned 
molecular analyses. Consequently, we exclusively used EtbΔOC mice with a deletion of 
Etb in retinal neurons and Müller cells only to study the neuroprotective role of Etb in the 
retina, which was the main goal of this study. 
 
4.4 Etb is essential for the neuroprotection of photoreceptors after 
light induced-damage 
Light damage experiments were performed in EtbΔOC mice and control littermates to 
induce photoreceptor cell death. Following light exposure, the deletion of Etb in retinal 
neurons and Müller cells led to a significantly increased apoptosis of photoreceptors, 
concomitant with a thinning of the outer nuclear layer (ONL), which strongly indicates 
that Etb mediates neuroprotective effects for photoreceptor survival. In accordance with 
these findings are our in vitro data obtained from serum-deprived 661WΔEtb cells that 
demonstrated a significantly higher number of apoptotic cells compared to serum 
deprived 661W control cells. Moreover, previous data from our group showed that a 
pharmacological inhibition of Etb mediated signalling using BQ788 (a specific Etb 
inhibitor) resulted in a significantly higher number of light-induced photoreceptor 
apoptosis in a mouse model with constantly elevated Et-2/Etb levels (Braunger et al., 
2013a) and others showed a significantly lower survival of photoreceptors following 
BQ788 treatment in a model of genetically induced photoreceptor degeneration (Joly et 
al., 2007). Taken together, these findings clearly highlight the importance of Etb 
mediated signalling in the retina for photoreceptor survival.  
Our data furthermore showed that the apoptosis of photoreceptors in EtbΔOC mice and in 
serum-deprived 661WΔEtb cells was mediated via an extrinsic pathway indicated by a 
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significant elevation of Caspase-8, which is an important mediator of the extrinsic death-
receptor mediated apoptosis (Niquet and Wasterlain, 2004).  
As the deletion of Etb in EtbΔOC animals affects retinal neurons and Müller cells, we 
cannot exclusively name the specific cell type that might be responsible for the observed 
neurodegenerative effect. The in vitro data from 661WΔEtb cells showed, that the deletion 
of Etb was sufficient to increase their apoptotic cell death, a finding that clearly supports 
the hypothesis that the Etb deletion might promote an autocrine-mediated cell death. 
However, unpublished data from our group show that mice with a Müller cell specific 
deletion of Etb (EtbΔMC) had a significantly higher number of apoptotic photoreceptor cells 
following light-induced degeneration. Thus, the pro-apoptotic effect might be additionally 
mediated in a paracrine manner presumably by Müller cells, which are coupled physically 
and metabolically to photoreceptors and control photoreceptors’ survival (Reichenbach 
et al., 1993; Rattner and Nathans, 2005).  
The undergoing neurodegenerative processes following light exposure also resulted in 
an activation of the Tgf-β signalling pathway, as we detected significant elevated levels 
of Tgf-β2 and Tgf-β3 in light-exposed EtbΔOC mice compared to controls. Our workgroup 
recently published that the Tgf-β signalling pathway protects retinal neurons from 
developmental programmed cell death, as Tgf-β receptor type 2-deficient mice showed 
a significantly increased apoptotic death of retinal neurons during embryonic and 
postnatal development (Braunger et al., 2013b). As the deletion of Etb in photoreceptors 
and Müller cells resulted in an increased retinal degeneration the activation of further 
neuroprotective signalling pathways like Tgf-β signalling might be an attempt of the retina 
to compensate for the ongoing degeneration. 
The precise role of endothelin signaling pathway in the retina is still not fully understood. 
There are reports e.g. that the intravitreal injection of Et-2 resulted in a breakdown of the 
blood retinal barrier with increased vascular leakage, vascular endothelial growth factor 
expression, and infiltrating macrophages (Saeds et al, 2018). In contrast, our workgroup 
published that an upregulation of Et-2 mediated the protection of photoreceptors from 
light damage via Etb mediated signaling (Braunger et al., 2013a) and others showed that 
elevated Et-2 levels promoted photoreceptor survival in a mouse model of inherited 
photoreceptor degeneration (Bramall et al., 2013). In the current study, we confirmed a 
significant increase of Et-2 expression in control and EtbΔOC mice following light induced 
photoreceptor degeneration. Remarkably, following light-induced damage, the Et-2 
expression was significantly higher in EtbΔOC mice compared to controls suggesting a 
higher susceptibility to light of Etb-deficient mice, most likely due to the disruption of the 
Etb -signalling. Although Eta, Et-2 and Et-3 were significantly overexpressed in light-
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exposed EtbΔOC retinae, most likely to compensate for the lacking function of Etb, this 
was obviously not sufficient to compensate for the neurodegenerative effect that we 
observed in EtbΔOC animals following light exposure. Taken together, these data strongly 
indicate that in particular Etb mediated signalling is essential for a functioning 
neuroprotective signalling in the retina and in particular for photoreceptor survival.  
Photoreceptor-derived Et-2 has already been shown to act as general stress signal 
following photoreceptor injury (Rattner and Nathans, 2005). There are reports that albino 
wildtype mice showed a significant upregulation of Etb in Müller cells following light-
induced damage, which suggests that photoreceptor-derived Et-2 can bind to Etb on 
Müller cells and that Müller cells can increase their sensitivity to Et-2 in response to 
retinal injury (Rattner and Nathans, 2005). Binding of Et-2 to its Etb receptor on Müller 
cells might furthermore result in an activation of Müller cells to mediate neuroprotection 
and repair mechanisms (Bringmann et al., 2006). Furthermore, there are reports that 
Müller cells react in a paracrine manner to photoreceptor cell stress (e.g. light induced 
degeneration) by an upregulation of the neuroprotective factors like leukemia inhibitory 
factor (Lif) and fibroblast growth factor 2 (Fgf2) (Joly et al. 2008; Gao und Hollyfield 1996; 
Joly et al. 2007). As expected, following light exposure Lif was significantly increased in 
controls and EtbΔOC mice. The cytokine Lif mediates its neuroprotective signal through 
two receptors specific for Lif signalling, the cytokine receptor gp130 and LIFRb, an 
obligatory co-receptor for LIF, which are both expressed in Müller cells and 
photoreceptors (Ueki et al., 2009). Quite intriguingly, the amount of Et-2 overexpression 
seems to correlate with Lif expression which might result from a dependent and 
reciprocal interaction between Et-2 and Lif. This has been confirmed by Joly et al. who 
showed that Lif-deficient mice had constitutively and significantly downregulated retinal 
Et-2 expression levels and expressed Et-2 only after intravitreal injections of recombinant 
LIF (Joly et al., 2008). Moreover, light-induced or genetic-induced photoreceptor 
degeneration resulted in an elevated expression of Lif in Müller cells, presumably 
mediated through the increased Et-2 expression levels (Bürgi et al., 2009; Joly et al., 
2008). Besides Müller cells, Lif is also expressed in astrocytes as well as in a small 
number of microglial cells (Banner et al., 1997). This might explain the increased Lif 
expression levels in EtbΔOC mice, although the Lif-mediating Et-2/Etb signalling was 
disturbed. 
In different models of photoreceptor degeneration, Fgf2 is significantly upregulated (Gao 
and Hollyfield, 1996) and is considered as survival-promoting factor for photoreceptor 
cells (Faktorovich et al., 1990). Fgf2 is expressed by various cells in the retina e.g. 
photoreceptors, Müller cells and astrocytes (Li et al., 1997, 1997; Amin et al., 1997; 
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Irmady et al., 2011) and mediates its signalling by fibroblast growth factor receptors (Fgfr) 
on Müller cells (Kinkl et al., 2002). Fgf2 mediated signalling plays an essential role in 
development and maintenance of photoreceptors (Cornish et al., 2004). Joly et al. 
showed that intravitreal injections of recombinant LIF induces the expression of Fgf2 in 
Lif-deficient mice, indicating a dependent and reciprocal interaction between Fgf2 and 
Lif, too (Joly et al., 2008). Hence, the observed significant upregulation of Fgf2 in light-
exposed EtbΔOC mice compared to light exposed controls is most likely a consequence 
of the concomitant and significant upregulation of Lif. Remarkably, light-exposed EtbΔOC 
mice showed a more pronounced photoreceptor damage compared to light-exposed 
control animals, although the neuroprotective factors Fgf-2 and Lif were significantly 
upregulated in EtbΔOC mice.  
The binding of cytokines like Lif to the gp130 receptor activates the PI3K/Akt signalling 
pathway (Alonzi et al., 2001). Moreover, Fgf2 can also stimulate the activation of 
PI3K/Akt signalling (Zubilewicz et al., 2001), (Hu et al., 2014). Above all, Akt is essential 
for cell survival as its activation regulates the expression of anti- and pro-apoptotic 
factors and multiple proteins, which mediate caspase-independent and caspase 
dependent apoptosis (Song et al., 2005; Datta et al., 1997; Zhou et al., 2000; Jeong et 
al., 2008; Suhara et al., 2002). Furthermore, the PI3K/Akt-signalling pathway has often 
been reported to act neuroprotective for several types of neuronal cells (Nakazawa et 
al., 2003) and in particular in promoting the survival of cytokine-dependent neurons 
(Alonzi et al., 2001). The activation of Akt involves its phosphorylation to phospho(p)Akt 
(Song et al., 2005). We detected comparable protein levels of Akt between light-exposed 
EtbΔOC mice and controls, whereas phospho(p)Akt was strongly decreased in light-
exposed EtbΔOC mice indicating an impaired activation of Akt. Quite intriguingly, our data 
strongly suggest that the Akt signaling pathway could not be stimulated through the 
significantly increased Lif or Fgf2 expression levels in light-exposed EtbΔOC animals. This 
finding clearly highlights the importance of Etb-mediated signalling in retinal neurons and 
Müller cells for the activation of Akt and its impaired activation might furthermore very 
well explain the observed enhanced neurodegeneration in EtbΔOC animals following light 
exposure. 
We therefore conclude that Etb is an essential key regulator of retinal neuroprotection 
that mediates its downstream signalling through activation of Akt signalling, concomitant 
with the regulation of caspase-mediated apoptosis. Moreover, our data identify Et-2 and 
its signalling through Etb as the essential and even more potent neuroprotective event 
for photoreceptor survival compared to that of Fgf2 and Lif. In summary, our data identify 
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Etb mediated signalling as a promising approach for the development of new therapeutic 
strategies in the context of retinal degenerations.   
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5 Future directions 
One of the future directions of the project will aim to elucidate the intracellular events of 
Etb mediated signaling. The proteome analysis of 661WΔEtb cells (in cooperation with Dr. 
S. Hauck and Dr. A. Neueder) allowed us to identify a group of proteins which are 
associated with proteasomal degradation processes (e.g. PSMA1/3, PSMD13, USP14 
Protein) indicating a proteasomal dysregulation following Etb-deficiency. The 
proteasome is essential for the maintenance of cellular homeostasis by controlling the 
intracellular degradation of defective proteins (Campello et al., 2013; Orlowski, 1999). 
Moreover, the proteasome regulates proteolytic processes in apoptosis and plays also 
an important role in the activation of Akt and the proteasomal degradation of its activated 
form pAkt (Wójcik, 2002; Noguchi et al., 2014), which identifies the Etb-triggered 
proteasomal dysregulation in 661WΔEtb cells as highly relevant in the context of 
neuroprotection. There is already data published showing that proteasomal insufficiency 
correlates with various forms of neurodegenerative disorders including Parkinson’s 
Disease (Lim and Tan, 2007), Huntington’s Disease (Ortega and Lucas, 2014) and 
inherited retinal degenerations like Retinopathia pigmentosa (Illing et al., 2002) and Age-
related Macular Degeneration, presumably associated with misfolding or mistargeting of 
cytosolic and membrane proteins (Lobanova et al., 2013). Thus, a more thorough 
understanding of the potential Etb-mediated regulation of proteasomal activity has the 
distinct potential to lead to the development of novel therapeutic strategies in the context 
of retinal degenerations. 
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6 Material and methods 
6.1 In vivo experiments 
6.1.1 Housing conditions 
EtbΔOC mice (Etb fl/fl;α-Cre), EtbΔeye mice (Etb fl/fl;CAG-CreERTM), Etb fl/fl littermates and 
albino (CD1) wildtype mice were used for the in vivo experiments in this thesis. Albino 
(CD1) wildtype mice were bred in the animal facility of the University of Regensburg. Etb 
fl/fl mice were a generous gift from Prof. Miles L. Epstein (Druckenbrod et al., 2008) 
(Department of Anatomy, Neuroscience Training Program, School of Medicine and 
Public Health, University of Wisconsin, Madison, Madison, Wisconsin). Etb fl/fl mice were 
initially in a 129SV background. To be able to perform light-induced photoreceptor 
degeneration, the mice and needed to be backcrossed with CD1 wildtype mice for at 
least seven generations to obtain albino Etb fl/fl mice. α-Cre mice (CD1 background, 
(Marquardt et al., 2001) and CAG-CreERTM (CD1 background, (Hayashi and McMahon, 
2002)), purchased from Charles River (Sulzfeld, Germany). 
All procedures conformed to tenets of the National Institutes of Health Guidelines on the 
Care and Use of Animals in Research, the EU Directive 2010/63/E, and the Uniform 
Requirements for manuscripts submitted to Biomedical journals. All animals used for this 
thesis were kept under optimizing conditions with a temperate at 23 °C + 2°C. The mice 
had access to food and water ad libitum. All mice were kept in a light-dark cycle of 12 
hours per day with a light intensity of approximately 400 lux. 
 
6.1.2 Animal models and Cre/loxP-System 
The Cre/loxP-System is a frequently used experimental approach for the deletion of 
target genes in a specific temporal or cell-type specific manner, that allows the 
circumventing of potential embryonic lethality (Kühn and Torres, 2002). The Cre gene 
encodes a DNA Cre recombinase originated from bacteriophage P1 (Sternberg and 
Hamilton, 1981). Cre recombinase is able to recognize and recombine characteristic 
DNA sequences ,the so called loxP or flox-sites, flanking the sequence of a specific 
target gene, (Sternberg and Hamilton, 1981; Tian et al., 2006), finally resulting in the 
deletion of the target gene (Kühn and Torres, 2002). The Cre recombinase is controlled 
through cell- or tissue-specific promotor elements and can be constitutive or drug-
inducible (Tian et al., 2006).  
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For the generation of EtbΔeye mice with a deletion of Etb in the entire eye, mice carrying 
two unrecombined Etb fl/fl alleles flanking exon 3 of the Etb gene (Druckenbrod et al., 
2008) were crossed with Etb fl/fl;CAG-CreERTM mice, that were heterozygous for 
transgenic CAG-CreERTM recombinase. The genetic background of all experimental 
mice was albino (CD1). Resulting Etb fl/fl;CAG-CreERTM mice were used as 
experimental animals als will be referred to as EtbΔeye. CAG-CreERTM -negative 
littermates with two unrecombined Etb fl/fl alleles were used and referred to as control 
mice. The Cre recombinase in CAG-CreERTM mice is tamoxifen-inducible under the 
control of a chicken-beta-actin hybrid promotor exhibiting a robust, ubiquitous activity 
following tamoxifen treatment. The Cre recombinase in CAG-CreERTM mice was 
activated through intraperitoneal injections of 50 µl tamoxifen [20mg/ml]. The mice were 
injected for 5 days and twice each day (9 am and 5 pm) starting at the age of 4 weeks. 
For the generation of EtbΔOC mice with a deletion of Etb in retinal neurons and Müller 
cells, mice carrying two unrecombined Etb fl/fl alleles flanking exon 3 of the Etb gene 
(Druckenbrod et al., 2008) were crossed with Etb fl/fl;α-Cre mice, that were heterozygous 
for transgenic α-Cre recombinase (Marquardt et al., 2001). The genetic background of 
all experimental mice was albino (CD1). Resulting Etb fl/fl;α-Cre mice were used as 
experimental animals and are referred to as EtbΔOC. α-Cre-negative littermates with two 
unrecombined Etb fl/fl alleles were used as control mice. The α-Cre recombinase is 
under the control of a Pax6 promotor, exhibits a robust expression starting at embryonic 
day (E) 10.5 in cells that derive from the inner layer of the optic cup.  
 
6.1.3 Light damage 
EtbΔOC mice at the age of 6 to 8 weeks were dark adapted for a period of 5 days before 
light exposure. For light-induced photoreceptor degeneration, the mice were placed in 
reflective plastic cages and exposed to diffuse cool, white fluorescent light coming from 
the top of the cage with an intensity of 5000 lux for 1 h. After light exposure, the mice 
were hold for 6 h (RNA and protein analysis), 30 h (TUNEL) or 14 days (morphometric 
analysis) in cyclic, dim light for recovery and then sacrificed. The light damage 
experiments were always performed in the early morning. 
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6.1.4 Puncture of the eye and intravitreal injections 
Wildtype albino (CD1) mice were anesthetized using isoflurane (Ecuphar GmbH, 
Greifswald, Germany) punctured through the basal limbus and in case of an injection, 
the mice received an injection of 3 μl 1xPBS in the vitreous using a 33-gauge needle. 
 
6.1.5 Preparation of ocular tissue 
The mice were sacrificed by atlanto-occipital dislocation and the eyes were enucleated. 
For histological sections, the entire eye was removed carefully und incubated in the 
respective fixative (Methyl Carnoy, 4 % (w/v) PFA or Cacodylat-Buffer). For molecular 
analysis, the eye was cut with a razor blade along the ora serrata and the anterior eye 
segment was removed without bruising the lens. The retina was detached from the RPE 
and sclera with gentle brushes from the position of the optic nerve head and transferred 
immediately in a 2 ml Eppendorf tube on ice for containing TriFast™ Trizol or EDTA-
Buffer (Chapter 6.3.6) for RNA or protein analyses.  
 
6.1.6 Cardial perfusion  
Mice were anesthetized by intraperitoneal injections containing a solution of ketamine 
(75mg/ml) and Xylazine (5mg/ml). After a complete anaesthesia of the mice, the thoracic 
and abdominal cavity was opened to gain access to the heart and the abdominal aorta. 
The injection needle was punctured into the left ventricle and a relief cut was carried out 
in the abdominal aorta. The mice were perfused with FITC-dextran to visualize retinal 
vasculature or fixative (Methyl Carnoy or 4 % (w/v) PFA) for immunohistochemistry. After 
perfusion, the eyes of the mice were enucleated for performing sagittal sections (Chapter 
6.5.2 and 6.5.3) or retinal flatmounts (Chapter 6.1.7). 
 
6.1.7 Preparation of retinal flatmounts 
If not yet perfused cardially, mice were sacrificed by atlanto-occipital dislocation. The 
eyes were enucleated and fixed in 4% (w/v) PFA for 1 h at room temperature. The eye 
was cut with a razor blade along the ora serrata and the anterior eye segment and the 
lens were removed. The retina was brushed out gently and transferred on an object slide, 
which had an area circuited with a fat pen (PapPen) and was moisturized with 0.1M 
phosphate buffer (Php). The retina was incised on four opposite positions, to spread the 
retina flat on an object slide.  
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6.2 In vitro experiments 
6.2.1 Cell line and culture conditions 
The murine immortalized photoreceptor cell line (661W) was provided from the 
laboratory of Prof. Dr. E. Tamm (Institute of Human Anatomy and Embryology, University 
of Regensburg). Untreated cells were cultured in an incubator (Hera Safe, Heraeus, 
Hanau, Germany) at 37°C and 5% CO2 conditions and nourished with 4,5% Glucose 
DMEM-Medium containing 1% fetal bovine serum (FBS), 10% Penicillin/Streptavidin 
(P/S). Transfected 661WΔEtb cells and controls were nourished with 4,5% Glucose 
DMEM-Medium containing 1% FBS, 10% P/S and 6 µg/ml Puromycin. All treatments, 
passaging and other procedures of the cells as well as production of buffers and 
solutions were performed under a sterile working bench (Hera Safe, Heraeus, Hanau, 
Germany). Glassware, buffers and solutions were autoclaved prior to use and sterile 
packed plastic material was used.  
 
6.2.2 Passaging of cells 
After reaching a confluence of 70-80%, the cell culture medium was removed and the 
cells were washed twice with 1xPBS to get rid of remaining culture medium. Afterwards, 
the cells were superseded from the bottom of the cell culture flask by trypsinization with 
1ml 0.25% trypsin and transferred in falcons. By adding serum-containing DMEM 
medium, trypsin was inactivated and the suspension was centrifuged for 5 min at 1000 
rpm. The cell pellet was resuspended in cell culture medium and a defined number of 
cells (100,000-200,000) were seeded in a new cell culture dish. The cells were harvested 
during the period of passage (P) 10 to 15. For further treatments, the cells were counted 
using Neubauer counting chamber and a defined number of cells (100,000-200,000) was 
seeded in 6 wells.  
 
6.2.3 Serum-deprivation for 24 h 
To cause cell stress and apoptosis, 661WΔEtb cells and controls (100,000) were seeded 
in 6-well plates with serum-containing DMEM-Medium (1% P/S, 10% FBS, 6 µg/ml 
Puromycin). After 2 to 3 hours, when the cells attached to the dish, the dishes were 
washed 3x times with 1xPBS to completely remove remaining medium. The cells were 
then incubated with 3 ml DMEM medium (1% P/S, 6 µg/ml Puromycin) containing 0% 
FBS for 24 h. For further analysis cells were fixed with 4%PFA or scraped from the dish. 
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6.2.4  CRISPR/Cas9-System 
Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-
associated (Cas9) protein 9 system is a genome editing tool (Zhang et al., 2014). In this 
thesis, it was used to delete Etb in the photoreceptor cell line 661W. 
6.2.4.1 Cas9-Vector and sgRNA 
The main components of the CRISPR/Cas9 system are sgRNA and theCas9 enzyme. 
Whereas the sgRNA guides the Cas9 enzyme to the target site on the genomic DNA, 
the Cas9 enzyme cleaves the target site (Harms et al., 2014). The used DNA plasmid 
vector (pSpCas9(BB)-2A-Puro-(PX459) V2.0) containing Cas9 from S. pyogenes with 
Puromycin resistance (E.coli: Ampicillin) and cloning backbone for sgRNA (Ran et al., 
2013) was purchased from Addgene (Massachusetts, USA). The targets of sgRNAs 
were designed (in cooperation with Dr. Andreas Neueder, University Ulm) using the 
software genome compiler. 
6.2.4.2 Transformation of the vector in E.coli 
The vector was transformed in the DH5α chemically competent E.coli strain purchased 
from Thermo Fisher (Schwerte, Germany) using the following protocol: 
• Unfreeze 50 µl of E.coli on ice 
• Add 5 ng vector and mix 
• Incubate for 30 min on ice 
• Temperature shock at 42°C for 45 sec (water bath) 
• Incubate on ice for 30 sec 
• Add 500 µl LB Medium  
• Incubate for 20 min at 37°C 
• Centrifugation for 20 min at full speed 
• Decant supernatant and resuspend the remaining LB Medium 
• Spread suspension on LB0 Plate and incubate overnight at 37°C 
 
The next day, a single colony was picked and incubated shaking in 5 ml LB Medium 
containing Ampicillin overnight at 37°C. Afterwards, the suspension was centrifuged at 
4000 rpm for 20 min and the supernatant was decanted. The vector was obtained by 
using the QIAPrep Spin MiniPrep Kit from Qiagen (Hilden, Germany) following the 
manufacturer’s’ instructions (Chapter 6.2.4.3). 
• Unfreeze 50 µl of E.coli on ice 
• Add 5 ng vector and mix 
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• Incubate for 30 min on ice 
• Temperature shock at 42°C for 45 sec (water bath) 
• Incubate on ice for 30 sec 
• Add 500 µl LB Medium  
• Incubate for 20 min at 37°C 
• Centrifugation for 20 min at full speed 
• Decant supernatant and resuspend the remaining LB Medium 
• Spread suspension on LB0 Plate and incubate overnight at 37°C 
 
6.2.4.3 Purification of DNA vector 
For purification of the DNA plasmid vector, the QIAPrep Spin MiniPrep Kit from Qiagen 
(Hilden, Germany) was used according to the manufacturer’s protocol: 
• Resuspend (by vortexing) pelleted bacterial cells in 250 µl Buffer P1 and transfer 
to Eppendorf tube 
• Add 250 µl Buffer P2 and mix thoroughly by inverting the tube 4-6 times until the 
solution comes clear. Do not allow the lysis reaction to proceed for more than 5 
min 
• Add 350 µl Buffer N3 and mix immediately and thoroughly by inverting the tube 4-
6 times 
• Centrifuge for 10 min at 13000 rpm  
• Apply 800 µl supernatant to QIAprep 2.0 spin column by pipetting 
• Centrifuge for 30-60 sec and discard the flow-through 
• Wash the column by adding 0.5 ml Buffer PB  
• Centrifuge for 30-60 sec and discard flow-through 
• Wash the column by adding 0.75 ml Buffer PE 
• Centrifuge for 30-60 sec and discard the flow-through 
• Centrifuge for 1 min to remove residual wash buffer 
• Place column in a clean 1.5 ml Eppendorf tube  
• To elute DNA, add 30 µl (preheated at 37°C) to the centre of the column 
• Centrifugation for 1 min at 13000 rpm 
 
6.2.4.4 Digestion with BbsI 
The restriction enzyme BbsI was used to cut the plasmid vector outside the Cas9 and 
sgRNA sequences to linearize the plasmid. Therefore, 10 µg of the vector were digested 
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with 2 µl BbsI (New England Biolabs, Frankfurt am Main, Germany) and 2.5 µl of the 
corresponding buffer and filled up with ddH2O to a Volume of 25 µl. The suspension was 
incubated overnight at 37°C.  
 
6.2.4.5 Gel extraction of the linearized vector 
The linearized vector was separated by gel electrophoresis with a 2% agarose gel for 20 
min at 120 V. Under UV-light, the band of the successful digested vector was cut out 
from the agarose gel and transferred to a 1.5 ml Eppendorf tube by using the 
NucleoSpin® Gel and PCR Clean-Up Kit from Macherey-Nagel (Düren, Germany) 
performing the following protocol: 
• Add 500 µl NT-buffer 
• Melt gel slice at 60°C and load on column 
• Spin column for 30 sec at 10000 rpm 
• Discard flow-through 
• Add 600 µl washing-buffer and spin for 30 sec at 10000 rpm 
• Discard flow-trough 
• Add 600 µl washing-buffer and spin for 30 sec at 10000 rpm 
• Discard flow-trough 
• Spin for 1 min at 13000 rpm 
• Transfer column on Eppendorf tube 
• add 50 µl 10 mM Tris-Cl pH 8.0 and  
• Incubate for 30 sec  
• spin for 30 sec at 10000 rpm to eluate of vector 
 
6.2.4.6 Phosphorylation annealing of oligonucleotides  
Regarding its short length, sgRNA can be synthesized directly from a double-stranded 
DNA template obtained by annealing two oligonucleotides (Harms et al., 2014). The 
suitable pair of DNA oligonucleotides contained the target sequence at Exon 2 of the Etb 
gene (Etb_2aI_fwd: CACCGGCCGGTGATTAACGGCCAGA; Etb_2aI_rev: 
AAACTCTGGCCGTTAATCACCGGCC; and purchased from Invitrogen, Germany). 
Furthermore, the oligonucleotides were phosphorylated to prevent a recirculation of the 
vector during ligation by using the T4 DNA Ligation Kit from New England Biolabs 
(Frankfurt am Main, Germany) and performing the following approach: 
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Reagent Volume 
Etb_2aI_fwd [100 µM] 1 µl 
Etb_2aI_rev [100 µM] 1 µl 
10x T4 Ligation Buffer 1 µl 
dH2O 6.5 µl 
T4 Polynucleotide Kinase 0.5 µl 
Table 1 Phosphorylation and annealing of oligonucleotides 
The suspension was incubated at 37°C for 30 mins and afterwards heat-shocked at 95 
°C for 5 min. After cooling down at room temperature, 190 µl dH2O was added.  
 
6.2.4.7 Cloning of sgRNA target sequences into a plasmid 
The DNA oligonucleotides were cloned in the linearized vector by the following approach: 
Reagent Volume 
Linearized plasmid vector 50 ng 
Oligonucleotides 1 µl 
10x T4 Ligation Buffer 1 µl 
T4 Ligase 1 µl 
Add dH2O 10 µl 
Table 2 Cloning approach 
The suspension was incubated for 20 min at room temperature. Afterwards, 4 µl of the 
ligation were transformed in E.coli by performing the transformation protocol from 
Chapter 6.2.4.2) Vector-containing E.coli were selected by an ampicillin-resistance, 
therefore it is essential to use LBAMP plates instead of LB0 plates. After picking a single 
colony, the vector was obtained by using the QIAPrep Spin MiniPrep Kit from Qiagen 
(Hilden, Germany) following the manufacturer’s’ instructions (Chapter 6.2.4.3). The 
eluated vector was sequenced (Microsynth SeqLab, Göttingen Germany) for its 
correctness. 
 
6.2.4.8 Transfection of 661W and generation of single colonies  
The cloned and circular plasmid vector (Chapter 6.2.4.16.2.4.7) was transfected in 661W 
cells for generating a cellular deletion of Etb (661WΔEtb). Control 661W cells still 
expressing Etb were transfected with the unmodified plasmid vector only containing 
Cas9 (Chapter 6.2.4.1). The day before transfection 200000 cells/per well were counted 
via Neubauer cell counter and seeded in a 6 wells plate with 2 ml DMEM Medium (1% 
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P/S, 10% FBS). For transfection JetPRIME in vitro DNA transfection reagent from 
Polyplus (Illkirch, France) was used according to the following protocol: 
• Dilute 1µg DNA plasmid vector in 200 µl jetPRIME Buffer  
• Mix by vortexing and spin down briefly 
• Add 2 µl jetPRIME, vortex for 10 sec and spin down briefly 
• Incubate for 20 min at room temperature 
• Add 200 µl of transfection mix per well drop wise onto the cells in serum containing 
DMEM  
• Incubate for 48 h at 37°C 
 
To create single colonies, 661WΔEtb and controls with a cell number of 50000 cells/well 
were seeded in a 6-well plate with 3 ml puromycin-containing DMEM Medium (1% P/S, 
10% FBS, 6 µg/ml Puromycin) and incubated to a confluency of 90%. Cells were 
removed from 6-well plate bottom with 1 ml Trypsin. The Trypsin cell suspension was 
1:100 diluted with DMEM Medium (1% P/S, 10% FBS, 6 µg/ml Puromycin) by mixing 0.1 
ml Trypsin cell suspension and 9.9 ml DMEM Medium. This was repeated twice and 
subsequently 100 µl of the diluted suspension were applied in a 96-well plate. Single 
wells of 96-well plate containing only a single cell were determined by using conventional 
light microscopy. We have chosen four single colonies each for 661WΔEtb and 661W 
control cells for further analysis. 
 
6.2.4.9 Antibiotica kill curve 
For creating a stable knockout cell line, 661WΔEtb cells and controls containing a 
Puromycin resistance were selected with Puromycin-containing DMEM Medium (1% 
P/S, 10% FBS, 6 µg/ml Puromycin). The optimal Puromycin concentration of 6µg/ml was 
determined by an antibiotic kill curve. The optimal dose was set as lowest antibiotic 
concentration that kills untreated 661W cells (without Puromycin-resistance) after one 
week. In this dose-dependent experiment, the untreated 661W cells were incubated with 
an increasing amount of Puromycin starting with a concentration of 2 µg/ml up to 22 
µg/ml. Therefore, cell number were determined by using the Neubauer counting chamber 
and 80000 cells/per well were seeded in a 24-well plate with DMEM Medium (1% P/S, 
10% FBS). The next day, Puromycin containing DMEM was added according to the 
following protocol: 
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0 µg/ml  2 µg/ml  4 µg/ml  
6 µg/ml  8 µg/ml  10 µg/ml  
   12 µg/ml     14 µg/ml      16 µg/ml  
   18 µg/ml     20 µg/ml      22 µg/ml  
Table 3 Schemata for Puromycin kill curve 
The optimal concentration of 6 µg/ml was determined. 
  
Increasing Puromycin concentration 
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6.3  List of material 
6.3.1 Reagents 
Description Supplier 
0,05 % Trypsin/EDTA PAA The Cell Culture Company, Pasching, 
Austria 
10 x PCR buffer Qiagen, Hilden, Germany 
2-mercaptoethanol Serva, Heidelberg, Germany 
Acetic acid Merck, Darmstadt, Germany 
Acetone Merck, Darmstadt, Germany 
Agarose Biozym Scientific, Oldendorf, Germany 
Albumin Fraction V (BSA) Roth, Karlsruhe, Germany 
Ammonium peroxodisulfate (APS), 10% 
(w/v) 
Roth, Karlsruhe, Germany 
BC Assay Reagent A + B Interchim, Wörgl, Austria 
BC Assay Reagent 1 + 2 Roth, Karlsruhe, Austria 
Bromphenolblau Sigma-Aldrich, Taufkirchen, Germany 
CDP-Star Roche, Penzberg, Germany 
Chloroform Roth, Karlsruhe, Germany 
Coomassie® Brilliant Blue R-250 Sigma-Aldrich, Taufkirchen, Germany 
Corn oil Sigma-Aldrich, Taufkirchen, Germany 
Desoxynucleosid-triphosphate (dNTPs) Qiagen, Hilden, Germany 
Dimethylsulfoxid (DMSO) Roth, Karlsruhe, Germany 
DL-Dithiothreitol (DTT) Sigma-Aldrich, Taufkirchen, Germany 
Dulbecco’s Modified Eagle Medium (DMEM) PAA The Cell Culture Company, Pasching, 
Austria 
EDTA Roth, Karlsruhe, Germany 
Epon Serva, Heidelberg, Germany 
Ethanol, absolute Roth, Karlsruhe, Germany 
Ethidiumbromide Serva, Heidelberg, Germany 
Fluorescent Mounting Medium DakoCytomatio, Hamburg, Germany 
Formaldehyde Roth, Karlsruhe, Germany 
Epon Serva, Heidelberg, Germany 
Glutaraldehyde, 25% in water Serva, Heidelberg, Germany 
Glycerin Merck, Darmstadt, Germany 
Glycin Merck, Darmstadt, Germany 
Guanidin HCL Roth, Karlsruhe, Germany 
HEPES Sigma-Aldrich, Taufkirchen, Germany 
Hydrochloric acid (37%) Merck, Darmstadt, Germany 
IsoFlo® Isoflurane Ecuphar GmbH, Greifswald, Germany 
Isopropanol Sigma-Aldrich, Taufkirchen, Germany 
Ketamine Wirtschaftsgenossenschaft Deutscher 
Tierärzte (WDT), Garbsen, Germany 
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Luminata™ Forte Millipore Corporation, Billerica, USA 
Magnesium chloride (50 mM) Bioloine, Luckenwalde, Germany 
Methanol Merck, Darmstadt, Germany 
Mowiol 4-88 Roth, Karlsruhe, Germany 
N,N,N’,N’,-Tetramethylethylenediamine 
(TEMED) 
Roth, Karlsruhe, Germany 
Non-fat milk powder (MM) Roth, Karlsruhe, Germany 
Paraformaldehyde (PFA) Non-fat milk powder 
PBS PAA The Cell Culture Company, Pasching, 
Austria 
Penicillin-Streptomycin Pasching, Austria 
peqGold TriFast™ PeqLab, Erlangen, Germany 
Phalloidin Sigma-Aldrich, Taufkirchen, Germany 
Phosphatase-Inhibitor Mix Sigma-Aldrich, Taufkirchen, Germany 
Potassium chloride Roth, Karlsruhe, Germany 
Protease-Inhibitor Mix Sigma-Aldrich, Taufkirchen, Germany 
Puromycin InvivoGen, California, USA 
Rotiphorese® Gel 30 (30% Acrylamide) Roth, Karlsruhe, Germany 
Saccharose Roth, Karlsruhe, Germany 
SDS (Sodium dodecylsulfat) Roth, Karlsruhe, Germany 
Sodium chloride Roth, Karlsruhe, Germany 
Tergitol® solution Sigma-Aldrich, Taufkirchen, Germany 
Tissue-k® Sakuram Zoeterwoude, Niederlande 
Tris HCl Roth, Karlsruhe, Germany 
Triton-X-100 Roth, Karlsruhe, Germany 
Tween® 20 Roth, Karlsruhe, Germany 
Urea Merck, Darmstadt, Germany 
Vectashield Mounting Medium for 
Fluorescence with DAPI 
Vector Laboratories, Burlingame, USA 
Water ROTISOLV® HPLC Gradient Grade Roth, Karlsruhe, Germany 
Xylazine Serumwerk Bernburg, Bernburg, Germany 
Table 4 Reagents 
 
6.3.2 Commercial kits and enzymes 
Enzyme/Kit Supplier 
BbsI New England Biolabs, Frankfurt am 
Main, Germany 
MWO I New England Biolabs, Frankfurt am 
Main, Germany 
QIAprep Spin Miniprep Kit Qiagen, Hilden, Germany 
Takyon™ kits for SYBR® Assays Eurogentec, Lüttich, Belgien 
Mango Taq Bioline, Luckenwalde, Germany 
Proteinase K Roth, Karlsruhe, Germany 
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qScriptTM cDNA Synthesis Kit Quanta Bioscience, Gaithersburg, USA 
BaseScope® Detection Reagent Kit Red Advanced Cell Diagnostics, Newark USA 
JetPRIME in vitro DNA transfection 
reagent 
Polyplus, Illkirch, France 
NucleoSpin® Gel and PCR Clean-Up Kit  Macherey-Nagel, Düren, Germany 
T4 DNA Ligation Kit  New England Biolabs, Frankfurt am 
Main, Germany 
Table 5 Commercial kits and enzymes 
 
6.3.3 Oligonucleotides for genotyping 
Primer Species Orientation Sequence 5’ to 3’ 
Cre Mus 
musculus 
forward ATGCTTCTGTCCGTTTGCCG 
Cre Mus 
musculus 
reverse CCTGTTTTGCACGTTCACCG 
Etb Mus 
musculus 
forward CTGAGGAGAGCCTGATTGTGCCAC 
Etb Mus 
musculus 
reverse CGACTCCAAGAAGCAACAGCTCG 
Etb Neo Mus 
musculus 
forward CGACTCCAAGAAGCAACAGCTCG 
Rd1 
common 
Mus 
musculus 
forward CTACAGCCCCTCTCCAAGGTTTATAG 
Rd1 WT Mus 
musculus 
reverse ACCTGCATGTGAACCCAGTATTCTATC 
Rd1 TG Mus 
musculus 
reverse AAGCTAGCTGCAGTAACGCCATTT 
Table 6 Oligonucleotide primer for genotyping 
 
6.3.4 Oligonucleotides for quantitative RT-PCR 
Primer Species Orientation Sequence 5‘ to 3‘ 
α-Sma Mus 
musculus 
forward CAACCGGGAGAAAATGACC 
α-Sma Mus 
musculus 
reverse CAGTTGTACGTCCAGAGGCATA 
Bad Mus 
musculus 
forward GGGAGCAACATTCATCAGCAGG 
Bad Mus 
musculus 
reverse CATCCCTTCATCCTCCTCGGTC 
Bax Mus 
musculus 
forward GTGAGCGGCTGCTTGTCT 
 
Bax Mus 
musculus 
reverse GGTCCCGAAGTAGGAGAGGA 
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BCl2 Mus 
musculus 
forward GTACCTGAACCGGCATCTG 
 
BCl2 Mus 
musculus 
reverse GGGGCCATATAGTTCCACAA 
 
Bim Mus 
musculus 
forward GACAGAACCGCAAGGTAATCCCGACG 
 
Bim Mus 
musculus 
reverse TAGGATCCCCTCAATGCCTTCTCCATACCAG 
 
Caspase 8 Mus 
musculus 
forward TTGAACAATGAGATCCCCAAAA 
 
Caspase 8 Mus 
musculus 
reverse CCATTTCTACAAAATTTCAAGCAG 
Caspase 9 Mus 
musculus 
forward GCCAGAGGTTCTCAGACCAG 
 
Caspase 9 Mus 
musculus 
reverse TCCCTGGAACACAGACATCA 
 
Cd31 Mus 
musculus 
forward CGGTGTCTAGCCAATTCC 
 
Cd31 Mus 
musculus 
reverse CGACAGGATGGAAATCACAA 
 
Et1 Mus 
musculus 
forward TCCTTGATGGACAAGGAGTGT 
Et1 Mus 
musculus 
reverse CCCAGTCCATACGGTACGA 
Et2 Mus 
musculus 
forward ACCTCCTCCGAAAGCTGAG 
Et2 Mus 
musculus 
reverse TTTCTTGTCACCTCTGGCTGTA 
Et3 Mus 
musculus 
forward TCCTTCTCGGGCTCACAG 
Et3 Mus 
musculus 
reverse GGGACCCTGGGACACACT 
Eta Mus 
musculus 
forward AGGAACGGCAGCTTGCGGAT 
Eta Mus 
musculus 
reverse AGCAACAGAGGCAGGACTGA 
Etb_Exon2 Mus 
musculus 
forward AATGGTCCCAATATCTTGATCG 
Etb_Exon3 Mus 
musculus 
reverse TCCAAATGGCCAGTCCTCT 
Fgf2 Mus 
musculus 
forward CCAACCGGTACCTTGCTATG 
Fgf2 Mus 
musculus 
reverse CCAGTCGTTCAAAGAAGAAACAC 
Gapdh Mus 
musculus 
forward TGTCCGTCGTGGATCTGAC 
Gapdh Mus 
musculus 
reverse CCTGCTTCACCACCTTCTTG 
Gnb2l Mus 
musculus 
forward TCTGCAAGTACACGGTCCAG 
Gnb2l Mus 
musculus 
reverse ACGATGATAGGGTTGCTGCT 
Iba-1 Mus 
musculus 
forward GGATTTGCAGGGAGGAAAAG 
Iba-1 Mus 
musculus 
reverse TGGGATCATCGAGGAATTG 
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Lif Mus 
musculus 
forward AAACGGCCTGCATCTAAGG 
Lif Mus 
musculus 
reverse AGCAGCAGTAAGGGCACAAT 
Ng-2 Mus 
musculus 
forward CTTGGCCTTGTTGGTCAGAT 
Ng-2 Mus 
musculus 
reverse CACCTCCAGGTGGTTCTCC 
Pdgfrb Mus 
musculus 
forward ACCTCAAAAGGTGTCCACGA 
Pdgfrb Mus 
musculus 
reverse GTGTGCTCACCACCTCGTAT 
Rpl32 Mus 
musculus 
forward GCTGCCATCTGTTTTACGG 
Rpl32 Mus 
musculus 
reverse TGACTGGTGCCTGATGAACT 
Tgf-β1 Mus 
musculus 
forward TGGAGCAGCATGTGGCACC 
 
Tgf-β1 Mus 
musculus 
reverse GTCAGCAGCCGGGTTACCA 
 
Tgf-β2 Mus 
musculus 
forward TCTTCCGCTTGCAAAACC 
 
Tgf-β2 Mus 
musculus 
reverse GTGGGAGATGTTAAGTCTTTGGA 
 
Tgf-β3 Mus 
musculus 
forward CCCTGGACACCAATTACTGC 
Tg-fβ3 Mus 
musculus 
reverse TCAATATAAAGGGGGTACA 
Tgf-βr1 Mus 
musculus 
forward AATGTTACGCCATGAAAATATCC 
Tgf-βr1 Mus 
musculus 
reverse CGTCCATGTCCCATTGTCTT 
Tgf-βr2 Mus 
musculus 
forward TGCTACCTCCAAGTGTGGCTG 
Tgf-βr2 Mus 
musculus 
reverse TATAGGGTCCCCAGCAGAGGC 
Ubiquitin C Mus 
musculus 
forward GTCGCTGTGTGAGGACTGC 
Ubiquitin C Mus 
musculus 
reverse CCTCCAGGTGATGGTCTTA 
Table 7 Oligonucleotide primer for real-time RT-PCR 
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6.3.5 Antibodies 
6.3.5.1 Primary antibodies 
Protein Blocking Source Supplier 
Akt 1:1000 5 % non-fat dry milk rabbit 
 
Cell Signaling Technology, 
Danvers, USA 
Collagen IV 
1:50 
2%BSA/0.1 M Php rabbit Rockland Immunochemicals 
Inc., Limerick, USA 
Eta 
1:100 
(histology) 
5 % non-fat dry milk rabbit Alomone Labs, Jerusalem, 
Israel 
Etb 1:1000 5 % non-fat dry milk rabbit Alomone Labs, Jerusalem, 
Israel 
Gapdh 
1:5000 
5 % non-fat dry milk rabbit 
H, M,  
Cell Signaling Technology, 
Danvers, USA 
Gfap 1:100 2 % BSA/0.2 % 
CWFG/0.1%Triton/0.1 
M Php 
chicken LifeSpan Biosciences, Seattle, 
USA 
Gs 1:100 
(histology) 
2 % BSA/0.2 % 
CWFG/0.1%Triton/0.1 
M Php 
goat Santa Cruz Biotechnology, Inc., 
Dallas, USA  
Hif1α 1:200 5 % non-fat dry milk rabbit Cayman Chemical, Michigan, 
USA 
Iba-1 
1:1000 
(histology) 
2 % BSA/0.2 % 
CWFG/0.1%Triton/0.1 
M Php 
rabbit Wako (Osaka, Japan) 
Ng-2 1:100 
(histology) 
5%BSA/0.3%Triton/ 
0.1 M Php 
rabbit Milipore, Massachusetts, USA 
phospho-
Akt1:1000 
3 % BSA rabbit Cell Signaling Technology, 
Danvers, USA 
Pv-1 1:25 
(histology) 
2 % BSA/0.2 % 
CWFG/0.1%Triton/0.1 
M Php 
Rat Santa Cruz Biotechnology, Inc., 
Dallas, USA 
Table 8 Primary antibody 
 
6.3.5.2 Secondary antibodies 
Secondary antibody Supplier 
Alexa Fluor® 488 donkey anti-goat IgG  
(H+L) (histology) 
Invitrogen, Carlsbad, USA 
 
Alexa Fluor® 488 goat anti-chicken IgG 
(H+L) (histology) 
Invitrogen, Carlsbad, USA 
 
Alexa Fluor® 546 goat anti-chicken IgG 
(H+L) (histology) 
Invitrogen, Carlsbad, USA 
 
Cy™3-conjugated AffiniPure anti-rabbit 
IgG (histology) 
Jackson ImmunoResearch Europe Ltd., 
Ely, UK 
Goat anti-rabbit IgG, HRP-linked Cell Signaling Technology, Danvers, 
USA 
goat anti-rabbit igG, AP-linked  Cell Signaling Technology, Danvers, MA, 
USA 
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Streptavidin, Alexa Fluor® 555 conjugate 
(histology)  
Life Technologies, Eugene, USA 
Table 9 Secondary antibodies 
 
6.3.6 Solutions and buffers 
Description Supplier 
EZ-Run Pre-Stained Rec Protein Ladder Thermo Fisher Scientific, Schwerte, 
Germany 
Gene Ruler 100 bp Plus DNA Ladder Thermo Fisher Scientific, Schwerte, 
Germany 
Table 10 Molecular weight standard and DNA standard 
 
Solution/buffer Composition 
0,1 M Cacodylat-Buffer 10,7g Cacodylacid in 500ml dH₂O 
0.1 M Phosphate buffer pH 7.4 
 
100 ml 0.2 M Na2HPO4 x 2H2O 
with 0.2 M NaH2PO4 x H2O to pH 7.4 
dilute to 0.1 M with dH2O 
10x electrode buffer 250mM Tris/HCl 
400mM Glycine 
1% (w/v) SDS in dH2O, ad 1 l 
10x TBS, pH 7.4 30 g Tris 
80 g sodium chloride 
2 g potassium chloride 
dH2O ad 1 l, autoclave 
Coomassie-Detaining Solution 500 ml Methanol 
10 ml Acetic acid 
0.2 g Coomassie-Brilliant Blue R-250 
Add dH2O 1 l 
Coomassie-Staining Solution 40 ml Methanol 
2ml Acetic acid 
0.2 g Coomassie-Brilliant Blue R-250 
Add dH2O 100 ml 
Detection Buffer, pH 9 15,76 g 0,1 M Tris(HCl (pH 6,8) 
5,84 g 0,1 M NaCl 
Add dH2O 1 l 
EDTA lysis buffer 0,5ml 1mM EDTA 
0,01753g NaCl 
50µl HEPES (1M) 
0,7µl 70% Tergitol (NP-40) 
6µl Protease-Inhibitor-Mix M 
6µl Phosphatase-Inhibitor-Mix 
637,3µl H₂O 
EM Fixative 2,5% Paraformaldehyd 
2,5% Glutaraldehyd 
in 0,1M Cacodylatbuffer 
Epon stem A 62 ml Glyidether 100 with 100 ml DDSA 
Epon stem B 100 ml Glyidether 100 with 89 ml NMA 
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In situ hybridization BaseScope® Fixative 25 ml Formalin 
225 ml dH₂O 
1g/l NaH2PO4 
1.625g/l Na2HPO4 
Lämmli-Buffer (6x) 350 mM Tris-HCl, pH 6,8 
10 % SDS 
30 % Glycerol 
5 % ß-Mercapoethanol 
0,2 % Bromphenolblue 
LB0-Medium 950 ml dH₂O 
10 gTryptone  
10 g NaCl 
5 g Yeast extract 
Methyl-Carnoy 60 % Methanol 
30 % Chloroform 
10 % acetic acid 
Mouse tail lysis buffer 100mM Tris-HCl, pH 8,0 
5mM EDTA 
0,2% SDS  
200mM NaCl 
add 400ml dH₂O 
Mowiol with DAPI 6.0 g Glycerine + 2.4 g Mowiol 4-88 
(1h,RT) 
add 6.0 ml dH2O (sterile) (1h, RT) 
add 12 ml 0.2 M Tris HCl, pH 8.5 
(2h,50°C) 
add 25 mg/ml DABCO 
DAPI (1:10) 
PBS, 10x, pH 7,4 80g NaCl 
2g KCl 
4,4g Na₂HPO4 
2,4g KH₂PO4 
 Add dH₂O  1l 
SDS-Solution, 19% (w/v) 10 g SDS  
Add dH₂O  100 ml 
SDS-PAGE-Running-Buffer, 10x 250mM Tris/HCl, pH 6,8 
30% Glycerin 
8% (w/v) SDS 
Add dH₂O  1l 
 
TBE, 10x 108g Tris-base 
55g boric acid 
40ml 0,5M EDTA pH 8,0 
Add dH₂O 1l  pH 7,0 
TBS, 10x, pH 7,4 30 g Tris 
80 g NaCl 
2 g KCl 
Add dH₂O 1l   
TBST, 1x 100 ml 10 x TBS 
0.05 % (v/v) Tween 20 
ad 1 l dH2O 
Transfer buffer, 10x 5,8 g Tris 
2.9 g Glycine 
200 ml Methanol 
3.7 ml 10% (w/v) SDS 
Ad 1 l H2O 
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Tris/HCl, 1,0 M, pH 6.8 121.14 g Tris/HCl 
ad 1 l dH2O 
Tris/HCl, 1,0 M, pH 8.8 181.71 g Tris/HCl 
ad 1 l dH2O 
Urea buffer 25 ml 10% SDS 
10 ml 1 M Tris pH 6.8 
100 μl 0.5 M EDTA pH 8 
750 μl β-mercaptoethanol 
24 g Urea 
Washing buffer for protein isolation 0,3 M Guanidin HCl 
dissolve in 95% Ethanol 
Table 11 Solutions and buffers 
 
6.3.7 Technical equipment 
Device designation Supplier 
Axiovert 40 CFL Zeiss, Göttingen, Germany 
CFX Connect Realt-Time System BioRad, München, Germany 
Consort E835 Electrophoresis Power 
Supply 
Sigma-Aldrich, Taufkirchen, Germany 
Embedder EM TP Leica, Wetzlar, Germany 
GenoPunch Fine Science Tools, Heidelberg, 
Germany 
HeatSealer RS 232 4titude, Berlin, Germany 
Hera Cell 150 incubator Heraeus, Hanau, Germany 
Hera Safe steril working bench Heraeus, Hanau, Germany 
Embedding station EM TP Leica, Wetzlar, Germany 
Inolab pH-Meter WTW GmbH, Weilheim, Germany 
Julabo SW20 waterbath JulaboLabortechnik GmbH,  Seelbach, 
Germany 
Kern PJL 2100-2M Analysenwaage Kern & Sohn GmbH, Balingen- 
Fommern, Germany 
LAS 3000 intelligent Dark Box Fujifilm, Duesseldorf, Germany 
Memmert water bath Memmert GmbH, Schwabach, Germany 
Mettler AE 163 special accurancy scales Mettler Toledo, Gießen, Germany 
Microm HM 500 OM Kryostat Microm International, Walldorf, Germany 
Microscop Axio Imager Z1 Zeiss, Goettingen, Germany 
MilliQ Plus PF Ultrapure water system Millipore Corporation, Billerice, USA 
Model 45-101-I Class II Electrophoresis 
System 
PeqLab Biotechnology GmbH, Erlangen, 
Gemrany 
NanoDrop-1000 Spectrophotometer PeqLab Biotechnology GmbH, Erlangen, 
Gemrany 
Pipetman Pipettes Gilson, Middleton, USA 
Research pipettes Eppendorf, Hamburg, Germany 
Semi-Dry electrophoretic transfer cell PeqLab Biotechnology GmbH, Erlangen, 
Gemrany 
Sonorex RK 102 BANDELIN electronic GmbH& Co. KG, 
Berlin, Germany 
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Sunrise-Basic ELISA Reader Tecam Austria GmbH, Karlsruhe, 
Germany 
SuperCut 2050 Cambridge Instruments, Nußloch, 
Germany 
Systec V75 Autoclave Systec GmbH, Wettenburg, Germany 
T100TMThermal Cycler Biorad, Munich, Germany 
Thermomixer comfort Eppendorf, Hamburg, Germany 
TonoLab Tonometer Icare Finnland, Helsinki, Finnland 
UV light screen Bachhofer Laboratoriumsgeräte, 
Reutlingen, Germany 
Ultracut E-Ultramicrotom Reichert-Jung, Kirchseeon, Germany 
Ultra Thurax Biolabproducts, Bebensee, Germany 
Vortex Genie 2 Scientific Industries Inc., New York, USA 
Centrifuges 5415D, 5415R, 5804R, 
5810R 
Eppendorf, Hamburg, Germany 
  
Table 12 Technical equipment 
 
6.3.8 Consumable supplies 
Description Supplier 
3 MM Blotting (“Whatman”)-Paper Neolab, Heidelberg, Germany 
Biosphere Filter Tips Sarstedt, Nürnbrecht, Germany 
CellScraper Sarstedt, Nürnbrecht, Germany 
Centrifuge 5415D, 5415R, 5804R, 
5810R 
Eppendorf, Hamburg, Germany 
Culture Slides BD Falcon, Bedford, USA 
Cover slips, 24 x 60 mm Menzel-Gläser, Braunschweig, Germany 
Dispomed Syringe, single use Dispomed Witt oHG, Gelnhausen, 
Germany 
Easy Flasks Nunclon ™Δ T25, T75 Nunc, Rosklide, Denmark 
Ecoflo Dissecting instruments Dispomed Witt oHG, Gelnhausen, 
Germany 
Falcon reaction tubes, 15 ml, 50 ml Sarstedt, Nürnbrecht, Germany 
Glasware Schott, Roth, VWR, Germany 
Green Nitrile Gloves Kimtech, Koblenz, Germany 
Hard-Shell®PCR plates 96-well, thin-wall BioRad, München, Germany 
Liquid Blocker PAP-Pen SCI Science Services, München, 
Germany 
Multidishes Nunclon ™Δ 6-well Nunc, Rosklide, Denmark 
Multi-Reaction tubes, 0,5 ml; 1.5 ml; 2 ml Roth, Karlsruhe, Germany 
Omnifix syringe, sterile B. Braun, Wertheim, Germany 
Optically Clear Heat Seal BioRad, München, Germany 
Parafilm Pechiney Plastic Packaging, Chicago, 
USA 
Pasteur pipettes Brand, Wertheim, Germany 
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PCRSoft Tubes, 0,2 ml Biozym, Hessisch Oldendorf, Germany 
Personna Razorblades American Safety Razor Company, 
Verona, USA 
Pipet tips Sarstedt, Nürnbrecht, Germany 
PCR Plates, 96 well 4titude, Berlin, Germany 
Petri dishes 94x16 mm PS Greiner bio-one, Kremsmünter, Austria 
Ro free blue gloves Ulma, Neu-Ulm, Germany 
Protein LoBind Tubes Eppendorf, Hamburg, Germany 
PVDF-Western Blot Membrane Roche, Mannheim, Germany 
Serological pipettes Sarstedt, Nürnbrecht, Germany 
Sterican injection cannula B. Braun, Wertheim, Germany 
SuperFrost®Plus object slides Menzel-Gläser, Braunschweig, Germany 
Table 13 Consumable supplies 
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6.4 Molecular biology 
6.4.1 DNA analysis 
6.4.1.1 Purification/Extraction of genomic DNA 
For genotyping, genomic DNA from an ear biopsy was isolated. Therefore, a 2 mm piece 
of the ear was punched by using the genopuncher (Fine Science Tools) under isoflurane 
(Ecuphar GmbH, Greifswald, Germany) anesthesia. The tissue samples were 
transferred in a 1.5 ml Eppendorf tube for digestion. 200 µl mouse tail lysis buffer 
(Chapter 6.3.6) and 2 µl Proteinkinase K were added for DNA isolation. Afterwards, the 
samples were incubated shaking overnight in 50°C and 750 rpm. The next day, 200 µl 
isopropanol were added in the tubes and mixed. For precipitation of the DNA the samples 
were incubated at 4°C for 5 min. After centrifugation for 5-10 min at 13000 rpm, the 
supernatant was discarded and 200 µl 70% Ethanol was added. The tubes were mixed 
and incubated at room temperature (RT) for 5 minutes to wash the pellet and dissolve 
any remaining salt in the tube. After centrifugation for 5-10 min at 13000 rpm, the ethanol 
was poured off and the tube again was centrifuged for 1 min 13000 rpm. The remaining 
ethanol was pipetted off and the pellet dried for 5 minutes. Finally, the DNA was dissolved 
in 50 µl of 5 mM Tris pH 8.0. After incubation for 5 min at RT the samples were 
centrifuged for 30 seconds to pellet the debris. The concentration was measured at the 
Nanodrop (Chapter 2.1.5) and to a concentration of 100ng/µl. 
6.4.1.2  Polymerase chain reaction (PCR) 
The PCR is a molecular method to amplify specific sequences of the DNA. Therefore, a 
sample of DNA with a target sequence, the template, and two primers, which are 
complementary to the target sequence and set the start point for DNA polymerase, are 
needed. The DNA polymerase is a heat stable enzyme which is able to synthesize new 
DNA strands by using deoxyribonucleotide triphosphates (dNTPs) as single units for the 
newly synthesized DNA and needs MgCl2 for its functionality. In general, PCR reactions 
consist of 20-50 cycles with 3 temperature steps. The first two steps are denaturation 
steps causing single strand DNA through melting and the annealing for the primer 
binding to the template. The last step is the elongation where the DNA polymerase 
synthesizes a new DNA strand by complementary base pairing of the dNTPs to the 
template. The duration and temperature of the single steps are dependent and variant 
on several parameters like length of primers or DNA polymerase. In addition to the 
samples that needed to be tested, every PCR analysis was carried out using a negative 
(containing H2O instead of DNA) and a positive (DNA from an animal that had already 
been screened positive before in the specific PCR) control. 
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6.4.1.2.1 Genotyping of leucin variant in RPE65 gene 
A point mutation at position 450 of the RPE 65 gene resulting in a base exchange from 
methionine to leucine defines the susceptibility of animals to light-induced photoreceptor 
degeneration (Wenzel et al., 2001).  As mice carrying the leucin mutation are more 
sensitive to light damage, it is important to genotype the experimental mice for the 
leucine variant of PRE 65. The following protocol and program were used: 
Reagent Volume in µl 
5x PCR buffer 10 
dNTPs 1 
MgCl2 (50 mM) 2,5 
Primer MWOI rev/fwd (1:10)  1 
Taq Polymerase 1 
H2O 32,5 
DNA  2 
Table 14 PCR reaction mix for RPE 65 PCR 
 
Gene Species Alignment Sequence 5’ to 3’ 
MWO I mus musculus forward CACTGTGGTCTCTGCTATCTTC 
 MWO I mus musculus reverse GGTGCAGTTCCACTTCAGTT 
 Table 15 Primer for RPE65 PCR 
 
Temperature Duration Cycles 
94°C 2 min  
94°C 30 s  
55°C 45 s 34 x 
72°C 1 min  
72°C 5 min  
10°C hold  
Table 16 Program for RPE 65 PCR 
 
12 µl of the 673 bp PCR product were digested with 8 µl H2O and 0.3 µl of the restriction 
enzyme MWO I at 37°C for 3 h. The leucine codon generates a restriction site for MWOI, 
which results after enzymatic digestion in two DNA products of 437 bp and 236 bp.  
 
 
Figure 55 PCR Product after digestion 
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6.4.1.2.2 Genotyping of Endothelin receptor type b 
The PCR strategy was designed to results in two products: one for the wildtype Etb 
situation (500 bp (WT)) and one for the floxed situation (199 bp (TG)). Due to of different 
annealing-temperatures of the specific primers that needed to be used, two different PCR 
protocols were used. Only mice carrying two floxed alleles (= 199bp positive PCR signal) 
for Endothelin receptor b (Etb) were used for experiments. 
 
ETB WT  ETB TG  
5x buffer 3.0 μl 5x buffer 3.0 μl 
dNTPs (10mM) 0.4 μl dNTPs (10mM) 0.4 μl 
MgCl2 (50mM) 0.5 μl MgCl2 (50mM) 0.5 μl 
WT forward primer 0.3 μl WT forward primer 0.3 μl 
WT reverse primer 0.3 μl Neo reverse primer 0.3 μl 
Taq polymerase 0.5 μl Taq polymerase 0.5 μl 
H2O 8.0 μl H2O 8.0 μl 
DNA 2.0 μl  2.0 μl 
Table 17 PCR reaction mix for Etb PCR 
 
Temperature Duration Cycles 
95°C 3 min  
94°C 45 s  
56°C (WT) 
62°C (TG) 
45 s 36 x 
72°C 1 min 10 sec  
72°C 5 min  
10°C hold  
Table 18 Program for Etb PCR 
 
 
  
Figure 56 PCR Product of Etb-
PCR. WT=Etb, TG=floxed Etb 
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6.4.1.2.3 Genotyping of Cre recombinase 
Only mice carrying the Cre recombinase (PCR-Product with 270 bp) will exhibit an Etb 
deletion after Cre mediated recombination. Therefore, all experimental mice were 
genotyped for Cre recombinase. Floxed Etb mice without Cre recombinase were used 
as controls. 
 
Cre  
5x buffer 3.0 μl 
dNTPs (10mM) 0.3 μl 
MgCl2 (50mM) 0.5 μl 
WT forward 
primer 
0.3 μl 
WT reverse 
primer 
0.3 μl 
Taq Polymerase 0.4 μl 
H2O 8.2 μl 
DNA 2.0 μl 
 
 
Figure 57 PCR-product for Cre-PCR 
  
Temperature Duration Cycles 
95°C 3 min  
94°C 30 s  
61°C  30 s 35 x 
72°C 35 sec  
72°C 5 min  
10°C hold  
Table 19 PCR reaction mix for Cre PCR (left) and program for PCR (right). 
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6.4.1.2.4 Genotyping of Rd1 (retinal degeneration 1) recombinase 
The mutation Retinal degeneration 1 (Rd1) leads to a degeneration of photoreceptors. 
As we focus on photoreceptors in the current thesis, it was of high interest to genotype 
all experimental mice for Rd1 mutation. The Rd1 PCR product results in two products of 
240 bp (WT) and 560 bp (TG). Mice only positive for 240bp (WT) were used for 
experiments. 
Rd1 WT  Rd1 TG  
5x buffer 5 μl 5x buffer 5.0 μl 
dNTPs (10mM) 0.5 μl dNTPs (10mM) 0.5 μl 
MgCl2 (50mM) 0.5 μl MgCl2 (50mM) 0.75 μl 
Rd1 common fwd 0.5 μl Rd1 common fwd 0.65 μl 
WT reverse 0.5 μl TG reverse 0.65 μl 
Mango Taq 
polymerase 
1.0 μl Mango Taq 
polymerase 
0.65 μl 
H2O 16.0 μl H2O 15.8 μl 
DNA 1.0 μl DNA 1.0 μl 
 
 
 
 
Figure 58 PCR-Product for Rd1-PCR. (1)  
negative control (2) +/- for Rd1 (3) -/- for Rd1 
 
Table 20 PCR reaction mix for Rd1 PCR 
Temperature Duration Cycles 
94°C 2 min  
94°C 30 s  
58°C  40 s 34 x 
72°C 45 sec  
72°C 5 min  
10°C hold  
Table 21: Program for Rd1 PCR 
1 2 3 
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6.4.1.2.5 Agarose gel electrophoresis 
The amplified PCR products were visualized and analysed by gel electrophoresis using 
2% agarose gels. For their preparation, 2g agarose in 100 ml TBE buffer was boiled and 
after short cooling mixed with 3 µl ethidium bromide. Ethidium bromide intercalates with 
the double stranded DNA and can be visualized by its fluorescence under UV light. 
during electrophoresis, the DNA fragments are separated according to their molecular 
size in the agarose gel. Therefore, 10 µl of the PCR products were loaded to the gel. To 
allow for a precise determination of the PCR product size, 2.5 µl of a DNA standard 
(Gene Ruler 100 bp Plus DNA Ladder) with defined molecular size was loaded on the 
very left position of each gel. Electrophoresis was performed at 130 V for 30 minutes and 
the PCR products were then visualized by using UV light with a wave length of 302 nm. 
 
6.4.2 RNA analysis 
6.4.2.1 RNA Isolation 
The prepared tissues or scraped cells were transferred in 2.0 ml tubes on ice and treated 
with 500 µl TriFastTM, a monophasic solution including phenol and guanidinium 
thiocyanate which inactivates RNAses and stabilizes the RNA. The samples were 
homogenized and RNA was isolated performing the following protocol:  
• Add 200 µl chloroform per ml TriFast, vortex 
• Incubate 10 min at RT 
• Centrifuge 20 min 14000 rpm, 4 °C 
• Transfer upper transparent aqueous phase to new 1.5 ml tube 
(store other phases for protein isolation at -20 °C, Chapter 6.4.3.1)   
• Add 500 μl isopropanol per ml TriFast, vortex 
• Freeze overnight at -20 °C 
• Centrifuge at 14000 rpm, 4 °C, remove supernatant   
• Wash pellet in 1 ml 70% ethanol per ml TriFast, vortex 
• Incubate 10 min on ice                                                                  
• Centrifuge at 14000 rpm, 4 °C, remove supernatant 
• Solve pellet in 14 µl RNase-free water 
• Store at -80 °C 
 
repeat 
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6.4.2.2 Quantification of RNA 
The concentration of the RNA was determined by using the NanoDrop 
spectrophotometer (Chapter 6.3.7). Thereby, the optical density at λ = 260 nm (OD260), 
the absorption maximum of nucleic acids (DNA, RNA), and at λ = 280 nm (OD280), the 
absorption maximum of proteins, was used in comparison to the solvent (H2O). The 
concentration was calculated with following formula: 
 
Concentration [µg/ml] = OD260 × 40 µg/ml 
 
The ratio of OD260 and OD280 gives information about the purity of the RNA. The optimum 
of peqGOLD TriFastTM isolated RNA should be > 1.7 A260/280-ratio. 
 
6.4.2.3 Synthesis of complementary DNA (cDNA) 
cDNA can be synthesized from messenger RNA (mRNA) templates by reverse 
transcriptase, an RNA-dependent DNA polymerase, which operates on the single strand 
of mRNA and generates its complementary DNA. First-strand cDNA synthesis was 
performed by using the qScriptTM cDNA Synthesis Kit (Quanta Bioscience, Gaithersburg, 
USA) according to manufacturer’s instructions. RNA that was not reversely transcribed 
served as negative control (-RT). The following protocol was used for cDNA synthesis:  
 Volume in µl  
Reagent + RT - RT 
iScript reverse transcriptase 1 - 
5x script 4 4 
1 µg RNA in H2O 15 16 
Table 22 PCR reaction mix for cDNA synthesis 
 
Temperature Duration 
22°C 5 min 
42°C 30 min 
85°C 5 min 
4°C hold 
Table 23 PCR protocol for cDNA synthesis 
The synthesized cDNA samples were used for RT-PCR and stored at -20°C. 
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6.4.2.4 Quantitative real-time RT-PCR 
Quantitative real-time RT-PCR analyses were performed with the reversed transcribed 
samples (+RT), each analysed as triplets, using the Bio-Rad CFX Connect™ Real-Time 
PCR Detection System. A H2O control and RNA that was not reverse transcribed (–RT) 
served as negative controls for real-time RT-PCR. The PCR products can be detected 
using SYBR-Green I, which intercalates within the double stranded cDNA. For relative 
quantification the geometric mean values of the housekeeping genes ribosomal protein 
L32 (RPL32), glyceraldehyde 3-phosphate dehydrogenase (Gapdh) and guanine 
nucleotide-binding protein subunit beta-2-like (Gnb2l) or ubiqutitin c (Ubc) were used. 
Quantitative real-time RT-PCR was performed with the following protocol: 
 
Reagent Housekeeper Neuroprotective 
factors 
10x Puffer ROX 7,50 μl 7.50 μl 
Primer fw stock 0,06 μl 0.06 μl 
Primer rv stock 0,06 μl 0.06 μl 
H2O 4,38 μl 1.38 μl 
cDNA 3 μl 6 μl 
Σ 15 μl 15 μl 
Table 24 Solution mix for real-time RT-PCR 
Step Temperature Duration Cycle 
Denaturation 94°C 20 sec  
Annealing 60°C 10 sec 50x 
Extension 60°C 20 sec  
Table 25 Real-time RT-PCR program 
 
Afterwards, the 96-well plate was heat sealed and the samples were centrifuged. Then, 
the plate was placed in the Real-time RT-Detection System and the program was run as 
described in Table 25. Using CFX ManagerTM Software and Excel software the relative 
expression of mRNA levels could be calculated according to the ∆∆CT-method (Livak, 
Schmittgen, 2001). 
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6.4.3 Protein analysis 
6.4.3.1 Protein isolation with peqGold TriFastTM 
The harvested retinae or scraped cells were prepared for RNA analysis and protein were 
isolated from the lower phase that emerges during the TriFast isolation process (after 
adding chloroform). The following steps were performed for protein isolation: 
 
• Add 300 µl 100 % ethanol per ml TriFast, vortex 
• Incubate 3 min at RT 
• Centrifuge 5 min at 2000 rpm, 4 °C 
• Remove pellet 
• Add 1500 µl isopropanol per ml TriFast, vortex 
• Incubate 10 min at RT 
• Centrifuge 10 min at 12000 rpm, 4 °C 
• Remove supernatant 
• Wash pellet 20 min with 2000 µl TriFast washbuffer at RT 
• Centrifuge 5 min at 7600 rpm, 4°C 
• Remove supernatant 
• Add 2000 µl 90 % ethanol per ml TriFast, vortex 
• Incubate 20 min at RT 
• Centrifuge 5 min at 7600 rpm, 4°C 
• Dry pellet 
• Solve pellet in 200 µl urea buffer with 0.1 % protease inhibitor and 0.1 % 
phosphatase inhibitor 
• Incubate 5 min in thermomixer at 1000 rpm, 95 °C 
• Centrifuge 5 min at 12000 rpm, 4 °C 
• Remove pellet 
• Store at – 20 °C (short term)/ – 80 °C (long term)  
 
6.4.3.2 Protein isolation with EDTA-Buffer 
EDTA Buffer is particularly used for the isolation of membrane bound proteins, like 
Endothelin receptor b (Etb). As it contains the non-ionic detergent Tergitol, it is able to 
detach Etb out of the cell membrane without its denaturation. For protein isolation, 200 
μl EDTA-buffer were used for each retina or each 6-well containing confluent cells. The 
retinae were homogenized, the cells were superseded with the use of cell scrapers and 
repeat 3x 
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transferred to a new reaction tube. The samples were incubated on a shaker at 4°C for 
1 h, then centrifuged at 13.000 rpm for 15 min. The supernatant contains the proteins. 
 
6.4.3.3 SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
The fractionation of proteins from retinal and cellular lysates for western blot analysis 
was performed on SDS-polyacrylamide gels using electrophoresis system of PeqLab 
Biotechnology GmbH. The concentration of the gels depends on the molecular weight of 
the analysed protein. In this work the resolving gel was prepared with a concentration of 
10 % (Table 26) and casted between two glass plates with two plastic spacers fixed in 
the casting frame. The liquid resolving gel was covered with isopropanol to sustain a 
clearly defined border to the stacking gel. After polymerization, the isopropanol was 
removed completely and the stacking gel (Table 26) placed on top. A comb was placed 
within the stacking gel to gain 10 chambers for loading the samples. The stacking gel is 
needed to concentrate the protein samples. In contrast, in the resolving gel the proteins 
are separated according to their molecular weight.  
 
Reagent Stacking gel Resolving gel (10%) 
dH2O 0.68 ml 1.9 ml 
Rotiphorese® Gel 30 0.17 ml 1.7 ml 
Tris-HCl, 1M, pH 6.8 0.13 ml - 
Tris-HCl, 1.5M, pH 8.8 - 1.3 ml 
10% SDS 0.01 ml 0.05 ml 
10% APS 0.01 ml 0.05 ml 
TEMED 0.001 ml 0.004 ml 
Table 26 Protocol for stacking and resolving gel 
After polymerization the gels were placed in an electrophoresis chamber according to 
the manufacturer’s instructions and filled with 1x electrode buffer (Chapter 6.3.6). The 
combs were removed, and the protein samples were pipetted in the pockets of the 
stacking gel. Additionally, 5 µl of the pre-stained protein ladder with defined molecular 
size was applied in the pocket on the left side. The separation of the proteins was 
performed at 20 mA per gel for about 60-80 minutes.  
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6.4.3.4 Semi-dry blotting 
The separated proteins were transferred from the gel to a PVDF-membrane (0.45 um 
pore size) using a semidry electroblot system. 6 Whatman paper and a PVDF membrane 
were cut to a size of 7 x 9 cm. The membrane was activated in methanol for about 30 
seconds and equilibrated in 1x transfer buffer. The Whatman paper were also incubated 
in 1x transfer buffer. The blotting was performed for 45 min at 14 V and 180 mA (per gel) 
and assembled as seen in Table 27. Thereby it is important to remove the sacking gel 
and to avoid bubbles between PVDF membrane and resolving gel. 
 
 
 
 
 
 
Table 27 Assembly scheme of semi-dry blot 
  
Cathode (-)  
3 whatman paper 
Resolving gel 
PVDF membrane 
3 whatman paper 
Anode (+) 
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2.2.3.4 Immunodetection of specific protein bands 
After semidry-blotting, the PVDF membrane was incubated at room temperature in 
blocking solution under permanent shaking for 1 h to block unspecific protein-binding 
sites. The blocking solution is listed in (Table 28). After blocking, the PVDF membrane 
was washed 3x 5 min in TBS-T and incubated with the primary antibody overnight at 4 
°C (unless otherwise stated in Table 28). The next day, the membrane was again washed 
three times with TBS-T for 5 min and then incubated at room temperature with the 
secondary antibody for 1 h.. All antibodies and corresponding blocking solution used in 
this thesis are shown in Table 28. After adding HRP substrate for HRP-coupled 
secondary antibodies or CDP-Star for AP-coupled secondary antibodies, the resulting 
chemiluminescence was detectable using the LAS 3000 Intelligent Dark Box (Fujifilm). 
The final evaluation of the target proteins relative to the housekeeper protein Gapdh was 
performed with Aida Image Data Analyzer v.4.06 software (Raytest) and Excel software. 
 
Protein Blocking solution Primary antibody Secondary antibody 
Etb 
 
5 % non-fat dry 
milk 
Rabbit-anti ETB 1:750 
in 0,5% Blotto/TBST, 
4°C, 2 nights 
(Alomone Labs) 
anti-rabbit HRP 
conjugated 1:5000 
in 0.5 % MM/TBST, 
4°C, overnight 
(Cell Signaling 
Technology) 
Akt 
 
5 % non-fat dry 
milk 
rabbit-anti AKT 1:1000 
in 0,5%Blotto/TBST, 
4°C, overnight 
(Cell Signaling 
Technology) 
anti-rabbit AP 
conjugated 1:5000 
in 0.5 % BSA/TBST, 
RT, 1h 
(Cell Signaling 
Technology) 
Hif1α 
 
5 % non-fat dry 
milk 
Rabbit-anti HIF1α 
1:200 in 
0,5%MM/TBST, 4°C, 2 
nights 
(Cayman Chemical) 
anti-rabbit HRP 
conjugated 1:5000 
in 0.5 % BSA/TBST, 
RT, 1h 
(Cell Signaling 
Technology) 
pAkt 
 
2%BSA rabbit-anti pAKT, 
1:2000 in 
0,2%BSA/TBST,4°C, 
overnight 
(Cell Signaling 
Technology) 
anti-rabbit HRP 
conjugated 1:5000 
in 0.5 % BSA/TBST, 
RT, 1h 
(Cell Signaling 
Technology) 
Gapdh 
1:1000, 
HRP-
linked 
 
Corresponding 
blocking buffer 
rabbit-anti GAPDH 
1:5000 in blocking 
buffer, 1h RT or 
overnight 4°C 
(Cell Signaling 
Technology) 
 
Table 28 Antibodies used for western blot analyses with blocking solution and secondary antibody 
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6.4.4 Proteomic analysis (Proteomics) 
In cooperation with Dr. Stefanie Hauck (Helmholtz Zentrum, Munich, Germany), we 
performed proteomics of 61WΔEtb cells and 661W control cells (James et al., 1997). The 
statistical analyses and WGCNA network analyses were performed in cooperation with 
Dr. Andreas Neueder (University Ulm, Germany).  
First, 100.000 cells were seeded in 6-well plates until reaching confluency. For cell lysis, 
medium was withdrawn by suction and the cells were washed three times with 1xPBS. 
500 µl EDTA-Buffer was added on each 6-well and incubated for 10 min on ice. Then 
the cells were scraped from the bottom of the plate and transferred to Eppendorf Protein 
LoBind Tubes and homogenized. Protein-lysates with a concentration of 10 µg were 
used for further proteasome analysis. Therefore, the data-independent acquisition (DIA) 
method, high resolution mass spectroscopy (Lepper et al., 2018) was performed by Dr. 
Stefanie Hauck (Helmholtz Zentrum, Munich, Germany). For describing correlation 
patterns among the analysed proteins, weighted correlation network analysis (WGCNA) 
was performed in cooperation with Dr. Andreas Neueder (Neurology, University Ulm). 
6.5 Histology 
6.5.1 Morphometric analysis of semi-thin sections 
For the analysis of the retinal morphology, semi-thin sections were performed and 
analysed via light microscopy. For a morphometric quantification spider diagrams were 
performed. 
 
6.5.1.1 Embedding and preparing of semi-thin sections 
For morphological and morphometric analysis, the dissected eyes were incubated in EM-
fixative (Chapter 6.3.6) for 24 h at 4 °C. The next day, the eyes were washed three times 
for 20 min with 0,1 M cacodylat-buffer (Chapter 6.3.6) and afterwards dehydrated 
through an ascending alcohol series (70 %, 80 %, 90 %, 100 %). Finally, the eyes were 
embedded in epon (Ethanol/Aceton 1:1, Aceton 100 %, Epon/Aceton 1:2, Epon/Aceton 
2:1, Epon 100 %) and hardened for 24 h at 60 °C and for 48 h at 90 °C. Semithin sections 
of 1.0 µm thickness were cut along the mid-horizontal (nasal-temporal) plane and stained 
by Richardson’s stain (RICHARDSON et al., 1960) and analysed via light microscopy. 
 
6.5.1.2 Spider diagrams 
For morphometric analysis, the thickness of the inner and outer nuclear layer was 
measured. Therefore, the length of both hemispheres of the sections was measured via 
Image J then the total length of each hemisphere divided through 10 to define the 
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distance between the individual measure points. Finally, the thickness of the outer 
nuclear layer was measured at the defined measure points. The means of the measure 
points were blotted in a spider diagram beginning at the OS of the temporal side across 
the ONH to the OS at the nasal side and statistical analysis was performed to compare 
single measure points between control and conditional knockout mice. 
 
6.5.2 Embedding and preparing of frozen sections  
Dissected eyes were fixed for 4 h in Methyl Carnoy (10 % glacial acetic acid, 60 % 
methanol, 30 % chloroform). Therefore, the eyes were transferred to 50 % and 25 % 
methanol for 20 min each and washed 2 times in 0.1 M Php. Afterwards the eyes were 
incubated in 10 %, 20 %, 30 % sucrose/PBS each at least 4 h at 4 °C. The eyes were 
shock frozen in Tissue TEK mounting medium and 12 µm sagittal sections were cut using 
a cryostat.  
Dissected eyes were fixed in 4%PFA for 4 h. Afterwards, the eyes were washed twice in 
0.1 M Php and then incubated in 10 %, 20 %, 30 % sucrose/PBS each at least 4 h at 4 
°C. The eyes were shock frozen in Tissue TEK and 12 µm sagittal sections were cut by 
using a cryostat. The sections were placed on glass slides and either immediately used 
for further staining or stored at -20 °C. 
 
6.5.3  Embedding and preparing of paraffin sections 
Eyes were fixed in 4 % PFA for 4 h and washed twice in 0.1 M Php. Afterwards, the eyes 
were transferred to 50 % and 70 % isopropanol each for 1 h and finally embedded in 
paraffin. Using a Supercut-microtome, 6 µm thin paraffin slices were cut and transferred 
onto glass slides. For further staining the paraffin sections were deparaffinized in the 
following steps: 
• 2 x 10 min xylol 
• 2x 10 min 100 % isopropanol 
• 2x 10 min 96 % isopropanol 
• 2x 10 min 80 % isopropanol 
• 10 min 70 % isopropanol 
• Aqua dest.   
6.5.4  Immunohistochemistry  
 
  
Material and methods page | 119 
6.5.5 Antibodies for immunochemistry 
Primary 
antiboy 
Fixation Pretreatment Blocking Secondary antibody 
Collagen 
IV 1:50, 
overnight 
4°C 
Methyl 
Carnoy 
(Kryo) 
none 2%BSA/0.1 M Php, 1 
h RT 
goat anti-rabbit Cy™3 
IgG 1:2000 in 
0.5%BSA/0.03%Triton
/ 0.1 M Php, 48 h 4°C 
Eta 
1:100, 
overnight 
4°C 
4%PFA 
(Kryo) 
none 5 % non-fat dry 
milk/0.1 M Php 
overnight 4°C 
Goat anti-chicken IgG 
Alexa 546 highly 
cross adsorbed, 1h 
RT 
Gfap 
1:2000, 
overnight 
4°C 
4%PFA 
(Kryo) 
none 2 % BSA/0.2 % 
CWFG/0.1%Triton/0.
1 M Php, 1 h RT 
Goat anti-chicken IgG 
Alexa 488 highly 
cross adsorbed, 1h 
RT 
Gs 1:100, 
(overnigh
t 4°C 
4%PFA 
(Paraffin) 
0.5% Triton, 
30 min RT 
2 % BSA/0.2 % 
CWFG/0.1%Triton/0.
1 M Php, 1 h RT 
Donkey anti-goat IgG 
Alexa 488 1:1000 
highly cross adsorbed 
1h RT 
Iba-1 
1:1000, 
overnight 
4°C 
Flatmounts, 
4%PFA 
(Paraffin) 
1 h 0.05 M 
NH4Cl 
1 h 
0.5%Triton/0.
1M Php 
2 % BSA/0.2 % 
CWFG/0.1%Triton/0.
1 M Php, 1 h RT 
goat anti-rabbit Cy™3 
IgG 1:2000 in 0.2% 
BSA, 0.02% CWFG, 
0.01% Triton, 0.1M 
Php 
Ng-2 
1:100, 48 
h 4°C 
FITC-
perfused 
flatmounts 
none 5%BSA/0.3%Triton/ 
0.1 M Php, 1 h RT 
goat anti-rabbit Cy™3 
IgG 1:2000 in 
0.5%BSA/0.03%Triton
/ 0.1 M Php, 48 h 4°C 
Pv-1 
1:25, 
overnight 
4°C 
Methyl 
Carnoy 
(Kryo) 
none 2 % BSA/0.2 % 
CWFG/0.1%Triton/0.
1 M Php, 1 h RT 
Biotinylated anti-rat 
IgG 1:500 1h RT, 
Streptavidin, Alexa 
Fluor® 555 conjugate 
Table 29 Antibodies used for immunohistochemistry blocking solution and secondary antibody 
 
6.5.6 Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) 
TUNEL is a method for detecting DNA fragmentation which is characteristic for 
apoptosis. The assay is based on the presence of nicks in the DNA that can be identified 
by terminal deoxynucleotidyl transferase. The terminal deoxynucleotidyl transferase 
detects dUTPs which are secondarily labeled with a fluorescence marker. Therefore, the 
Apoptosis Detection System (DeadEnd Fluometric TUNEL, Promega) was used to 
detect apoptotic cell death in retinae of animals 30 h after light damage. The TUNEL 
assay was performed on paraffin sections (4% PFA) with the following protocol and the 
sections were afterwards mounted with Mowiol containing Dapi. 
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Reagent Duration in minutes 
50% Isopropanol 5 
Aqua dest. 5 
0,89% NaCl 5 
1x PBS 5 (2x) 
4% PFA 15 
1xPBS 5 (2x) 
Proteinase K (1:500 in 0,1 M Php) 8 
1xPBS 5 (2x) 
4% PFA 5 
1xPBS 5 (2x) 
Equilibration Buffer (37°) 60 
2xSSC 15 
1xPBS 5 
Table 30 Protocol for TUNEL-assay 
 
6.5.7 In situ hybridization Base Scope® 
In situ hybridization (ISH) Base Scope® was performed to detect mRNA signals of Etb in 
sagittal sections of CD1 wildtype mice, EtbΔeye and EtbΔOC mice and corresponding 
controls and 661WΔEtb cells and 661W control cells. In situ hybridization (ISH) Base 
Scope® reagents and probes were provided by courtesy of Prof. Dr. Charlotte Wagner 
(University Regensburg, Germany). 
6.5.7.1 Fixation 
Mice were perfused (Chapter 6.1.6) with In situ hybridization Base Scope® Fixative 
(Chapter 6.3.6) and incubated with this buffer for 24 h at room temperature. The day 
before performing ISH Base Scope® cells were seeded (10000 cells/well) on glass 
platelets in a 6-well plate until reaching confluency of 70-80%. Afterwards the cells were 
fixed on the glass platelets in 4%PFA for 30 min at room temperature and washed three 
times with 1xPBS. 
6.5.7.2 Paraffin embedding of murine ocular tissue 
After fixation, the eyes were enucleated and embedded in paraffin according to the 
following protocol. All analytical reagents were used with the quality grade pro analysis 
(p.a.). 
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• 2 x 70% EtOH  
• 2 x 80% EtOH  
• 2 x 90% EtOH  
• 1 x 100% EtOH  
• 1x 100 % isopropanol 
• 1x 100 % isopropanol (45°C), 45 min 
• 1x 1:1 isopropanol/paraffin suspension (60°C), 45 min 
• 2x 24h paraffin (60°C) 
 
By using a Supercut-microtome, 6 µm thin paraffin slices were cut and transferred onto 
glass slides. 
 
6.5.7.3 Deparaffinization and preparation for In situ hybridization Base Scope® 
Before performing in situ hybridization Base Scope® by using the Base Scope® Detection 
Reagent Kit Red the slices were deparaffinized according to the manufacturers’ protocol: 
• Dry slices for 1 h at 60°C in the dry oven 
• 2x10 min Xylol, RT 
• 2x 2 min 100% EtOH, RT 
• Dry slices on air for 5 min, RT 
• Drop Base Scope® H2O2 on slides and incubate for 10 min, RT 
• 2x 15 sec RNAase free H20 
• 15 min Base Scope® Target Retrieval Reagent 
• 2x 15 sec RNAase free H20 
• 2x 100 % EtOH, RT 
• Dry slides overnight, RT 
• Draw barrier with hydrophobic barrier pen around each sagittal section 
 
Base Scope® Detection Reagent Kit Red 
• 30 min BaseScope® Protease III, 40°C in oven 
• 3-5x short washing steps with RNAase free H20 
• 2h BaseScope® Target probe (mM-ETB), 40°C 
• 2x 2 min washing step with BaseScope® washing buffer 
• Hybridize signal amplification molecule (AMP0) for 30 min, 40°C 
• 2x 2 min washing step with BaseScope® washing buffer 
• Hybridize signal amplification molecule (AMP1) for 15 min, 40°C 
30 min, shaking at 
room temperature  
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• 2x 2 min washing step with BaseScope® washing buffer 
• Hybridize signal amplification molecule (AMP2) for 30 min, 40°C 
• 2x 2 min washing step with BaseScope® washing buffer 
• Hybridize signal amplification molecule (AMP3) for 30 min, 40°C 
• 2x 2 min washing step with BaseScope® washing buffer 
• Hybridize signal amplification molecule (AMP4) for 15 min, 40°C 
• 2x 2 min washing step with BaseScope® washing buffer 
• Hybridize signal amplification molecule (AMP5) for 30 min, RT 
• 2x 2 min washing step with BaseScope® washing buffer 
• Hybridize signal amplification molecule (AMP6) for 15 min, RT 
• 2x 2 min washing step with BaseScope® washing buffer 
• Incubte with Reagent A and Reagent B solution (1:60) for 10 min to detect signal 
• 2x1 min Haematoxylin solution to stain nuclei 
• 3x short washing steps with RNAase free H20 until slides are clear 
• 1x 10 sec 0.02 % ammonium hydroxide-solution 
• 3-5x short washing steps with RNAase free H20 
• Dry slides for 15 min in the dry oven, 60°C 
• Mount slides  
 
We performed additional co-staining against Gs, Gfap and Collagen IV in the Cd1 
wildtype mice. Subsequently to the last washing step the regular staining protocols 
(Chapter 6.5.5) were performed.  
6.5.8  Microscopy 
The immunohistochemical stainings were analysed using the Axio Imager Z1-
mircoscope (Carl Zeiss, Goettingen, Germany) or the Laser Scanning microscope LSM 
510 Meta (Carl Zeiss, Goettingen, Germany). 
 
6.5.9  Statistical analysis  
Comparisons between the mean variables of two groups were made by a 
two-tailed Student's t-test (heteroscedastic, two-tailed) using Excel software and 
comparisons between the mean variables of more than two groups were made by One-
way ANOVA followed by Bonferroni post-hoc test using SPSS software. P values ≤ 0.05 
were considered to be statistically significant. All results are expressed as mean ± SEM. 
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